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ABSTRACT
Yeast Elongator was initially isolated based on its interaction 
with the hyper-phosphorylated form of RNA polymerase I I .  Later on, 
it was shown to possesfan intrinsic histone acetyl-transferase activity 
and to crosslink to nascent RNA in vivo. The six ELP genes were also 
identified, among other genes, in a genetic screen in Saccharomyces 
cerevisiae fo r targets of the toxin zymocin. KTI12, which stands for 
lactis toxin Insensitive 12", was one of those other genes. kti!2A  
mutant cells display phenotypes closely resembling those of elpA 
mutants. Moreover, Ktil2 protein was shown to co-immunoprecipitate 
with Elongator and with RNA polymerase I I ,  indicating a functional 
interaction with both factors.
The experiments presented in the firs t part of this thesis 
confirm genetically and biochemically that Elongator is a six-subunit 
complex. In  vitro and in vivo studies were performed to reveal the 
molecular architecture of this complex. Briefly, strong pair-wise 
interactions between Elpl and Elp3, Elp4 and Elp6 and between Elp5 
and Elp6 were uncovered. Additionally, a weak interaction between 
Elp3 and Elp4 was observed. In  vitro HAT assays and RNA 
immunoprecipitation experiments suggested that Elp2 is dispensable 
for the in vitro histone acetyl-transferase and the in vivo RNA binding 
activity of Elongator. In contrast, Elp3 was shown to be critical for 
both the integrity of the complex and its in vivo RNA binding activity. 
Moreover, the localisation of yeast Elp3 protein was studied, in an 
attempt to address the possibility that Elongator continuously 
shuttles from the cytoplasm to the nucleus.
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In the second part, biochemical and genetic studies strongly 
suggested that Ktil2 interacts with Elongator and might regulate its 
in vivo HAT activity. Finally, the molecular mechanism of action of the 
toxin zymocin was studied. In  particular, preliminary experiments, 
which test the possibility that the RNAPII gets degraded in response 
to zymocin treatment of 5. cerevisiae cells, are presented.
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CHAPTER 1
INTRODUCTION
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1.1 The RNA Polymerase I I  transcription cycle
1.1.1 Transcriptional activation
Expression of protein-coding genes in eukaryotic organisms is 
regulated in a highly orchestrated and elaborate fashion to ensure 
that specific genes are turned on and o ff in a temporally and spatially 
appropriate manner according to genetic blueprints, cell cycle 
requirements, environmental factors and, in metazoans, tissue- 
restrictive controls.
Over the last two decades, intensive efforts have succeeded in 
identifying the cellular components mediating the regulation of mRNA 
synthesis in eukaryotes. These polypeptides were initially isolated 
using biochemical purification strategies by tracking activities in 
reconstituted in vitro assays (Reese, 2003). Using such assays, core 
RNAPII was found to require additional biochemically defined factors, 
referred to as general transcription factors (GTFs), in order to 
perform promoter-specific transcription. Experiments performed in 
the early 1980s demonstrated that RNAPII and GTFs are sufficient 
to mediate basal transcription (Matsui et al., 1980). However, high 
levels of regulated transcriptional activity additionally required the 
action of sequence-specific activators that bind to cognate DNA 
elements. Conversely, transcription can be inhibited by gene-selective 
transcriptional repressors, which when bound to repressive DNA 
elements prevent the transcriptional machinery from transcribing a 
gene (Wolffe et al., 1997).
Very early on, it was shown that transcriptional activators 
posses modular domains that mediate binding to DNA and 
transactivation functions, respectively (Mitchell and Tjian, 1989). The
activation domains were initially thought to directly recruit
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components of the transcription machinery to the promoters (Mitchell 
and Tjian, 1989). However, the identification of factors, which 
interact with and facilitate or mediate the action of sequence-specific 
regulators, led to critical re-evaluation of the early models. These 
factors were named co-activators (Berger et al., 1990; Chen and 
Evans, 1995; Dynlacht et al., 1991; Kelleher et al., 1990; Kim et al., 
1994b; Meisterernst and Roeder, 1991; Pugh and Tjian, 1990). The 
recent finding that many of the co-activators harbor chromatin 
directed activities, such as histone modifier complexes and chromatin 
remodeling complexes, added another level of complexity. Now it is 
well established that transcriptional co-activators can be classified 
into two categories: (i) co-activators that interact with or are 
themselves components of the RNA Polymerase I I  machinery, such as 
TFIID and Mediator and (ii) chromatin-directed co-activators, such 
chromatin remodeling complexes and histone modifiers, which prepare 
the nucleosomal environment for binding of other components of the 
transcription machinery (Naar et al., 2001). According to the current 
model there is a synergistic effect on transcriptional activation by 
multiple copies of the same activator or even different activators, 
which recruit different co-activator complexes on the same promoter. 
This allows gene-specific and often highly sensitive transcriptional 
responses to cellular signals and small changes in activator abundance 
(Naar et al., 2001).
A number of recent studies, utilizing the chromatin 
immunoprecipitation assay, have shed light on the order of events, 
which lead to transcriptional activation of a number of different 
genes (Cosma, 2002). According to results from work with model- 
genes, the activators can be classif ied into two categories: those that
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bind to nucleosomal templates and are able to perturb chromatin 
structure, such as Pho4, estrogen receptor and Swi5 (Cosma et al., 
1999; Reinke et al., 2001; Shang et al., 2000) and those, which bind to 
promoter regions only after nucleosomes have been conformationally 
changed, such as SBF and E2Fs (E2F1, E2F2, E2F3) (Cosma et al., 
1999; Rayman et al., 2002). The latter need chromatin-modifying 
activity to precede their binding.
Both activators and co-activators facilitate the recruitment 
and assembly of the components of the pre-initiation complex. The 
next steps in transcription initiation include open complex formation, 
promoter melting and finally formation of the firs t phosphodiester 
bond (initiation). Then, when the actual process of transcription has 
begun, polymerase needs to escape from the promoter and become 
engaged in processive mRNA production (promoter clearance, early 
elongation). A transcription elongation complex, composed of the 
elongating form of RNA Polymerase I I  and its co-factors (different 
from the ones that are needed for initiation), is now formed, and 
travels along the coding region of the gene (transcript elongation). As 
transcript elongation proceeds, the RNA matures by co- 
transcriptional capping, splicing, and poly-adenylation. Finally, 
transcription terminates and the mature RNA is ready to be 
transferred to the cytoplasm for translation. Factors required for 
RNA export are also believed to associate with RNAPII and the 
nascent transcript already during transcript elongation (Svejstrup, 
2004). Through all this, it  should be remembered that not only 
initiation, but also subsequent events occur in the context of 
chromatin.
Next, I  will f irs t describe the mechanism of transcription
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initiation and then the co-activators, which function prior to or during 
this process.
1.1.2 The mechanism of transcription initiation
The mechanism of transcription initiation can be subdivided in 
three steps: pre-initiation complex assembly, open complex formation 
and finally, promoter melting and initiation. In  vitro and in vivo data 
have suggested that there are two models for pre-initiation complex 
assembly: the stepwise and the holo-enzyme model (Svejstrup, 2004). 
The “stepwise" model is characterized by a distinct series of events:
1. Recognition o f core promoter by TF IIb  (TBP and associated 
factors)
TF IIb  is composed of TBP (TATA-binding protein) and at least 
14 tightly associated factors, the TBP associated factors (TAFIIs) 
(Albright and Tjian, 2000). Numerous studies have established that 
this multi-subunit complex is responsible for recognition of the TATA 
element, a process which involves DNA distortion (Kim et al., 1993a; 
Kim et al., 1993b; Tsai and Sigler, 2000). More recent structural 
evidence show that TBP is responsible for bending the TATA box 
DNA, creating a context for the binding of TFIIB, and a curvature in 
the DNA appropriate fo r wrapping around RNA Polymerase I I  
(Bushnell et al., 2004). The binding of TFIIb  on the TATA element is 
believed to act as a platform fo r the nucleation of the remaining 
factors of the pre-initiation complex. However, there are promoters, 
which lack a canonical TATA box. These can be recognized by TBP-like 
factors (TLFs), or other complexes, which include TAFIIs but do not 
contain TBP or TBP-like factors (Juo et al., 1996; Rabenstein et al.,
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1999; Wieczorek et al., 1998). Finally, it should be mentioned that it is 
now generally believed that, apart from TBP or TLFs, TAFIIs also play 
an important role for DNA sequence recognition (Burke and Kadonaga, 
1997; Wu et al., 2001).
2. Recognition o f TFIIb-promoter complex by TFIIB
The binding of TFIIB to the TFIID-promoter complex results 
in a more stable ternary complex. Early studies in yeast demonstrated 
that TFIIB interacts with RNA Polymerase I I  and that this 
interaction is crucial for specifying the start site of transcription (Li 
et al., 1994; Pinto et al., 1992). TFIIB contains two functional domains. 
The conserved C-terminus interacts with TBP (Buratowski et al.,
2002). Both human and yeast TFIIBc have been shown to bind 
upstream and downstream of the TATA box (Bushnell et al., 2004; 
Tsai and Sigler, 2000). The N-terminus binds to the RNA Polymerase 
I I /T F I IF  assembly and brings it into the pre-initiation complex 
(Bushnell et al., 2004; Pardee et al., 1998). Structural studies have 
recently suggested that interactions of TFIIB with both TBP and with 
RNAPII determine the location of the transcription start site 
(Bushnell et al., 2004). The C- and N-terminal domains of TFIIB are 
separated by a flexible linker, which is believed to act as a molecular 
switch, regulating changes in the conformation of TFIIB. This 
conformation change may a ffect start-site selection, promoter 
recognition and transcription activation (Fairley et al., 2002).
3. Recruitment o f a TFIIF/RNAPII complex
Once TFIID and TFIIB have assembled on the promoter, RNA 
Polymerase I I  can enter the pre-initiation complex. However,
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polymerase cannot stably associate with this GTFs sub-assembly and 
must be escorted to the promoter by TFIIF. TFIIF is composed of 
two subunits and was shown very early on to reduce the non-specif ic 
DNA affinity of RNAPII in vitro, thereby ensuring that polymerase 
only enters productive complexes at a TATA-box (Finkelstein et al., 
1992). This function of TFIIF was also suggested by more recent 
photo-cross-linking studies, where it was shown to locate both 
upstream and downstream of the transcription start site (Forget et 
al., 2004), all in all allowing the proposition that the recognition of the 
TFIID-TFIIA-TFIIB complex at the TATA box by an RNAPII-TFIIF 
complex might be an early ‘'checkpoint" for correct promoter complex 
assembly (Svejstrup, 2004). TFIIF has been shown to have other 
roles during the transcription cycle; stabilization of binding of RNA 
Polymerase I I  to TFIID and TFIIB at the promoter, facilitation of 
the entry of TFIIE and TFIIH (Buratowski et al., 1991; Flores et al., 
1992), contribution to open complex formation by the DNA helicase 
activity of TFIIH (Conaway and Conaway, 1993) and to synthesis of 
the firs t phosphodiester bond of nascent transcripts (Tirode et al.,
1999). Moreover, as will be discussed later, TFIIF may also play a role 
during transcript elongation. Finally, after transcription termination, 
TFIIF is thought to recruit and stimulate the activity of the TFIIF- 
associating CTD phosphatase (FCP1) for recycling of the hyper- 
phosphorylated form of RNA Polymerase I I  (IIO ) to the un- 
phosphorylated one (IIA ), before the next round of transcription 
initiation (Chambers et al., 1995; Friedl et al., 2003; Kamada et al., 
2003).
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4. Binding o f TFIIE and TFIIH
I t  is widely accepted that TFIIE and TFIIH  stabilize and 
activate PIC formation by binding to all the other general 
transcription factors as well as to RNA Polymerase I I ,  and at the 
same time open up the double stranded DNA (dsDNA) at the region 
from -9 to +2, relative to the transcription initiation site (+1), in a 
manner that is dependent on ATP hydrolysis (Douziech et al., 2000; 
Dvir et al., 1997; Holstege et al., 1996; Leuther et al., 1996; Robert et 
al., 1996; Yamamoto et al., 2001). A fte r promoter melting, 
transcriptional initiation occurs by the incorporation of nucleotide 
triphosphates into a nascent RNA chain. TFIIE and TFIIH  both 
appear to play important roles in the subsequent transition from 
initiation to elongation, a process known as promoter clearance 
(Goodrich and Tjian, 1994; Kumar et al., 1998; Yamamoto et al., 2001).
The function of TFIIE is closely related to that of TFIIH. In 
particular, TFIIE facilitates the recruitment of TFIIH to the PIC, 
and stimulates TFIIH-dependent ATP hydrolysis. The latter is 
necessary fo r  promoter melting and TFIIH-dependent 
phopshorylation of the RNAPII CTD, which is required for efficient 
promoter clearance (Ohkuma, 1997; Watanabe et al., 2000). Moreover, 
TFIIE has been proposed to be the direct target of certain gene- 
specific transcriptional activators (Sauer et al., 1995; Zhu and 
Kuziora, 1996). Such interactions are needed for TFIIE recruitment 
to the PIC.
TFIIH, on the other hand, is a nine-subunit complex (Svejstrup 
et al., 1994). TFIIH can be disrupted biochemically into a six-subunit 
core-TFIIH, which forms part of a larger assembly (or “repairosome") 
that functions in NER (nucleotide excision repair) (Svejstrup et al.,
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1995), and a three-subunit TFIIK complex, which has CTD kinase 
activity (Feaver et al., 1994; Svejstrup et al., 1994; Takagi et al.,
2003). The major contributions of TFIIH in RNAPII transcription is 
in A TP-dependent promoter melting (Douziech et al., 2000) and the 
regulation of the transition from initiation to elongation by 
phosphorylating the C-terminal repeat domain (CTD) of Rpbl, the 
largest RNAPII subunit. Kin28/CDK7 is the kinase responsible for this 
phosphorylation (Feaver et al., 1994). Consistent with this scenario, 
recent ChIP experiments show a dependence of CTD Ser5 
phosphorylation on the presence of active TFIIH (Komarnitsky et al.,
2000). Moreover, TFIIH was shown to promote the transition of very 
early elongation complexes to stable elongation complexes in vitro 
(Dvir et al., 1997). Thus, TFIIH is believed to perform multiple roles, 
affecting steps before, during and immediately after initiation of 
transcription. TFIIH may also affect transcript elongation.
5. Recruitment o f TFIIA
TFIIA can be recruited at any stage after the binding of 
TFIID and stabilizes the initiation complex. The precise role of 
TFIIA  in transcription initiation has been the subject of much 
controversy, because the requirement for TFIIA in reconstituted 
transcription varies from system to system. Early in vitro studies 
indicated that TF IIA  was largely dispensable fo r activator- 
independent transcription (DeJong et al., 1995; Hansen and Tjian, 
1995). However, more recent studies shed light on the essential role 
for TFIIA in transcription activation of many genes. TFIIA binds TBP 
opposite to the side where TBP dimerizes, and interacts with TFIIB 
(Coleman et al., 1999; Liu et al., 1999). Binding of TFIIA  to auto­
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repressed TBP dimers induces their dissociation and accelerates the 
kinetics of TBP-DNA binding (Coleman et al., 1999). The association of 
TFIIA with TBP/TFIID is inefficient and enhanced by transcriptional 
activators (Xing et al., 2001).
The holo-enzyme model
According to the model so far described for pre-initiation 
complex assembly, the GTFs exist separately in solution and come 
together only upon association with promoter DNA. However, some 
studies have reported that a subset of GTFs exist in a pre-assembled 
form, in an RNA Polymerase I I  “holo-enzyme", which has been 
proposed to bind to promoters in a single step. Ten years ago, two 
“holo-enzyme" complexes were purified from yeast and named SRB and 
Mediator complex (Kim et al., 1994a; Koleske and Young, 1994; 
Thompson et al., 1993; Wilson et al., 1996). I t  soon became apparent 
that they were the same complex, except that the holo-enzymes 
isolated by Young and co-workers also contained general transcription 
factors, while the Kornberg holo-enzyme did not. Since then, studies 
from both Young and Reinberg groups suggested the presence of holo- 
enzymes in mammalian cells as well. These enzymes contained RNAPII, 
a subset of GTFs and homologues of yeast Srb proteins (Chao et al., 
1996; Maldonado et al., 1996).
However, more recently, the use of chromatin 
immunoprecipitation assays has shed more light on the process of 
transcription initiation. A number of genes in different organisms have 
been used as models to dissect the mechanism which underlies the 
activation of transcription (Cosma, 2002). Based on these more recent 
data, all the proteins are recruited to genes promoters in a stepwise,
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ordered manner. There are several examples where RNAPII is 
recruited independently of GTFs (Agalioti et al., 2000), and even ones 
where RNAPII is recruited after the Mediator complex (Cosma et al., 
1999), strongly supporting the “stepwise" model of transcription 
activation. In further support of this model, recent evidence from 
both in vitro and in vivo studies has also suggested that GTFs such as 
TFIID, TFIIA and TFIIB, as well as the Mediator complex, stay 
behind at the promoter when RNAPII engages in transcript 
elongation, allowing rapid entry of new polymerases for re-initiation of 
transcription at the gene (Yudkovsky et al., 2000). This finding is not 
consistent with the idea that pre-assembled holo-polymerase 
complexes play an important role for transcription.
1.1.3 The role of co-activators in transcription initiation
Mediator complex
The firs t indications of a common target for transcriptional 
activators came from the observation that one activator protein could 
interfere with the effects of another in an in vitro transcription 
system (Gill and Ptashne, 1988). This finding inspired the experiments 
that led to the discovery of co-activators and eventually to 
identif ication of a yeast Mediator complex which was able to reverse 
the interference and respond to activators in a pure in vitro 
transcription system (Flanagan et al., 1991; Kelleher et al., 1990; Kim 
et al., 1994b). Subsequently, yeast Mediator was purified both as a 
complex with RNAPII and as a discrete entity comprising 20 subunits, 
which was functionally defined by three activities: (1) stimulation of 
basal transcription in a highly purified system, (2) response to
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transcriptional activators in vitro and in vivo and (3) stimulation of 
TFIIH-mediated phosphorylation of RNA Polymerase I I  (Kim et al., 
1994b; Myers et al., 1998). To date, a number of mammalian 
complexes, which are thought to be the counterparts of yeast 
Mediator, have also been purified based on their ability to support the 
function of activators (Lemon and Tjian, 2000; Malik and Roeder, 
2000).
The general requirement fo r individual Mediator subunits in 
global gene regulation differs from subunit to subunit. Some Mediator 
components are needed fo r the regulated expression of nearly all 
genes, whereas others are only required at a certain subset of genes 
(Holstege et al., 1998). Various biochemical experiments have 
suggested the existence of distinct sub-complexes of yeast Mediator. 
One of the more comprehensive approaches used urea to 
differentially dissociate yeast Mediator and to investigate the 
content of the distinct sub-complexes (Kang et al., 2001). These 
experiments identified two functionally distinct modules, called the 
Srb4 and the Rgrl module, respectively. The Srb4 module interacts 
with the RNAPII CTD and other members of the general transcription 
machinery, such as TBP and TFIIB. The Rgrl module comprises 
distinct Galll and Med9/10 sub-modules (Kang et al., 2001). Though 
the Med9/10 sub-complex interacts with the RNAPII transcription 
machinery, the Galll sub-module seems to be a major recognition unit 
for activators (Kang et al., 2001). Finally, the Srb8, -9, -10 and -11 may 
also constitute a distinct module. This module was recently purified as 
a separate entity from yeast extracts and its components have 
repressive functions in yeast (Borggrefe et al., 2002; Hengartner et 
al., 1998). Likewise, the human SrblO-Srbll pair (CDK8-cyclin-C)
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represses activator-dependent transcription in vitro and the large, 
transcriptionally inactive human ARC-L Mediator complex contains 
MED230, MED240, CDK8 and cyclin C, homologues of yeast Srb8, -9, - 
10 and -11, respectively (Akoulitchev et al., 2000; Taatjes et al., 
2002).
A model has been proposed to explain the fate of Mediator 
during the transcription cycle (Svejstrup et al., 1997). According to 
this model, Mediator is recruited to gene-promoters via interaction 
with activators, binds to the un-phosphorylated form of RNAPII and 
stimulates CTD phosphorylation by TFIIH, which leads to promoter 
escape and transcript elongation. At this point, Mediator dissociates 
from phosphorylated RNA Polymerase I I .  A fter completing a round of 
transcription, the CTD is de-phosphorylated by CTD phosphatases. 
The un-phosphorylated Pol I I  can then enter a new cycle of 
transcription by again interacting with Mediator. Recently, Han and 
collaborators shed light on the re-initiation process of transcription 
(Yudkovsky et al., 2000). A fter transcription initiation, Mediator 
remains at the promoter and forms a scaffold with TFIID, TFIIA, 
TFIIH, and TFIIE that facilitates re-initiation. Interestingly, the 
stability of this scaffold is increased in the presence of activators.
Chromatin modifying complexes
Within a eukaryotic cell nucleus, genetic information is 
organized in a highly conserved structural polymer, termed chromatin. 
The fundamental repeating unit of chromatin is the nucleosome, which 
consists of 146 base pairs of DNA wrapped around an octamer of core 
histone proteins with two copies each of histone H2A, H2B, H3 and 
H4 (Kornberg, 1974). Linker histones of the HI class and other
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chromatin-bound proteins, such as high-mobility group (HMG) proteins, 
associate with DNA between single nucleosomes establishing the firs t 
higher level of organization, the so-called "solenoid" helical fibers (30 
nm fibers) (Kornberg and Lorch, 1999). Chromatin architecture beyond 
these fibers is less clear, but folding and unfolding of putative super­
structures are thought to have a pronounced impact on genomic 
function and gene activity (Fischle et al., 2003).
A number of studies have demonstrated that nucleosomal DNA 
is generally repressive to transcription (Grunstein, 1990). Therefore, 
an obvious question is how transcriptional activators and the core 
transcription machinery gain access to their cognate DNA binding 
sites and promoter elements in the restrictive environment of 
nucleosomal DNA. Part of the answer to this question was provided by 
the identification of dedicated chromatin modifying complexes, which 
serve to locally alter the structure of chromatin, facilitating gene- 
specific release from nucleosomal repression. Examples of such 
modifying complexes can be broadly grouped into two classes: (i) 
enzymes which covalently modify histones and (ii) A TP-dependent 
chromatin remodeling machines.
Core histone proteins are evolutionary conserved and consist 
mainly of flexible amino-terminal tails protruding outward from 
nucleosomes, and globular carboxy-terminal domains making up the 
nucleosome scaffold (Kornberg and Lorch, 1999). Histones, and mainly 
their N-terminal tails, function as acceptors for a variety of post- 
translational modifications, including acetylation, methylation and 
ubiquitination of lysine residues, phosphorylation of serine and 
threonine and methylation of arginine residues.
The subject of this thesis is very closely related to histone
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modification and transcriptional regulation, since the yeast Elongator 
complex, the focus of this study, has been shown to posses histone 
acetyl-transferase (HAT) activity and to have roles in chromatin 
modification in vivo (Kristjuhan et al., 2002; Winkler et al., 2002). 
Moreover, sequence similarity analysis have been used to suggest that 
Elp3 might have a histone de-methylase activity as well (Chinenov,
2002). Therefore, it is relevant to here provide a short overview of 
the recent findings on histone modifications and transcriptional 
regulation.
Histone acetylation
One of the best-understood histone modifications is histone 
acetylation. I t  is now generally accepted that hyper-acetylation of 
histone tails, accomplished by histone acetyl-trasferase (HAT) 
enzymes, is mostly associated with activated, or euchromatic genomic 
regions, at both the local and global level. By contrast, de-acetylation, 
accomplished by histone de-acetylases (HDAC), mainly results in 
repression and silencing (heterochromatin) (Kuo and Allis, 1998).
Histone acetyl-transferases generally belong to one of two 
categories (Sterner and Berger, 2000): type A, located in the nucleus, 
which acetylate nucleosomal histones within chromatin and are 
potentially linked to transcription, and type B, mostly located in the 
cytoplasm, which are believed to have somewhat of a housekeeping 
role in the cell, acetylating newly synthesized, free histones. I t  should 
be mentioned that some of the A type enzymes also acetylate non­
histone proteins (factor acetyl-trasnferases, FAT) (Imhof et al.,
1997).
The firs t type A HAT identified was the Tetrahymena histone 
acetyl-transferase A (HAT A), which was found to be homologous to
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Gen5, a genetically defined transcriptional co-activator in yeast 
(Brownell et al., 1996). Since then, all the Gcn5-related HATs, one of 
which is the Elongator complex, have been grouped in the superfamily 
of GNAT (Gcn5-related N-acetyl-tranferase) enzymes. Another group 
of evolutionary related proteins that are known to be HATs belong to 
the MYST family, named for its founding members: human MOZ, yeast 
Ybf2/Sas3, Sas2, and human Tip60 protein (Borrow et al., 1996). 
Finally, a number of previously characterized transcriptional co­
activators were shown to also posses HAT activity. This group includes 
the RNAPII-related human co-activators p300/CBP, SRC-1, ACTR, 
TIF2, and the TAFII250 subunit from various organisms (Chen et al., 
1997; Mizzen et al., 1996; Ogryzko et al., 1996; Spencer et al., 1997).
The majority of the above mentioned HATs are found in multi­
subunit complexes, which are recruited to gene promoters via an 
interaction with activators (Carrozza et al., 2003). The resulting 
acetylation of histone tails changes the overall charge of the 
nucleosome, which likely decreases the inter-nucleosome interaction 
and the interaction of nucleosome tails with linker DNA, thereby 
allowing greater chromatin flexibility and thereby accessibility for 
transcription factors. Moreover, the acetylated lysines work as 
histone marks, which are recognized by other proteins. Binding of 
those proteins, typically carrying a bromodomain, to acetylated 
histones facilitate downstream events resulting in altered gene 
expression (Hassan et al., 2002; Matangkasombut and Buratowski, 
2003).
Histone methylation
Unlike histone acetylation, histone methylation does not alter 
the overall charge of the nucleosome. To date, there are five lysines
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(K) and 3 arginines (R) within histone H3, and one lysine and one 
arginine within histone H4 that become methylated in a transcription- 
related manner. An arginine residue can be mono- or di-methylated, 
whereas a lysine residue can be mono-, di- or tri-methylated. The 
corresponding histone methyl-transferases display remarkable 
specif icity regarding the level of methylation they catalyze (Sims et 
al., 2003).
The firs t identified and best-characterized histone methyl- 
transferase (HMT) selectively methylates H3-K9 (Rea et al., 2000). 
This modification correlates with or results in silencing and 
heterochromatin formation (Heard et al., 2001; Peters et al., 2002). 
Recent reports suggest that methylation of lysines H3-K27 and H4- 
K20 also correlate with repressed chromatin structures (Nishioka et 
al., 2002). In contrast, transcriptionally competent euchromatin is 
typically methylated at one or more of the three positions, H3-K4, 
H3-K36 and H3-K79. Di-methyaltion of H3-K4 appears to be a global 
epigenetic mark in euchromatic regions and tri-methylation of H3-K4 
is found in promoters of transcriptionally active genes (Ng et al., 
2003c; Santos-Rosa et al., 2002). Methylation of lysines K4, K36 and 
K79 is also linked to transcript elongation, as will be discussed later in 
this chapter (Krogan et al., 2003a; Krogan et al., 2003b; Li et al.,
2002). Finally, histone H3 and H4 arginine (R) methylation has also 
been linked to transcriptional activation (Koh et al., 2001; Wang et al.,
2001).
As in the case of histone acetylation, histone H3 K9 methylation 
serves as a “mark" or binding sites for chromatin-associated proteins 
typically related to heterochromatin protein 1 (HP1) (Bannister et al., 
2001; Lachner et al., 2001; Nakayama et al., 2001). These factors
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contain chromo-domain modules, which bind to histone tails bearing 
methyl-lysine in a highly specific manner, with affinity being highest 
for tri-methyllysine and lowest for mono-methyllysine. Binding of HP1 
has been linked to chromatin condensation and gene silencing 
(Bannister et al., 2001; Lachner et al., 2001; Nakayama et al., 2001).
One very interesting issue, recently also linked to Elongator, 
which was proposed to have de-methylase activity (Chinenov, 2002), is 
the mechanism which underlies the removal of methyl-groups. So far, 
attempts to identify an enzyme with de-methylase activity have not 
been successful. Early studies concluded that histone methylation is 
not reversible (Byvoet et al., 1972; Duerre and Lee, 1974). However, 
this is contradictory to several recent cases, which support the idea 
that active reversal of methylation may be expected to be necessary 
to regulate gene expression (Bauer et al., 2002; Nielsen et al., 2001; 
Santos-Rosa et al., 2002; Strahl et al., 2001).
Histone ubiquitination
In addition to the well-known modifications, such as acetylation 
and methylation, histones can also be modified through ubiquitination. 
Histones H2A, H2B, H3 and HI have been shown to be modified with 
ubiquitin groups (Chen et al., 1998; Nickel and Davie, 1989; Pham and 
Sauer, 2000; West and Bonner, 1980). However, only ubiquitination of 
histone H2B and histone HI has been so far linked to transcriptional 
regulation (Kao et al., 2004; Pham and Sauer, 2000). In particular, the 
co-activator TAFII250 catalyzes the ubiquitination of histone HI in 
vitro and in vivo. This modification is critical for the expression of 
developmental^ regulated genes in Drosophila (Pham and Sauer,
2000). Ubiquitination of histone H2B by the Rad6 protein has recently 
been the focus of attention of numerous studies in yeast (Briggs et
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al., 2001; Dover et al., 2002; Krogan et al., 2003a; Ng et al., 2003a; Ng 
et al., 2003b; Ng et al., 2002b; Sun and Allis, 2002). Moreover, the 
Ubp8 component of the SAGA complex was identified as the enzyme 
which catalyses the reciprocal reaction, that is, the removal of 
ubiquitin from histones (Henry et al., 2003; Kao et al., 2004). All of 
the above studies support the idea that ubiquitination of histone H2B 
is linked to transcriptional activation through its impact on other 
histone modifications.
Histone phosphorylation
Phosphorylation of serine 10 of histone H3 has been linked to 
transcriptional activation (Cheung et al., 2000b; Lo et al., 2000). Two 
models have been proposed to explain the e ffect of histone H3 
phosphorylation on gene expression (Cheung et al., 2000a). One 
possibility is that the addition of negatively charged phosphate groups 
to the N-terminal H3 tails may disrupt electrostatic interactions 
between the basic H3 tails and the negatively charged DNA backbone, 
and thereby increase the accessibility of the underlying DNA to 
nuclear factors. Another model favors the idea that H3 
phosphorylation serves as a recognition Mmark" fo r recruitment of 
transcription factors or regulatory complexes. Interestingly, proteins 
participating in receptor tyrosine kinase-mediated signal transduction 
pathways, bearing an SH2 domain, have been shown to bind phospho- 
tyrosines (Hunter, 2000). However, to date, no factors that have 
specific phospho-serine binding motifs have been identified.
The histone code
I t  is clear from the previous paragraphs that histone tails serve 
as substrates for extensive posttranslational modifications. These 
modifications are not just a means of reorganizing nucleosome
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structure, but also provide a rich source of epigenetic information. I t  
has been suggested that combinations of specific tail modifications 
constitute a “code" that defines actual or potential transcriptional 
states. The code is thought to be set by histone modifying enzymes of 
defined specificity, and read by non-histone proteins that bind 
histones in a modification-specific manner (Jenuwein and Allis, 2001; 
Turner, 2002).
In particular, phosphorylation of serine 10 and acetylation of K9 
of histone H3 were found to both correlate with transcriptional 
activation, and at the same time prevent K9 methylation of histone H3 
by Su(var) 3-9, in vitro (Cheung et al., 2000b; Lo et al., 2000; Rea et 
al., 2000). Reduction of K9 methylation was also caused by acetylation 
of H3 K14. Additionally, functional effects of methylated lysine K20 
of histone H4 may be modulated by acetylation of H4 K16 and visa 
versa. I t  is possible that H4meK20 is a mark associated with 
chromatin condensation and reduced transcription, whereas H4AcK16 
specif ies the opposite chromatin state (Rice et al., 2002).
The above examples reveal an interplay of modifications in cis. 
These results were not unexpected, since posttranslational 
modifications within or adjacent to sites of protein-protein 
interaction are likely to have some effect on that interaction. 
However, recent experiments in yeast have revealed a much more 
surprising relationship. In budding yeast, histone H3 K4 methylation is 
abolished by mutations in Rad6 or H2B K123 (Dover et al., 2002; Sun 
and Allis, 2002). As mentioned previously, Rad6 is the major activity 
responsible for the attachment of ubiquitin to lysine 123 of H2B in 
yeast. Moreover, rad6A deletion mutants lose methylation at H3 
lysine 4 and 79, modifications found in transcriptional active genes
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(Krogan et al., 2003a; Santos-Rosa et al., 2002). This was thus an 
example of unexpected trans interplay between modifications in 
different histone proteins.
Both cis and trans interplay of histone modifications have roles 
in the long-term maintenance and heritability of transcriptional 
states. However, these modifications have also been associated with 
more short-term aspects of transcriptional regulation, particularly 
initiation. Recent data strongly suggest that sequential modif ications 
at defined sites on histone tails facilitate recruitment/binding of 
transcription-related factors in the assembly pathway (Agalioti et al., 
2000; Cosma, 2002; Cosma et al., 1999; Shang et al., 2000).
A TP-dependent chromatin remodeling
ATP-dependent chromatin remodeling is involved in all major 
reactions performed on chromatin substrates. Its  role in activation 
and repression of transcription affects control of the cell cycle, cell 
differentiation and hence the development of multi-cellular organisms. 
Most of the chromatin remodelers are multi-subunit complexes with 
an ATPase as the catalytic centre. These ATPase subunits can be 
classified into three families; the SWI2/SNF2-, the ISW I- and the 
Mi-2/CHD-ATPase families (Varga-Weisz, 2001). They all contain a 
highly conserved core domain and N- and C- terminal domains, which 
d iffer considerably between the above families.
Over the past few years, several models fo r nucleosome 
mobility and remodeling have been proposed. The three more 
prevalent are DNA twisting, which is displayed by members of both 
SWI/SNF and ISW I classes (Flaus and Owen-Hughes, 2001; Havas et 
al., 2000; Varga-Weisz and Becker, 1998), structural changes in the
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octamer that alters the histone-DNA interactions (Kingston and 
Narlikar, 1999; Narlikar et al.# 2001) and DNA translocation (Saha et 
al., 2002).
Genes encoding components of the SWI/SNF complex were 
originally discovered and characterized as pleiotropic transcriptional 
activators, which fits  nicely with the concept that they remodel 
chromatin in preparation for promoter activation (Abrams et al., 1986; 
Happel et al., 1991; Hirschhorn et al., 1992). However, more 
systematic genome-wide analysis showed that only a small fraction of 
yeast genes require SWI/SNF for activation, and that several genes 
are also up-regulated in the absence of Swi/Snf, suggesting a role for 
the complex in both repression and activation (Holstege et al., 1998; 
Sudarsanam et al., 2000). The finding that only a fairly small number 
of genes require SWI/SNF for activation contrasts with the notion 
that the process of transcriptional activation has to contend with a 
repressive chromatin structure in most if not all genes (Hirschhorn et 
al., 1992). A possible explanation for this discrepancy was provided by 
Krebs et al., who proposed that SWI/SNF is globally required for 
genes expressed in the wake of mitosis, when chromatin is not fully 
de-condensed (Krebs et al., 2000).
The ATPase IS W I (imitation switch) was f  irst discovered in D. 
melanogaster. Visualization of the protein on polytene chromosomes 
showed that the bulk of IS W I does not co-localize with the bulk of 
RNA Polymerase I I ,  which indicated that transcriptional regulation is 
unlikely to be the main role of ISW I, at least in the specialized 
salivary gland tissue (Deuring et al., 2000). However, in in vitro model 
reactions, ISWI-containing remodeling factors can stimulate 
transcription from chromatin templates (Ito  et al., 1997). Three
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ISWI-containing remodeling complexes have been discovered in D. 
melanogaster following d iffe ren t biochemical assays; NURF 
(nucleosome remodeling factor), ACF (ATP-utilizing chromatin 
assembly and remodeling factor) and CHRAC (chromatin accessibility 
complex) (Eberharter et al., 2001; Varga-Weisz et al., 1997; Xiao et 
al., 2001). All three complexes are able to induce the sliding of 
nucleosomes to neighbouring DNA segments, thereby rendering DNA 
segments accessible to interacting factors, and facilitating 
transcription initiation.
Like ISW I, the CHD ATPase is able to disrupt histone-DNA 
interactions and to induce nucleosome sliding on DNA fragments 
(Brehm et al., 2000; Wang and Zhang, 2001). The more intensively 
studied CHD3 (Mi-2a) and CHD4 (Mi-2p) contain two PHD fingers- 
presumed protein recognition modules in addition to the chromo­
domains. Mi-2 was f irs t  identified as a dermatomyositis-specific 
antigen and later shown to reside in so-called NRD/NuRD/NURD 
complexes in various species (Knoepfler and Eisenman, 1999). The 
name of this complex (Nucleosome Remodeling and De-acetylation) 
hints at the subunit composition: in addition to Mi-2 and several other 
subunits, a module consisting of the histone de-acetylases HDAC1/2 
and the H4 interacting proteins RbAp46/48 are also present (Guschin 
et al., 2000). NURD complexes are of considerable interest since they 
physically combine aspects of the two fundamental strategies for 
chromatin remodeling: covalent modification (de-acetylation) and ATP- 
dependent remodeling. This combination suggests that energy might 
also be spent to render the histone N-termini accessible for 
coordinated de-acetylation. Consistent with this idea, the ATPase 
activity of Mi-2 can increase the efficiency of histone de-acetylation
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by NURD complexes in cell-free systems (Guschin et al., 2000; Tong 
et al., 1998). Since hypo-acetylated histone N-termini are generally 
correlated with repression of transcription, NURD complexes were 
suspected of being involved in establishing a repressive chromatin 
environment. This idea was also supported by identification of a 
mammalian NURD subunit, the MBD3 protein (Wade et al., 1999; 
Zhang et al., 1999). This protein is highly related to the methyl- 
cytosine binding protein MBD2. MBD2 itself can associate with NURD 
to form the previously known MeCPl complex, which preferentially 
interacts with DNA methylated at CpG residues (Ng et al., 1999). 
Through interaction with MBD2, NURD is targeted to bind, remodel 
and de-acetylate nucleosomes containing methylated DNA, providing a 
possible mechanism by which DNA methylation may lead to silencing of 
genes.
1.1.5 The mechanism of RNA Polymerase H  transcript elongation
Though the transcription initiation step has almost monopolized 
the focus of studies over the past 20 years, interest in transcript 
elongation and termination has recently grown. I t  has thus become 
obvious that all the three basic steps of transcription are closely 
linked to ensure the accurate synthesis of mRNAs. The main focus of 
this section is to present the current view about the regulation of 
transcript elongation and the proteins, which are thought to play 
crucial roles in this process.
TFIIS
The firs t RNA Polymerase I I  elongation factor to be purified 
was named TFIIS  (transcription factor I I  S) and was initially
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identified by its ability to promote efficient synthesis of long 
transcripts in vitro (Sekimizu et al., 1976). Biochemical studies 
subsequently revealed that TFIIS promotes elongation by preventing 
premature arrest of polymerase at discrete sites within transcribed 
DNA sequences (Reines et al., 1989). The proposed mechanism for 
that process favours a direct interaction of S II with RNAPII and the 
transcript itself. TFIIS reactivates arrested RNA Polymerase I I  by 
triggering RNAPII-mediated cleavage of the incorrectly positioned 
nascent RNA in the polymerase active site, a process which realigns 
the active site with the end of the RNA and allows release of the 
polymerase from the site of arrest (Izban and Luse, 1992; Rudd et al., 
1994; Wang and Hawley, 1993). Consistent with the above model, 
recent structural data reveal that S II extends from the polymerase 
surface via a pore to the internal active site and interacts with RNA 
Polymerase I I  at sites near the pore (through which nucleotides are 
thought to enter the RNA Polymerase I I  active site) (Cramer et al., 
2000; Cramer et al., 2001; Gnatt et al., 2001; Kettenberger et al., 
2003). Moreover, S II  was found to be cross-linked to the 3'-end of 
transcripts in the arrested RNA Polymerase I I  elongation complex 
(Powell et al., 1996).
Yeast cells lacking the S I I  (DST1/PPR2) gene exhibit 
transcriptional defects when grown in the presence of the drug 6- 
azauracil, an inhibitor of GTP and UTP metabolism. These defects are 
synergistically enhanced when the S I I  deletion was combined with 
mutations in genes encoding RNA Polymerase I I  subunits or other 
transcription elongation-specific factors, such as DSIF/NELF, 
Elongator and FACT (Hemming et al., 2000; Lennon et al., 1998; 
Lindstrom and Hartzog, 2001). More recently, chromatin
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immunoprecipitation experiments from yeast confirmed that S II is 
present along the promoter and coding regions of multiple genes 
(Pokholok et al., 2002). Finally, S II has been shown to affect yeast 
transcription in vivo, by stimulating the passage of RNA Polymerase I I  
through an artificial arrest site (Kulish and Struhl, 2001).
TFIIF. ELL ELONGIN
Efforts to identify activities that stimulate the rate of 
elongation by RNA Polymerase I I  on naked DNA templates, led to the 
purification of TFIIF and members of the ELL and Elongin families. 
Their mode of action includes suppression of transient pausing of 
RNAPII at all or most steps of nucleotide addition (Shilatifard, 1998; 
Shilatifard et al., 1996). In  vitro studies have suggested that this is 
achieved by helping to maintain the 3'-OH terminus of the nascent 
transcript in proper alignment with the catalytic site of polymerase, 
thereby preventing backtracking by the enzyme (Elmendorf et al., 
2001; Gu and Reines, 1995; Takagi et al., 1995; Wang and Hawley, 
1993). Consistent with this idea, TFIIF, ELL and Elongin complexes 
have been shown to inhibit Sll-induced cleavage of nascent 
transcripts by paused RNAPII (Elmendorf et al., 2001).
Studies in cells, however, have suggested that these three 
factors (also) serve quite different functions. Apart from a role in 
pre-initiation complex formation (PIC), which was mentioned 
previously, more recent work revealed a function fo r TFIIF in 
promoter escape as well (Yan et al., 1999). TFIIF was found to play a 
major role in reducing the frequency at which RNAPII aborts 
transcription during synthesis of the firs t few phosphodiester bonds 
of nascent transcripts, ensuring that they reach a sufficient length
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(>6 to 8 nucleotides) to be relatively resistant to abortion. Consistent 
with this role, chromatin immunoprecipitation experiments in 5. 
cerevisiae cells revealed that TFIIF localizes only near promoter 
regions and dissociates from RNA Polymerase I I  elongation complexes 
shortly a fte r transcription initiates (Pokholok et al., 2002). 
Therefore, by ensuring an efficient promoter escape, TFIIF might 
stimulate the rate of transcription.
In contrast, the founding member of the ELL family, Ell, seems 
to have a more direct role in transcript elongation. For example, 
Drosophila Ell was found at a large number of transcriptionally active 
sites on polytene chromosomes and was rapidly re-localized with RNA 
Polymerase I I  to heat shock genes when embryos were subjected to 
elevated temperatures (Gerber et al., 2001). Moreover, as expected 
for a bona fide elongation factor, Ell mutations in Drosophila 
preferentially affect expression of large genes, such as the Cut, the 
Notch and the Sex combs reduced genes, but not shorter genes 
(Eissenberg et al., 2002).
Finally, Elongin is a heterotrimeric protein complex composed of 
a transcriptionally active A subunit and two smaller subunits, Elongin B 
and C, which can form a discrete BC sub-complex (Aso et al., 1995; 
Garrett et al., 1994). The A subunit has been shown to bind to the 
Elongin BC complex through a sequence motif referred to as the BC- 
box (Aso et al., 1995; Garrett et al., 1994). Recent evidence has 
identified a novel role for Elongin. Elongin A was shown to be linked via 
Elongin B and C to a heterodimeric module composed of Cullin family 
proteins and the RING-H2 finger protein Rbxl. These multi-subunit 
complexes have a function as E3 ubiquitin ligase, opening the 
possibility tha t Elongin might ubiquitylate proteins during
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transcription (Kamura et al., 2001). Consistent with a role for Elongin 
subunits in transcription-coupled protein ubiquitylation, the Mediator 
subunit Med8 interacts with Elongin BC and assembles into an ubiquitin 
ligase in mammalian cells (Brower et al., 2002).
Elongation factors that taraet the C-terminal domain o f Robl
The transition from transcription initiation to elongation is 
accompanied by changes in the phosphorylation status of the C- 
terminal domain (CTD) of the largest subunit (Rpbl) of RNAPII. In 
fact, the transition correlates perfectly with the hyper­
phosphorylation of the CTD (Dahmus, 1996). The current model 
proposes that the form of RNA Polymerase I I ,  which enters promoter 
is un- (or at least hypo-) phosphorylated (PolII/0, whereas after the 
initiation/elongation transition (promoter clearance) the polymerase is 
hyper-phosphorylated (PolIIo). The predominant sites of 
phosphorylation are at serine 2 and serine 5 of the CTD repeat. 
Chromatin immunoprecipitation experiments, using antibodies that 
specifically recognize either of these two sites showed that 
phosphorylated serine 5 is predominantly found on polymerases close 
to the promoter (promoter escape/early elongation). However, as 
elongation continues, the phosphoserine 5 signal seems to slowly be 
lost while the serine 2 position becomes highly phosphorylated 
(Komarnitsky et al., 2000). I t  is believed that the CTD serves as a 
scaffold for factors involved in different stages of transcription and 
that the phosphorylation transitions regulate the sh ift from 
initiation- to elongation-specific factors that are associated with 
polymerase.
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Initial efforts to understand the role of CTD phosphorylation in 
transcription were aided greatly by protein kinase inhibitors, such as 
the 5,6-dichloro-l-p-D-ribofuranosyl-benzimidazole (DRB), which can 
block CTD phosphorylation and induce arrest of elongating RNA 
Polymerase I I  in vivo and in crude transcription systems in vitro 
(Chodosh et al., 1989; Marshall and Price, 1992). These studies 
predicted the existence of two classes of elongation factors 
responsible fo r DRB-sensitive transcription: a class of negatively 
acting factors that inhibit transcription and a class of positively 
acting factors that overcome this inhibition. Fractionation of crude 
DRB-sensitive transcription systems led to the discovery of three 
novel elongation factors: the P-TEFb (Positive Transcription 
Elongation Factor b) (Marshall and Price, 1995), which is a positively 
acting, DRB-sensitive factor and two negatively acting factors, NELF 
(Negative Elongation Factor) (Yamaguchi et al., 1999) and DSIF (DRB 
Sensitivity Inducing Factor) (Wada et al., 1998).
P-TEFb is composed of the ~43kD Cdk9 kinase (also referred to 
as PITALRE) and one of several cyclins (Tl, T2a, T2b or K). This 
kinase is capable of phosphorylating the CTD of RNA Polymerase I I  
(Marshall et al., 1996) and the Spt5 subunit of DSIF (Kim and Sharp,
2001). The firs t evidence implicating P-TEFb kinase in regulation of 
transcription elongation in vivo came from the finding that P-TEFb is 
recruited to early RNA Polymerase I I  elongation complexes, which 
were engaged in synthesis of the human immunodeficiency virus-1 
(HIV-1) transcripts. This recruitment is mediated via the interaction 
of cyclin T subunit with the HIV-1 encoded Tat protein (Wei et al.,
1998). Later on, P-TEFb was found to be broadly distributed at sites 
of transcription on Drosophila polytene chromosomes and rapidly
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redistributed to heat shock genes when they were activated by 
temperature shift (Lis et al., 2000). Moreover, RNAi experiments in C. 
elegans showed abolishment of CTD serine 2 phosphorylation by 
inactivating P-TEFb, strongly suggesting that a major substrate for 
this kinase is serine 2 of the CTD (Shim et al., 2002).
Yeast proteins with functional similarity to Cdk9 are the Burl 
and Ctkl kinases. The latter phosphorylates serine 2 of the CTD (Cho 
et al., 2001). The former has been shown to prefer serine 5 in vitro 
(Keogh et al., 2003). However, mutations in BUR1 do not significantly 
affect the phosphorylation state of either serine 2 or serine 5, 
indicating an in vivo substrate for Burl other than RNAPII. Consistent 
with a role in elongation, both Ctkl and Burl (as well as its cyclin 
partner Bur2) are associated with transcribed chromatin (Keogh et al.,
2003).
The two negatively acting factors, DSIF and NELF, were 
purified from HeLa cells. The former was found to be composed of 
two subunits (Spt4 and Spt5), ubiquitously expressed in eukaryotes 
from yeast to man (Wada et al., 1998), and the latter of five subunits, 
which are all required fo r inhibition of RNA Polymerase I I  elongation 
(Yamaguchi et al., 1999). Although the precise mechanism of action for 
both factors is unknown, it likely involves a direct interaction with 
polymerase and the nascent transcript (Yamaguchi et al., 2002). More 
recently, it was suggested that DSIF and NELF associate with the 
promoter of hsp70 in brosophila before heat shock, and cause un- 
phosphorylated RNA polymerase I I  ( IIA ) to pause in promoter 
proximal regions. Upon elevation of the temperature, the HSF 
activator contributes to dissociation of NELF from the elongation
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complex, whereas DSIF remains associated and could serve a positive 
role in elongation (Wu et al., 2003).
In all likelihood, efficient elongation requires that the CTD is 
kept phosphorylated during the entire length of the run. However, as 
soon as one cycle of transcription is finished, RNAPII has to be 
recycled for utilization in a new round of transcription. This requires 
de-phosphorylation of the CTD. This process is not yet well defined. 
The best-characterized CTD phopshatase so far is the Fcpl protein. 
Fcpl was shown to associate with elongating RNAPII in vivo at both 
promoters and coding regions of genes (Cho et al., 2001). The same 
study showed, that in yeast, Ser2 phosphorylation increases, while 
Ser5 phosphorylation levels are relatively unchanged in the absence of 
functional Fcpl. In contrast, human Fcpl has been shown to be capable 
of de-phosphorylating both serine 2 and serine 5 residues of the C- 
terminal domain of Rpbl in vitro (Lin et al., 2002). Finally, it should be 
mentioned that two novel CTD phosphatases have recently been 
identified. Both these enzymes, Scpl and Ssu72, show a preference 
for phospohrylated serine 5 residues (Krishnamurthy et al., 2004; Yeo 
et al., 2003).
Factors which facilitate transcript elongation throuoh chromatin
The need fo r RNA Polymerase I I  to transcribe through 
chromatin in vivo led investigators to identify factors that facilitate 
this process. The most prominent of those are the Spt family of 
proteins, the FACT complex, the Swi/Snf family of proteins and the 
Elongator complex (which will be discussed in detail later).
SPT genes were firs t identified in 5. cerevisiae by screening 
fo r genetic suppressors of certain promoter insertion mutations
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(Fassler and Winston, 1988; Simchen et al., 1984). One class of SPT, 
the histone class, includes SPT4, SPT5, SPT6, SPT16, SPT11 and 
SPT12. The last two encode the histones H2A and H2B. The genes of 
this class share a number of mutant phenotypes that inspired the view 
that these proteins express their function through effects on 
chromatin (Malone et al., 1991; Swanson and Winston, 1992). When 
mutations in SPT4, SPT5 or SPT6 genes are combined with a deletion 
of the DST1/PPR2 gene (which encodes the transcription factor 
TFIIS), the cells display conditional growth defects. Moreover, 
deletion of SPT genes renders cells sensitive to the drug 6-azauracil, 
a transcript elongation-specific inhibitor (Hartzog et al., 1998). 
Consistent with a role in transcript elongation, several transcripts 
show decreased levels in the spt5A  cold-sensitive mutants. 
Interestingly, the Spt4, Spt5 and Spt6 proteins co-immunoprecipitate 
with each other and with RNA Polymerase I I  (Hartzog et al., 1998), 
co-localize on Drosophila polytene chromosomes in a pattern that 
closely resembles that observed for PolIIO (hyper-phosphorylated 
form, engaged in elongation), and are recruited to the promoter and 
transcribed regions of heat shock genes upon elevation of 
temperature (Kaplan et al., 2000). Recently, Kaplan et al. 
demonstrated an in vivo requirement for Spt6 for maintaining normal 
chromatin structure during transcript elongation, thereby repressing 
transcript initiation from cryptic sites (Kaplan et al., 2003).
Using recombinant or highly purified transcription factors, DNA 
assembled into chromatin and HeLa nuclear extracts, Orphanides et 
al. established an in vitro system for transcript elongation through 
chromatin (Orphanides et al., 1998). Using this system, a complex of 
proteins named FACT (Facilitates Chromatin Transcription) was
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purified based on its ability to support efficient elongation through 
chromatin-bound DNA. FACT is composed of two subunits, hSPT16 and 
SSRP1, which are homologues of yeast proteins Cdc68/Sptl6 and 
Pob3, respectively (Orphanides et al., 1999). FACT functions optimally 
when present in near stoichiometric quantities to nucleosomes, by 
promoting the disassembly of one H2A/H2B dimer from the 
nucleosome, thus de-stabilizing its structure to allow RNAPII passage 
(Orphanides et al., 1999). FACT was also found to have histone 
chaperone activity, suggesting that it plays a role in re-establishing 
chromatin structure after RNAPII traverses a nucleosome (Saunders 
et al., 2003). Finally, FACT interacts genetically and biochemically 
with other transcript elongation-related factors, such as Spt4, Spt5 
and the Pafl complex (Costa and Arndt, 2000; Formosa et al., 2002; 
Krogan et al., 2002b; Squazzo et al., 2002).
The role of ATP-dependent chromatin-remodeling complexes 
during transcript initiation has been studied extensively. However, in 
the last few years a number of results have revealed an important and 
unique role for these complexes during transcript elongation as well. 
Studies in mammalian systems suggest such a role for the Swi/Snf 
complex. In particular, using as a model the hsp70 from mammalian 
cells in an in vitro system, Brown et al. identified mutations in the 
activation domain of the activator HSF1, which were required to 
release paused RNA polymerase I I  on a nucleosomal template (Brown 
et al., 1996). These mutations abolished the interaction of HSF1 with 
the Swi/Snf complex, indicating a role for the latter in the remodeling 
of chromatin adjacent to polymerase pause sites on the hsp70. More 
recently, work with immortalized fibroblasts showed that the 
previously mentioned mutations in HSF1 activator are capable of
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directing RNAPII transcription initiation on the hsp70 promoter to 
the same degree as wild-type HSF1, but that the mutants cannot 
support Swi/Snf recruitment, remodeling or subsequent hsp70 
induction (Corey et al., 2003). Thus, localized recruitment of Swi/Snf 
to the hsp70 by an activator occurs concurrently with localized 
chromatin remodeling and stimulation of elongation (Corey et al.,
2003). Finally, in yeast, deletion mutants for genes encoding Swi/Snf 
subunits were found to be synthetically lethal when combined with a 
mutation in the DST1/PPR2, which encodes the transcription 
elongation factor TFIIS, further suggesting a role for components of 
the Swi/Snf complex in transcript elongation (Davie and Kane, 2000).
I t  should be mentioned that the transcription-coupling repair 
factor CSB (Cockayne's syndrome B) and its yeast homologue Rad26 
also belong to the Swi/Snf family of proteins. CSB enhances 
transcript elongation on naked DNA in vitro (Selby and Sancar, 1997), 
and chromatin remodeling in vivo (Citterio et al., 2000). Interestingly, 
Rad26, the yeast homologue, was also suggested to promote RNA 
Polymerase I I  transcript elongation in vivo (Lee et al., 2001; Lee et al., 
2002).
Other recently identified proteins with proposed roles in transcript 
elongation
Proteomic approaches have been used to identify a large 
network of protein-protein interactions between RNAPII and 
transcript elongation factors. In most cases, these observations were 
complemented by strong genetic interactions that are indicative of 
shared functions and of potential roles in transcript elongation.
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The Pafl complex consists of Pafl, Cdc73, Hprl, Ccr4, Ctr9, 
R tfl and Leol and was originally isolated as an RNAPII-associated 
factor (Krogan et al., 2002b). The genes that encode the Pafl complex 
components are not essential. However, mutations in these genes 
resulted in changes in abundance of a small but significant subset of 
yeast transcripts (Krogan et al., 2002b). Moreover, genetic and 
biochemical data supported the idea that the Pafl complex travels 
along the coding region of transcribed genes and mediates 
interactions of RNAPII with chromatin (Krogan et al., 2002b; Squazzo 
et al., 2002).
The Chdl protein is an ATP-dependent chromatin remodeling 
enzyme, which has been shown by a ffin ity  purification, co- 
immunoprecipitation and two-hybrid experiments to interact with the 
Pafl and the FACT complex (Kelley et al., 1999; Krogan et al., 2002b; 
Mueller and Jaehning, 2002; Tran et al., 2000). Localization studies in 
Drosophila showed that Chdl associates with transcriptionally active 
genes in vivo (Stokes et al., 1996), whereas the yeast homolog of Chdl 
was found to be recruited to coding regions of transcribed genes 
(Krogan et al., 2002b).
Another ATP-dependent chromatin remodeling enzyme, Iswl, 
was also recently shown to have a role in transcript elongation 
(Morillon et al., 2003a). Isw l is an ATPase, which is found in two 
distinct complexes, Iswla and Iswlb. The Iswla complex was shown to 
repress gene transcription at initiation through specif ic positioning of 
a promoter proximal di-nucleosome, whereas the Iswlb complex acts 
within coding regions to control the amount of RNA Polymerase I I  
released into productive elongation and to coordinate elongation with 
termination and pre-mRNA processing. Interestingly, these effects
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are controlled via phosphorylation of the CTD of RNAPII and 
methylation of the chromatin template (Morillon et al., 2003a).
Finally, members of the winged-helix forkhead (Fkh) family of 
proteins were recently reported to be involved in regulation of 
transcript elongation (Morillon et al., 2003b). In yeast, there are two 
genes, which encode Fkh factors, FKH1 and FKH2. Both proteins were 
found to be associated with coding regions of active genes, and 
influence, in opposing ways, transcript elongation and termination. I t  
was proposed that the opposing action of Fkhl and Fkh2 may be part 
of a checkpoint mechanism to coordinate transcription and pre-mRNA 
processing waCTD phosphorylation (Morillon et al., 2003b).
Transcript elongation and chromatin modification
As discussed previously, histone modifications have been linked 
very strongly to regulation of gene expression. In the last few years, a 
number of studies have proposed a link between the methylation 
status of lysines 4, 36 and 79 of histone H3 and transcript elongation. 
In yeast, methylation of lysine 4 of histone H3 is catalyzed by the 
histone methyl-transferase (HMT) complex named COMPASS 
(COMplex of Proteins Associated with Setl) (Briggs et al., 2001; 
Krogan et al., 2002a; Miller et al., 2001). COMPASS was found to 
interact with the Pafl complex and the form of RNA Polymerase I I  
phosphorylated at serine 5 of the CTD. Both the interaction with RNA 
Polymerase I I  and the methylation of lysine 4 require the presence of 
the Pafl complex (Krogan et al., 2003a; Ng et al., 2003b). Methylation 
of lysine 4 of histone H3 and members of the COMPASS complex have 
been shown to localize to the 5' regions of active mRNA coding genes. 
Their recruitment is dependent on TFIIH-associated kinase (Kin28),
50
which is the kinase that phosphorylates the RNAPII CTD at serine 5 
and mediates the transition from initiation to elongation (Ng et al., 
2003b).
Methylation of lysine 36 is catalyzed by another SET domain- 
containing protein in yeast, Set2 (Strahl et al., 2002). In an e ffo rt to 
understand the role of Set2, different groups have shown that Set2 
interacts directly with RNA Polymerase I I ,  preferentially with the 
form phosphorylated at serine 2 of the CTD (Krogan et al., 2003b; Li 
et al., 2003; Li et al., 2002; Xiao et al., 2003). This interaction 
requires the presence of the CTD, the Pafl complex and the CTD 
serine 2 kinase, Ctkl. Moreover, Ctkl kinase is required for efficient 
methylation of lysine 36, revealing a possible targeting of Set2 to 
coding regions of transcribed genes via the CTD phosphorylation 
activity of this kinase.
Finally, methylation of lysine 79 of yeast histone H3 is 
catalyzed by a protein named Dotl (Lacoste et al., 2002; Ng et al., 
2002a; van Leeuwen et al., 2002). Although this modification was firs t 
hypothesized to exclusively regulate the repression of genes in 
telomeric regions, recent reports show that methylation of lysine 79 
occurs in euchromatic regions as well. As for lysine 4 methylation, 
ubiquitination of lysine 123 of histone H2B is also required for 
methylation of lysine 79 of histone H3 (Ng et al., 2002b). Consistent 
with a role fo r the Pafl complex as a “platform" fo r interaction of 
histone methyl-transferases with elongating RNA Polymerase I I ,  
methylation of lysine 79 is also dependent on the presence of 
components of the Pafl complex (Krogan et al., 2003a). However, so 
far only genetic interactions between components of the Pafl complex 
and Dotl have been observed. The presence of Pafl at both promoters
51
and coding regions of actively transcribed genes suggested a possible 
role for methylation at lysine 79 of histone H3 in both early and late 
transcript elongation (Krogan et al., 2003a).
The identification of methylated histone residues allowed the 
investigators to propose a model for a role of histone methylation as a 
mark of "transcriptional memory" for recently transcribed genes. 
According to this model, histone methylation at the promoter and the 
coding region of genes inform the cell that transcription of a given 
gene has occurred and how far RNA Polymerase I I  has transcribed 
through the body of that gene in the recent past (Gerber and 
Shilatifard, 2003).
1.1.6 Coordinating roles for RNAPII elongation complex in mRNA 
processing and export
A number of recent studies have supported the notion that 
RNA Polymerase I I  is not simply an RNA synthesis machine, but that 
it also serves a more fundamental role as a platform for recruiting and 
coordinating the actions of proteins responsible for mRNA maturation 
and export to the cytoplasm.
Both hyper- and hypo-phosphorylated forms of CTD stimulate 3' 
cleavage in vitro (Hirose and Manley, 1998; Ryan et al., 2002), whereas 
only the hyper-phosphorylated form stimulates pre-mRNA splicing and 
capping in vitro (Hirose and Manley, 1998; Hirose and Manley, 2000). 
Moreover, protein interaction studies have shown that splicing factors 
as well as components of the capping machinery interact directly with 
the phosphorylated form of RNA Polymerase I I  (Ho and Shuman, 
1999; Mortillaro et al., 1996). In addition, results of chromatin 
immunoprecipitation experiments indicate that components of the
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mRNA capping complex are transiently associated with the promoter 
and the coding region of transcribed genes (Takase et al., 2000). 
Interestingly, the Ssu72 protein was found to be an integral 
component of the CPF polyadenylation complex (Dichtl et al., 2002). 
ssu72A mutant cells display defects in RNAPII transcript elongation 
and termination, thereby linking the two processes. Finally, Ssu72 was 
also shown to be a CTD phosphatase, reinforcing the idea that the 
CTD and its modifications are instrumental in ensuring correct mRNA 
maturation (Krishnamurthy et al., 2004).
In order to be translated, the newly synthesized mRNA has to 
be transported to the cytoplasm. A link between the RNAPII 
elongation complex and the mRNA export machinery was recently 
brought to light with the identification of the yeast THO/TREX 
complex (Chavez et al., 2000). This complex was shown to interact 
with free and transcribing RNA polymerase I I  and cells carrying 
mutations in its subunits exhibit apparent defects in RNA Polymerase 
I I  transcript elongation of both long and G+C rich transcripts, and in 
nucleocytoplasmic transport of properly processed mRNAs (Chang et 
al., 1999; Chavez et al., 2001; Jimeno et al., 2002; Strasser et al.,
2002). These recent findings raised the intriguing possibility that the 
THO complex may recruit the mRNA export machinery directly to 
transcribing RNAPII to facilitate the transport of mRNA from the 
nucleus to their sites of translation in the cytoplasm.
As should be obvious from the above overview on the 
transcription cycle, the last few years have seen the emergence of 
very convincing data to suggest that cells have put in place 
sophisticated checkpoint mechanisms to ensure that transcription is 
productive. In  other words, all the steps from initiation of
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transcription to RNA export are extraordinarily inter-linked, so that 
when a transcription cycle starts this will lead to translatable mRNA. 
This model is sensible, but at the same time very complicated, since it 
predicts inter-communication between different protein complexes. 
Several labs are working on this extremely interesting model, trying 
to reveal the functional network that cells utilize to achieve co­
ordinated regulation of gene expression.
1.2 Elonaator complex
The Elongator complex, which is the focus of this thesis, has 
been isolated from both S. cerevisiae and human cells. The exact role 
of this complex remains unclear, but several lines of evidence indicate 
a role in regulation of chromatin modification, and as a co-factor for 
RNA Polymerase I I  during elongation. Below is presented an overview 
of the Elongator literature. This overview will also be useful as an 
introduction for the next Chapters and the work that is described in 
this thesis.
Purification o f yeast Elonaator complex
As mentioned previously, the form of RNA Polymerase I I  
engaged in transcript elongation is hyper-phosphorylated on the CTD 
of the largest polymerase subunit, Rpbl. The ternary 
RNAPII/DNA/RNA complex is extremely stable and, thus, associates 
with chromatin in a salt-stable manner (Svejstrup et al., 1997). In an 
attempt to identify new transcription elongation-specific factors, 
Otero et al. took advantage of these features to isolate the hyper- 
phosphorylated, elongating form of RNAPII from yeast chromatin
(Otero et al., 1999). Three polypeptides with apparent molecular
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weights of 150, 90 and 60 kDa were found to co-purify with the 
polymerase. Mass spectrometry analysis revealed the identity of 
these proteins and the genes that encode them, which were named 
ELP1 (for EJongator protein 1), ELP2 and ELP3, respectively (Fellows et 
al., 2000; Otero et al., 1999; Wittschieben et al., 1999).
When Elpl protein was purified by conventional means from the 
soluble fraction of yeast extracts it was found to associate directly 
with the Elp2 and Elp3 proteins. The three-subunit complex was 
named “Elongator" and shown to associate directly with the hypo- and 
hyper-phosphorylated form of RNAPII. However, binding was more 
stable with hyper-phosphorylated RNAPII (Otero et al., 1999).
To further investigate the role of the Elongator complex in 
transcript elongation, yeast deletion mutant strains for each of the 
ELP genes were constructed and tested for a number of phenotypes 
(Fellows et al., 2000; Otero et al., 1999; Wittschieben et al., 1999). 
These mutant cells displayed only a slightly slower growth rate than 
wild type under normal conditions (glucose), but showed very 
prominent delays in their ability to adjust to growth in media 
containing other carbon sources, such as galactose, sucrose or 
raffinose. Additionally, all the elpA mutants were sensitive to high 
salt concentrations (1 M NaCI) in the growth medium. Northern blot 
analysis showed that these phenotypes could be directly correlated 
with transcription defects in vivo. In fact, experiments studying the 
kinetics of transcription of several inducible genes revealed that they 
displayed a reduced rate of induction, most prominently at the early 
time points. In contrast, the constitutively expressed genes tested 
were unaffected (Fellows et al., 2000; Otero et al., 1999; 
Wittschieben et al., 1999).
55
The deletion mutants for all of the three initially identified 
Elongator genes also exhibited other phenotypes, such as temperature 
sensitivity and sensitivity towards the transcript elongation inhibitors, 
such as 6-AU (azauracil) and mycophenolic acid. Interestingly, when an 
ELP deletion was combined with a deletion of the gene that encodes 
the transcript elongation factor TFIIS (D5T7), the elpA/dstlA 
double mutant cells displayed hypersensitivity to those inhibitors. 
Sensitivity to these compounds is a common characteristic of cells 
lacking transcript elongation-specific factors, such as TFIIS and 
Spt4/Spt5, suggesting a synergistic role of Elongator and TFIIS in 
transcript elongation (Fellows et al., 2000; Otero et al., 1999; 
Wittschieben et al., 1999).
Database searches revealed that the ELP genes have well 
conserved homologues from yeast to man (Fellows et al., 2000; Otero 
et al., 1999; Wittschieben et al., 1999). Computational analysis of the 
Elpl protein identified domains with weak homology to WD40 and 
Tetratricopeptide repeats (TPR) (Otero et al., 1999). More recently, 
it has also been proposed that yeast Elpl has a putative nuclear 
localization signal (NLS) at the C-terminus (Fichtner et al., 2003). 
Szquer\cz analysis of yeast Elp2 and Elp3 uncovered eight WD40 
repeats for the former, and three C-terminal motifs for the latter 
that are conserved among acetyl-transferases in the GNAT (Gcn5- 
related N-Acetyl-Transferase) super-family (Fellows et al., 2000; 
Wittschieben et al., 1999). Interestingly, Elp3 was also recently found 
to have a N-terminal domain similar to the catalytic domain of S- 
adenosylmethionine (SAM) radical enzymes, suggesting that the Elp3 
might be involved in de-methylation, fo r example of histones 
(Chinenov, 2002). Whether Elongator possesses histone de-
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methylation activity is currently under investigation in the Svejstrup 
laboratory.
The use of in-gel HAT assays suggested that recombinant Elp3 
was capable of acetylating all four histones at their amino-terminal 
tails (Wittschieben et al., 1999). Upon mutating two conserved 
tyrosine residues that are predicted to be directly involved in acetyl- 
CoA binding, this HAT activity was significantly reduced. In addition, 
expression of Elp3 carrying either of these mutations could not 
complement the phenotype of cells lacking ELP3. However, the 
mutated Elp3 molecules could still incorporate into Elongator 
complexes, suggesting an important role for the acetyl-transferase 
activity of Elp3 in Elongator function in vivo (Wittschieben et al., 
2000).
Importantly, cells lacking the ELP3 gene were inviable in the 
absence of the histone H4 N-terminal tail, and temperature sensitive 
when they lacked the histone H3 tail. The interpretation of this result 
was that Elp3 is mainly involved in H3 and to a lesser extent in H4 
acetylation in vivo (Wittschieben et al., 2000). Additionally, elp3A 
cells were also more temperature sensitive when they carried point 
mutations in histone H3 tail sequences encoding the “transcription- 
related" lysine residue 14, or the H4 lysine residues 8 and 16. In 
contrast, this phenotype was not observed when the elp3A deletion 
was combined with mutations in residues primarily thought to be 
related to nucleosome deposition (H3 K9R; H4 K5, 12R), further 
suggesting a role fo r Elp3 in transcription-associated chromatin 
modification and remodeling (Wittschieben et al., 2000).
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Yeast holo-Elonaator is a six-subunit complex
As described above, the Elongator complex isolated from the 
chromatin fraction of yeast whole cell extract was initially thought to 
be a three subunit complex. However, when a ffin ity  tagged Elpl 
protein was purified from the soluble fraction, six proteins were 
found to co-elute in a stoichiometric manner (Winkler et al., 2001). 
The three new proteins were named Elp4, Elp5 and Elp6. Gel filtration 
chromatography confirmed that all six proteins exactly co-purify. 
Experiments, which further support the idea that Elongator is a six- 
subunit complex, will be presented in Chapter 3.
Database searches revealed a number of ELP4 homologues in 
higher eukaryotes, including human and mouse (Winkler et al., 2001). 
Interestingly, the human and mouse Elp4 proteins are encoded by the 
human and mouse PAXNEB genes. The human gene is localized in a 
region implicated in the human disease WAGR syndrome (Wilrn's 
tumour, Aniridia, genitourinary abnormalities and mental Retardation). 
Although simple BLAST database searches with the ELP5 and ELP6 
genes revealed no apparent similarity to any sequence of other 
organisms, more advanced searches identified orthologues across 
eukaryotes, in fungi, C. elegans, Drosophila and mammals (Ponting,
2002). The precise function of the Elp4, Elp5 and Elp6 proteins 
remains unclear. However, sequence-based analysis suggested that 
both Elp4 and Elp6 are distant homologues of P-loop 
ATPases/GTPases, in which the ATPase/GTPase activity has been 
inactivated (Ponting, 2002). The work that will be presented in 
Chapter 3 aims to reveal roles for these three proteins in the context 
of the Elongator complex.
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The purification of a six subunit Elongator complex from the 
soluble fraction of yeast extracts raised the question of why the 
complex between RNAPII and Elongator, purified from the chromatin 
fraction was apparently composed only of three Elongator proteins 
(Elpl, Elp2 and Elp3). One obvious possibility was that chromatin- 
bound Elongator is also a six-subunit complex, but that it is disrupted 
either by anion-exchange chromatography or by the high salt 
concentrations used during the purification procedure. Indeed, when 
the six-subunit purified complex from soluble fraction was subjected 
to Mono Q chromatography and eluted with increasing salt 
concentrations, it was found to be disrupted into two sub-complexes, a 
"large" core-Elongator complex composed of Elpl, Elp2 and Elp3 
proteins and a "small" sub-complex, composed of Elp4, Elp5 and Elp6 
(Winkler et al., 2001). Moreover, as will be shown in Chapter 3, 
affinity resin-associated holo-Elongator could be disrupted into the 
two mentioned sub-complexes upon treatment with high salt. Thus, 
holo-Elongator is a fragile multi-subunit complex, explaining the 
failure to identify all the six subunits in the RNA Polymerase I I  holo- 
enzyme originally isolated from yeast chromatin.
Concomitantly with Winkler et al., two other groups also 
isolated the six-subunit yeast Elongator complex from the soluble 
fraction, by following different purification strategies (Krogan and 
Greenblatt, 2001; Li et al., 2001). Moreover, microarray analysis of 
gene expression in elpA strains, performed by Krogan and Greenblatt 
(2001) showed that, in the elpA cells a subset of genes had reduced 
and that another subset of genes had Increased expression levels, 
compared to wild type. More importantly, the effects of the elp4A 
and elp6A mutations on mRNA expression correlated almost perfectly
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with the effects of elplA and e!p2A, strongly indicating that the two 
sub-complexes have similar effects on gene expression, and thereby 
further supporting the idea that all Elp proteins function in the same 
complex (Krogan and Greenblatt, 2001).
In an attempt to make a crude map of interactions between 
Elongator subunits, Schaffrath and co-workers performed Elongator 
immunoprecipitation experiments using extracts from wild type and 
elpA mutant cells (Fichtner et al., 2002b; Frohloff et al., 2003). Due 
to a lack of antibodies against all the Elp proteins, the authors were 
unable to make firm conclusions about the binary interactions between 
Elongator subunits. The experiments described in Chapter 3 present 
the firs t comprehensive analysis of the molecular architecture of 
yeast Elongator complex.
Overlapping roles fo r the histone acetvl-transferase activities of 
SAGA and Elonaator in vivo
The purified yeast holo-Elongator complex was used in in vitro 
HAT assays, which showed that it has a strong preference for the 
histone H3 tail and to a lesser extent the H4 tail, either in the 
context of core histones or nucleosomes (Winkler et al., 2001). 
Edman-sequencing was used to identify the acetylation target sites. 
The, predominant target was found to be lysine 14 of histone H3 and 
to a lesser extent lysine 8 and lysine 12 of histone H4. More 
importantly, core-Elongator, composed of only Elpl, Elp2 and Elp3, had 
no activity, suggesting that the Elp4/Elp5/Elp6 sub-complex is 
required to make Elongator an active HAT (Winkler et al., 2001).
Combining the ELP3 deletion with GCN5 deletion, (GCN5 
encodes a well-characterized transcription-related HAT), gave rise to
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severe synthetic growth phenotypes (Wittschieben et al., 2000). In 
contrast to the single mutants, the elp3A gcn5A double mutant cells 
were unable to grow on galactose-, raffinose- or sucrose-containing 
medium. The same was true for growth at high temperature (37°C). 
Further studies showed that the functional overlap between Gen5 and 
Elp3 was due to their intrinsic HAT activity, as even combination of 
single point mutations in the active sites of these proteins resulted in 
severe growth defects. Remarkably, mutation of specific de- 
acetyloses (HOS2 and HDA1) suppressed the elp3A gcn5A phenotype, 
suggesting that the Elp3 and Gen5 proteins have a role in maintaining 
an enzyme-regulated balance between acetylation and de-acetylation 
in living cells (Wittschieben et al., 2000).
To support and further extend the above genetic data, the level 
of histone acetylation in different chromosomal regions was compared 
in the wild type, elp3A, gcn5A and the elp3A gcn5A double mutant by 
chromatin immunoprecipitation (ChIP) experiments (Kristjuhan et al., 
2002; Winkler et al., 2002). When the ChIP analysis was focused on 
promoters and coding regions of several randomly selected genes it 
became clear that in the elp3A gcnSA double mutant, the “overall 
level of acetylation" was dramatically reduced, compared to wild type 
cells (Kristjuhan et al., 2002).
Elongator binds RNA co-transcriptionallv
Elongator was originally isolated as a component of native 
elongation complexes containing both template ON A and RNA product 
(Otero et al., 1999). Later on, Winkler et al. reported that Elongator 
could bind DNA and mononucleosomes in vitro (Winkler et al., 2002). 
More recently, the same complex was shown to bind to RNA both in
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vitro  and in vivo. In fact, Elongator, like RNAPII, was found to 
crosslink along the entire length of nascent, un-spliced pre-mRNA in 
vivo (Gilbert et al., 2004). These results strongly indicated that 
Elongator plays a role during RNAPII transcription and that it is a 
component of the RNAPII elongation complex. In Chapter 3 are 
presented experiments, which demonstrate the role of individual 
Elongator subunits in RNA-binding in vivo.
Genetic interaction between Elonaator and other transcription-related 
proteins
In line with the identified physical association of Elongator with 
RNAPII (Otero et al., 1999), genetic data have shown that the ELP3 
deletion is lethal when combined with a deletion of the RPB9 (encoding 
a non-essential subunit of RNAPII) (Van Mullem et al., 2002). The 
same was true fo r the rpb9A gcn5A double mutant cells. This 
correlates with the proposed model by Wittschieben et al. and 
Kristjuhan et al. fo r an overlapping role between Elp3 and Gen5 
(Kristjuhan et al., 2002; Wittschieben et al., 2000).
Moreover, synthetic lethal phenotypes were also observed in 
elp3A ctklA  (CTK1 encodes a subunit of the RNAPII C-terminal 
domain kinase, Ctdkl) (Jona et al., 2001), or elp3A fcplA  double 
mutant cells (FCP1 encodes the RNAPII CTD phosphatase) (Stephanie 
E. Kong, 2004). Finally, synthetic slow growth phenotypes are 
conferred upon combination of ELP deletions with deletions of genes 
encoding subunits of Mediator, the Paf complex, the Sptl6 subunit of 
the general histone chaperone FACT, and histone modifiers such as 
the Sin3/Rpd3 histone de-acetylase and the Rad6 histone 
ubiquitylating enzyme (Formosa et al., 2002; Stephanie E. Kong, 2004).
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Though the significance of these interactions is unknown, they support 
a function of Elongator complex in transcript elongation and chromatin 
modification.
Human Elonaator complex
Following the purification of the human homologues for Elpl and 
Elp3, two independent studies provided biochemical evidence for the 
existence of a human Elongator complex (Hawkes et al., 2002; Kim et 
al., 2002). In both cases, a three-subunit core complex, including 
human Elpl (IKAP), hElp3 and the human homologue of yeast Elp2, was 
identified. However, when Hawkes et al. utilized an alternative 
purification scheme in order to avoid anion-exchange chromatography 
(previously shown to disrupt yeast Elongator), a larger six-subunit 
Elongator was purified. The three additional proteins had molecular 
sizes comparable to the yeast Elp4, Elp5 and Elp6 proteins. Mass 
spectrometry analysis has confirmed that these subunits are indeed 
the human homologues of yeast Elp4, Elp5 and Elp6 (Hawkes et al., 
2002; Svejstrup lab, unpublished data). Similar to yeast Elongator, 
human six-subunit Elongator, but not core Elongator (composed of only 
hEIpl, hElp2 and hElp3), had HAT activity directed against the tails of 
histone H3 and H4 (Hawkes et al., 2002).
The two studies also provided compelling, yet contradictory, 
evidence on the sub-cellular localization of hElongator (Hawkes et al., 
2002; Kim et al., 2002). Hawkes et al. detected IKAP and hElp3 
proteins predominantly in the nucleus of HeLa cells. Some staining was 
also detected in the nucleoli and the cytoplasm. In contrast, Kim et al. 
detected the majority of these proteins in the cytoplasm, and only a 
minor fraction in the nucleus. The reason fo r the dramatic
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differences remains unclear. I t  should also be mentioned that the 
localization studies that have been published for yeast Elongator 
complex also suggest that the majority of the Elp proteins is found in 
the cytoplasm under normal growth conditions (Fichtner et al., 2002b; 
Pokholok et al., 2002). In conclusion, Elongator is believed to be 
predominantly cytoplasmic in most cell types, in spite of having an 
important role in nuclear processes and being present in this 
compartment as well. The cytoplasmic role of Elongator remains 
unknown.
Consistent with data obtained with the yeast complex, 
hElongator also interacts directly with purified RNAPII (Hawkes et 
al., 2002; Kim et al., 2002). Additionally, purified hElongator was 
found in elongation complexes formed in vitro. Moreover, using an in 
vitro reconstituted chromatin template, Kim et al. (Kim et al., 2002) 
showed that hElongator stimulates transcription through nucleosomes 
in an acetyl-CoA-dependent manner, but has no effect on transcription 
on naked DNA.
As mentioned above, the human homologue of the yeast Elpl 
protein is the previously identified IKAP protein. This protein has 
been proposed to be a modulator of different signalling pathways, 
such as NF-kB- and c-Jun N-terminal kinase-dependent pathways 
(Holmberg et al., 2002; Krappmann et al., 2000). However, it is 
currently unknown whether IKAP alone or in the context of the 
Elongator complex has these functions.
Interestingly, mutations in the IKBKAP gene, encoding IKAP, 
have been shown to be responsible for the autosomal recessive human 
disease familial dysautonomia (FD) (Anderson et al., 2001; 
Slaugenhaupt et al., 2001). In this disease there is a major FD
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haplotype, which is the result of a truncated IKAP protein (caused by 
a splice site mutation), and a minor FD haplotype, which disrupts a 
consensus phosphorylation site in IKAP. Finally, the mouse homologue 
of the yeast Elp2 protein is the Stat3-interacting protein (StIPl), 
which was found to regulate the ligand-dependent translocation of 
Stat3 into the nucleus (Collum et al., 2000). Again it is unknown 
whether the other Elongator subunits have any roles in the above 
functions attributed to IKAP and hElp2. From the studies reviewed in 
this section, it is clear that the potentially multiple roles of Elongator 
(or at least Elp proteins) still remain poorly understood.
1.3 Zymocin
In  competing fo r limited resources, microorganisms have 
evolved sophisticated strategies to gain selective advantages over 
their competitors. One of these is the secretion of toxic compounds 
that results in killing or growth arrest of other species or genera. 
Yeast Kluyveromyces lactis secretes a toxin, referred to as zymocin, 
which inhibits cellular growth of various sensitive yeast genera, 
including 5. cerevisiae (Frohloff et al., 2001). Fluorescence-activated 
cell sorter (FACS) analyses revealed that upon encountering zymocin, 
budding yeast cells arrest at the un-budded G1 phase of cell cycle 
with an un-replicated (In) DNA content. The exact way the toxin 
works is not yet known. The initial thoughts that zymocin functions 
either by blocking the production of cAMP, which is essential for 
mitotic growth and cell division, or by antagonizing G1 cyclin function, 
were ruled out (Frohloff et al., 2001). Nevertheless, further evidence 
that zymocin might act in late G1 before START was provided by the
finding that cells, which have been chemically arrested in S phase by
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hydroxyurea prior to zymocin treatment, are able to complete one 
round of cell division and get arrested in the new un-budded G1 cell 
cycle stage when released from the chemical S block in the continued 
presence of zymocin (Frohloff et al., 2001).
The native toxin is a heterotrimeric (apy) structure composed 
of three subunits (Jablonowski et al., 2001b). Cytotoxicity resides 
solely within the y subunit. Intracellular expression of this subunit 
alone in 5. cerevisiae cells is lethal. The a subunit, which exhibits an 
exo-chitinase activity in vitro, and the p subunit, predicted to 
associate with the cell membrane, are required for native zymocin to 
act from the cell's exterior by docking to the cell wall-associated 
chitin and mediating y-toxin translocation.
Elonaator is linked to zvmocin function
Genetic screening for mutations that confer resistance towards 
the intracellular expression of y subunit of zymocin identified seven 
genes that were named TOT1-7 ( Toxin Target) (Frohloff et al., 2001; 
Jablonowski et al., 2001c; Otero et al., 1999). Interestingly, among 
these were all the genes that encode the subunits of yeast Elongator 
complex (Elpl/Totl, Elp2/Tot2, Elp3/Tot3, Elp4/Tot7, Elp5/Tot5, 
Elp6/Tot6) and the Elongator-related Ktil2 protein (Tot4). Deletion 
of any of these genes also confers resistance towards the holo-toxin 
secreted from K. lactis cells. Interestingly, point mutations in Elp3, 
which abolish its HAT activity, also confer toxin resistance. Moreover, 
mutagenesis studies on the ELP3 gene showed that there are 
mutations outside the HAT domain, which confer sensitivity to killer 
toxin, but not the so-called “Elongator" phenotype (separation of 
function mutations) (Jablonowski et al., 2001c). This suggested that
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the requirement of Elongator fo r y tox in  sensitivity could be 
genetically dissociated from general Elongator function. Therefore, it 
was proposed that although the HAT activity of Elp3 is essential for 
zymocin to act, it is not per se sufficient for sensitivity (Jablonowski 
et al., 2001c). The deletion of other HAT-encoding genes, like SA53, 
HPA3, HAT1 and GCN5 did not confer zymocin resistance, further 
suggesting that Elp3 itself and not just any HAT activity is the target 
of the toxin (Kitamoto et al., 2002).
Effects o f mutations in transcription-related penes on zymocin 
sensitivity
In contrast to deletions of ELP, which conferred resistance 
towards zymocin, deletion of most genes encoding subunits of other 
transcription-related complexes rendered cells even more sensitive 
(Kitamoto et al., 2002). This is true for all the genes, which encode 
subunits of the SAGA, the SWI/SNF, the Mediator and the Ccr4-Not 
complex. Zymocin hypersensitivity is also observed in cells carrying 
deletions of transcription elongation-related factors, such as Ctkl, 
Fcpl, and R tfl or mutants of Rpb2. In contrast, histone de-acetylase 
(HDAC)-defective cells displayed either wild type or even reduced 
zymocin sensitivity. Based on this Kitamoto et al. suggested that 
situations which favour histone hyper-acetylation reduce the cells' 
need for the HAT activity of Elongator and therefore reduce zymocin 
toxicity (Kitamoto et al., 2002).
Zymocin targets the RNA Polymerase I I  complex
The physical association of Elongator, which is a primary target 
of zymocin, with RNA Polymerase I I  prompted the Schaffrath
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laboratory to study the effect of the toxin on RNAPII-dependent 
transcription. Low resolution hybridization showed that global poly 
(Ay mRNA levels decline in the presence of zymocin, and Northern 
blot analysis showed significantly reduced levels of certain RNA 
Polymerase II-dependent transcripts (SIC1, CLN3, HHT1 and ACT1) 
upon zymocin treatment (Frohloff et al., 2001; Jablonowski and 
Schaffrath, 2002). The same studies suggested that the presence of 
zymocin correlates with a reduction in the total cellular amount of the 
un-phosphorylated form of RNA Polymerase I I .  Chromatin 
immunoprecipitation experiments suggested that RNAPII became 
stalled in the early coding region of transcribed genes in a toxin- 
dependent manner (Jablonowski and Schaffrath, 2002). Preliminary 
experiments that will be presented in Chapter 4 focus on the effect 
of zymocin on RNA Polymerase I I  protein levels.
In an attempt to reinforce the notion that zymocin action is 
linked to a functional RNA Polymerase I I ,  the Schaffrath laboratory 
studied the effects on zymocin toxicity of genetic conditions known or 
assumed to directly impair RNAPII activity, such as mutations in the 
RNAPII kinase encoded by the BUR1/BUR2 genes, deletion of the 
CTK1, which encodes the a-subunit of the CTDK-I kinase, deletion of 
the 5RB10 CTD kinase gene and inactivation of the kinase activity of 
TFIIH (Jablonowski and Schaffrath, 2002). In all these cases the 
cells exhibited hypersensitivity towards zymocin. Moreover, 
hypersensitivity was caused not only by the impairment of RNA 
Polymerase I I  function by (partial) loss of CTD-kinase activities, but 
also by truncation of the CTD itself, further supporting the idea of a 
functional link between zymocin and the CTD of RNA Polymerase I I  
(Jablonowski and Schaffrath, 2002).
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Ktil2: g new Elonaator subunit?
Apart from ELP, KTT12 was also identified from the genetic 
screen fo r targets of the toxin zymocin. Cells lacking this gene 
displayed slightly slower growth rates under normal conditions, very 
slow growth at high temperature (39°C) and in the presence of the 
transcription elongation-specific inhibitor 6-azauracil (6-AU), as well 
as hypersensitivity to Calcoflour White (indicative of cell wall defect), 
and to caffeine (Fichtner et al., 2002a). Thus, ktil2A  cells display the 
“Elongator" phenotype that was described earlier for elpA mutant 
cells.
Database searches with the KTI12 revealed significant 
homology with proteins from human, mouse, Arabidopsis, Drosophila, 
fission yeast, C. elegans and archaea, suggesting that Ktil2 (like the 
Elongator subunit Elp3), is a universal and ancient protein (Fichtner et 
al., 2002a; Nelissen et al., 2003). Regions of highest homology are 
located within the amino-termini, including a P-loop motif, which is a 
conserved ATP/GTP binding domain. This function seems to be 
essential for the protein, since a 5. cerevisiae amino-terminally 
truncated Ktil2 variant devoid of the P-loop motif failed to 
complement the zymocin resistant phenotype associated with ktil2A  
cells.
The similar phenotypes observed for the 5. cerevisiae elp A and 
ktil2A  cells prompted the Schaffrath laboratory to study possible 
physical interactions between these proteins. Low stringency co- 
immunoprecipitation experiments indicated interaction of Ktil2 with 
Elongator and with the serine 5 phosphorylated form of RNAP I I  
(Jablonowski and Schaffrath, 2002). However, deletion of KTI12 did 
not affect the structural integrity of six-subunit Elongator complex,
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making it unlikely that Ktil2 is a structural component of Elongator. 
Although, co-immunoprecipitation experiments were utilized to map 
the interactions of Ktil2 with Elongator proteins, no firm conclusions 
were reported fo r direct interactions (Fichtner et al., 2002b; 
Frohloff et al., 2001). Therefore, it was obvious that the exact nature 
of the physical and functional interaction between Elongator and Ktil2 
remained to be established (see Chapter 4).
Immunolocalization studies suggested that, like Elongator, Ktil2 
is present mainly in the cytoplasm (Fichtner et al., 2002b). In the 
same study the authors also presented low quality ChIP data 
suggesting that Ktil2 might occupy the promoter but not the coding 
region of the AO HI. Interestingly, this promoter recruitment 
appeared to be enhanced in the presence of zymocin (Fichtner et al., 
2002a). However, data, which will be presented in Chapter 4, argue 
against the presence of Ktil2 only at the promoter of the AOH1 gene.
Model for a functional interplay between Elonaator, K till, Ktil2 and 
Sit4 in zymocin mode o f action
Three recent reports have focused on the role of proteins 
thought to interact physically and/or functionally with Elongator in 
regulating zymocin's mode of action (Fichtner et al., 2003; 
Jablonowski et al., 2001a; Jablonowski et al., 2004). One of these 
proteins is called K t il l (Killer toxin insensitive 11). TAP-tag 
purification of this protein revealed an interaction with the three 
largest subunits of Elongator, Elpl, Elp2 and Elp3 (Fichtner et al.,
2003). Surprisingly, the same laboratory previously reported that 
they could not co-immunoprecipitate any Elongator subunit with the 
K till protein (Fichtner and Schaffrath, 2002). Therefore, the value
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of the data on co-purification must be considered questionable, until a 
functional relationship between the two proteins is presented. The 
authors also reported that the K till protein is dispensable for 
Elongator complex formation. However, they noticed that the Elpl 
protein that co-purified with K till migrated in three distinct forms in 
a SDS-PAGE (Fichtner et al., 2003). Interestingly, the pattern of Elpl 
PAGE migration changed in extracts from KTIU  deletion mutants so 
that the most prominent form was now the faster migrating. Mass 
spectrometry analysis showed that the two faster migrating forms 
were truncations of the full length Elpl protein (the slower migrating 
form). Thus, the authors suggested that Elpl might be prone to 
proteolysis, which is normally suppressed by K till, but failed to 
demonstrate any functional significance for the presence of truncated 
Elpl proteins (Fichtner et al., 2003). Studies in the Svejstrup 
laboratory are now under way to establish the physical and functional 
interaction between Elongator and Ktill.
Genetic data from the Schaffrath laboratory also suggested a 
role for the protein phosphatase Sit4 in the mechanism underlying 
zymocin function (Jablonowski et al., 2001a). Deletion of SIT4 
conferred resistance to the toxin. The same was true for a double 
mutant, which lacked the genes for two activators of Sit4 function 
(Sapl85, 190 (Sit4-associated protein)), suggesting a role for the 
Sit4/Sapl85/Sapl90 complex in zymocin action. Given that mutations 
in the ELP genes also confer resistance towards zymocin and that 
sit4A or sapl85A sapl90A double mutant cells share some phenotypes 
with elpA mutants, such as high temperature sensitivity and 
sensitivity to 6-AU (6-azauracil), Jablonowski et al. studied a possible 
functional link between Sit4 and Elongator (Jablonowski et al., 2004).
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Although, Sit4 was found not to play any apparent role In Elongator 
gene expression, assembly or integrity, it was suggested that it might 
be crucial for de-phosporylation of Elpl (Jablonowski et al., 2004). In 
s it4 A  cells the equilibrium between phosphorylated and un- 
phosphorylated Elpl was shifted towards the former. In contrast, 
cells lacking either KTI11 or KTI12 had no phosphorylated form of 
Elpl, suggesting that the Sit4 and the K til2 /K till proteins have 
antagonistic effects on the phosphorylation of Elpl. Based on the 
above and other observations, Jablonowski et al. proposed a model 
according to which de-phosphorylation of Elpl by Sit4 is needed for 
G1 exit. In the presence of zymocin, sequestration of Elongator 
prevents START execution and G1 exit (Jablonowski et al., 2004). 
However, no direct evidence has been presented for a functional 
significance of the phosphorylation of Elpl and a cell-cycle dependent 
role of Elongator complex.
As should be obvious from the text above, a large and somewhat 
confusing body of recent data has implicated a number of different 
proteins (Ktil2, K till, and Sit4) with the structural integrity and/or 
the role of Elongator in zymocin action. However, very little  is known 
about the real effect of these proteins on Elongator. Studies that will 
be presented in Chapter 4 and others, which are currently under way 
in the Svejstrup laboratory, are focused on providing better evidence 
of these effects.
1.4 Aims of the thesis
The main focus of this study was to provide an outline of the 
molecular architecture of the Elongator complex, identify roles for its 
individual subunits, and uncover the physical and functional
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relationship between this complex and the Ktil2 protein. Additionally, 
the role of Elongator, Ktil2 and Defl protein in the mechanism of 
zymocin action is studied.
Key questions that will be addressed in the next Chapters 
include: what are the roles of the individual Elongator proteins in the 
integrity of the complex and the functions that are attributed to it? 
Does Elongator shuttles continuously from the cytoplasm to the 
nucleus and back? Is there a physical interaction between Elongator 
and Ktil2 and what are the functional consequences of this 
interaction? Is there an overlapping role for Ktil2 and Elongator in 
vivo other than the mediation of zymocin function? Does zymocin 
function lead to degradation of RNA Polymerase II?
73
CHAPTER 2
MATERIALS ANO METHOOS
Many of the methods given here are taken, or adapted from 
Sambrook et al., 1989 (Sambrook J, 1989).
2.1 Commonly used buffers and solutions
Materials used were generally obtained from Sigma and were of 
the highest purity available, unless otherwise stated.
lOx Blue Juice: 0.25% bromophenol blue, 0.25% xylene cyanol FF, 
30% glycerol in deionised water (dH20).
lOx Gel running Buffer (CRB): 0.25 M Tris base, 1.92 M glycine, 
35 mM SDS.
3x Laemmli sample buffer (Laemmli buffer): 20% glycerol, 2% B- 
mercaptoethanol, 9% SOS, 0.1875 M Tris-.HCI pH 6.8, 0.0125% 
bromophenol blue.
LB: 0.5% bacto-tryptone, 0.25% bacto-yeast extract, 170 mM 
NaCI, pH to 7.0 with NaOH. Sterilise by autoclaving.
LB/Amp: LB with 100 //g/ml ampicillin.
PBS; 137 mM NaCI, 2.7 mM KCI, 10 mM Na2HP04, 1.7 mM KH2P04, 
pH to 7.4 with HCI. Sterilise by autoclaving.
PBST: PBS with 0.02% Tween20.
Ponceau S stain: 1.3 mM Ponceau S, 30% (w/v) Trichloroacetic 
acid, 118 mM Sulphosalicylic acid.
5x TBE: 0.45 M Tris base, 0.45 M boric acid, 10 mM EDTA (pH
8.0).
TE: 10 mM Tris.HCI (pH 8.0), 1 mM EDTA (pH 8.0).
Transfer buffer: 25 mM Tris base, 192 mM glycine, 20% methanol.
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YPD: 1% yeast extract, 2% peptone, 2% glucose.
YNB: 0.67% Yeast nitrogen base without amino acids (Difco), 2% 
glucose, appropriate amino acids at 40 ^g/l final concentration.
2.2 General methods
Agarose gels
Agarose gels of 0.7-2% were prepared (Gibco BRL) and run in 
lxTBE. Ethidium Bromide was added to the gel to a final concentration of 
0.5 fjg/ml. Blue Juice was used as loading buffer at a final lx  dilution. Gel 
running equipment was BioRad mini (50 ml gel), which was run at 80 V until 
the required separation was achieved. Gels were visualised on a 
transilluminator (Ultra Violet Products). I f  necessary, DNA bands were 
excised from gel and purified using Qiaquik Gel Extraction kit (QIAGEN) 
according to manufacturer's protocol.
Enzymatic reactions
Restriction digests, ligations and de-phosphorylations were 
performed with buffers and protocol supplied with the enzymes. 
Restriction enzymes and T4 DNA ligase were from NEB, calf intestinal 
alkaline phosphatase was from Boeringher Mannheim. Enzymes and small 
DNA fragments were removed after reactions with Qiaquik Nucleotide 
Removal Kit (Qiagen) according to manufacturers protocol.
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Oligonucleotide preparation
Oligonucleotides were obtained from the CR-UK synthesis service. 
The pellet was dissolved in 200 /yl oligo buffer (0.3 M sodium acetate, 10 
mM magnesium chloride) and 600 cold ethanol was added. The solution 
was placed on dry ice for 15 minutes then centrifuged at 14000 rpm for 
20 minutes at 4°C. The pellet was washed in 80% ethanol in H2O then 
dried in a speed-vac. The oligo was dissolved in sterile water at a final 
concentration of 500 pmol/ /^l.
SbS-Polvacrvlamide Gel Electrophoresis (505-PAGE)
Gels containing 6-10% 37.5:1 acrylamide.bis-acrylamide were cast 
according to Sambrook et al. in Mini-Protean I I  gel system (Bio Rad). 
Alternatively, pre-cast gels from Bio Rad were used according to 
manufacturer's recommendation. Samples to be loaded were mixed with 
3x SDS loading buffer and denatured by incubation at 100°C in a heat 
block for 5 minutes. Gels were subjected to 200 V in lx  Laemmli buffer 
until size markers (Broad Range Protein Markers, New England Biolabs) 
were appropriately separated.
Coomassie stainina of protein gels
For Coomassie staining, the gel was transferred into a clean plastic 
box and Coomassie stain added to cover the gel. This was incubated at 
room temperature with agitation for 30 minutes. The stain was removed 
and kept for re-use. The stain was removed by three 30 minute washes in 
de-staining solution, with the inclusion of a sponge piece to help absorb 
the excess dye. A fte r the stain was sufficiently removed the gel was
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soaked in 5% glycerol in dHzO before air-drying between 2 porous 
cellophane sheets (BioRad).
Coomassie Stain: For 1 Litre; 450 ml dH2O, 450 ml methanol, 100 
ml glacial acetic acid, 1 g coomassie blue.
De-staining solution: 10% methanol, 10% acetic acid in dH2O.
Silver staining of protein oels
After proteins were separated on a SDS-PAGE gel, the gel was 
fixed in Solution 1 fo r at least 1 hour and then in Solution 2 for 30 
minutes. I t  was then rinsed for 1 minute in Solution 3 and washed with 
H2O three times over 1 minute. The gel was then incubated in Solution 4 
for 20-45 minutes before another wash with H2O, as above. The signal 
was developed during incubation in Solution 5 until the desired intensity, 
and the reaction was stopped by incubation in 1% acetic acid for at least
1 hour.
Solution 1 Solution 2
Methanol 50% v/v
Acetic Acid 12% v/v 
Formaldehyde 0.05% v/v
Ethanol 50%
Solution 3
Na2S2 0 3  0.02% w/v
Solution 4
AgN0 2  0.2% w/v
Formaldehyde 0.075% v/v
Solution 5
N qzCOz 6% w/v
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NCI2S2O3 0.0004% w/v 
Formaldehyde 0.05% v/v
Western Blot Analysis
A fte r  proteins were separated by SDS-PAGE, they were 
transferred onto nitrocellulose (Hybond-C, Amersham) using the Mini- 
Protean I I  Western system according to manufacturers instruction. The 
membrane was then blocked for one hour in 5% milk powder (Marvel) in 
lx  PBS, 0.02% Tween before incubation with primary antibodies for 
either overnight at 4°C or two hours at room temperature. The blot was 
then washed three times, 10 minutes in lx  PBS, 0.02% Tween and then 
probed with secondary antibody fo r one hour at room temperature. 
After washing again as above, the signal was visualised with Super Signal 
West Pico Chemiluminescent Substrate from PIERCE according to 
manufacturer's instructions. I t  should be mentioned that all the 
antibodies (Table 2.1) were diluted in 5% milk in PBST (0.02% Tween).
Protein concentration determination
1 fj\ sample extract was added to 800 fj\ dH2 0  in an Eppendorf 
tube, and was mixed by vortex. 200 //I BioRad protein assay reagent was 
added and mixed. The samples were transferred to plastic cuvettes 
(Elkay) and the absorbance at 595 nm determined using a Shimadzu 
spectrophotometer. A standard curve was prepared using this method 
and known concentrations of bovine serum albumin (BSA). From this, the 
concentration of protein in the samples was interpolated (Figure 2 .1).
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(595nm)
0.0668X * 0.0095
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[BSA] (mg/ml)
Figure 2.1 Standard curve from bradford protein reagent using known amounts 
of BSA. The samples were prepared as described above.
Polymerase chain reaction (PCR)
PCR reactions were performed in a DNA Engine (GRI) thermal 
cycler in 50 pi reaction volumes. Templates were either plasmids or yeast 
chromosomal DNA, and oligonucleotides were as listed in Table 2.2. The 
template was denatured for 3 minutes at 95°C and was typically amplified 
by 25-30 cycles of
95°C 2 min Reaction conditions
95°C 30 sec lx PCR buffer 5 pi
52-62°C 1 min Template 100 ng
72 °C 3 min Oligonucleotides 20 pmoles each
72 °C 10 min dATP, dCTP, dGTP, dTTP (Pharmacia)
0.2 mM each 
PFU polymerase (Roche) 1 unit 
Modified conditions were used when necessary.
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2.3 E. coli manipulation
Mini preparation of plasmid DNA from £ coli (Mini preps)
E. coli cultures were grown overnight in 5 ml LB containing 100 
/yg/ml ampicillin and the cells were precipitated by centrifugation. 
Plasmid DNA extraction was prepared using the QIAGEN kit according to 
the manufacturer's recommendations.
Transformation
An aliquot of competent cells (BL21 DE3 or DH5a Library Efficient 
Competent Cells from STRATAGENE) thawed on ice. 1-5 /yl ligation 
reaction or miniprep DNA was added to chilled Eppendorf tubes and 100 
/yl cells were added. A fte r mixing the transformation mixture was 
incubated on ice fo r 30 minutes, then at 42°C for 45sec, then re-placed 
on ice for 2 minutes. 900 p\ LB was added and the cells incubated for 30 
minutes at 37°C, a fter which time samples were plated onto LB plates 
with the addition of the appropriate antibiotic and incubated overnight at 
37°C.
2.4 Yeast manipulation
Preparation of media
Yeast cultures were grown in conical f  lasks in YPD liquid medium at 
30°C, with agitation at approximately 200rpm. The volume of culture did 
not exceed one quarter of the nominal flask volume to ensure adequate 
aeration. Solid YPD media contained 2% agar. Diluted liquid yeast cultures
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were plated fo r single colonies using 5 to 10 sterile 4mm glass balls 
(Fisher) per plate. Normally, yeast colonies were streaked out to give 
single colonies. Plates were incubated at appropriate temperature in the 
dark. In case of solid selective media, YNB with 2% agar and the required 
amino acids were mixed. The carbon source was normally 2% glucose 
unless otherwise stated. Finally, liquid synthetic complete (SC) medium 
was prepared by mixing 3.35 gr. of Yeast Nitrogen Base (SIGMA), and 1.4 
gr. Yeast Drop out Medium Supplement (without histidine, uracil, 
tryptophan and leucine, SIGMA) in 1 I of water. This was sterilised and 
the required amino acids and the carbon source was added.
Phenotypic analysis
Growth analysis under the indicated conditions (high salt, 30°C, 
37°C, 200 ng/ml LMB) was tested either by streaking or by spotting 
serial dilutions of the cells on the appropriate medium. To analyze killer 
toxin sensitivity, K. lactis cells expressing or not the toxin zymocin were 
left to grow o/n on YPD medium, and the next day approximately 10000 
5. cerevisiae cells, from the indicated strains, dissolved in water and 
spotted at the vicinity of the K. lactis. The growth of the different cell 
types was compared to the characteristic eclipse growth of wild type 5. 
cerevisiae cells.
Transformation
A culture of the strain to be transformed was grown to mig- 
logarithmic growth phase. lxlO9 cells were harvested by centrifugation, 
washed twice in TE then re-suspended in 1 ml LiAc solution (0.1M
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L1CH3CO2 pH 7.5 in TE). On top of a cell pellete derived from 200 fj\ of 
the above suspension were added sequentially 240 y\ of PEG (50% 
Polyethylene glycol MW 3350), 36 //I of 1 M LiAc, 25 jyl single stranded 
herring sperm carrier DNA (2 mg/ml) and 50 j j \ of a mixture of sterile 
water and transforming DNA (0.1-10 fjg). The cells were re-suspended by 
vortex and incubated with agitation for 30 minutes at 30°C followed by 
20-30 minutes at 42°C. Finally the cells were precipitated by 
centrifugation at 6000 rpm, re-suspended in 1 ml of sterile TE, and 
plated directly onto the appropriate selective media.
Genomic DNA preparation
Genomic DNA was prepared from 5 ml yeast cultures in YPD or 
selective media, grown overnight at 30°C, using the Yeast Genomic Mini 
Kit from CAMGEN according to the manufacturers protocol.
In  vivo taQQina of yeast proteins
For the construction of both Elp4-HisHA and Ktil2-HisHA strains 
the C-terminus of the open reading frame of both genes was amplified 
using the primers that are shown in Table 2.2 and cloned into 
pSE.HISHA-304, using the Kpn I  and BamH I  sites to produce plasmid 
pELP4-HISHA-304, and pKTI12-HISHA-304, respectively. In both 
cases, after yeast transformation with linearized plasmids, a TRP+ clone 
was isolated in which the 3' end of either the ELP4 or the KTI12 gene 
was replaced by homologues recombination, resulting in expression of an 
Elp4-(His)10-HA or Ktil2-(His)10-HA fusion protein. The presence of the 
tag was confirmed by PCR analysis. To ensure that the (His)lO-HA
epitope tag did not interfere with Elp4 or Ktil2 function, phenotypic 
analysis was performed.
As far as the construction of strains carrying 18Myc-tagged Elpl, 
Elp3 and Ktil2, and 6HA-tagged Ktil2 protein concerns, wild type or any 
mutant cells were transformed with a PCR product, which includes the C- 
terminus of the genes that encode the above proteins and the multiple 
epitopes, using the primers that are shown in Table 2.2. This PCR product 
replaces the endogenous C-terminal region of these genes by homologous 
recombination. The plasmids that were used as a substrate for the PCR 
were kindly provided by Dr. Kim Nasmyth (Knop et al., 1999). Details are 
available on request.
Finally, the GFP-tagged Elp3 strain that was used was constructed 
based on the study from Longtine et al. (Longtine et al., 1998). The 
plasmid that was used as a substrate for the PCR was a kind g ift from Dr. 
Akash Gunjan (Chromosome Dynamics Lab, Clare Hall, CR-UK). The strain 
xpol-1 transformed with plasmids pKW457 and pKW430 was kindly 
offered from Dr. John F. Diffley (Chromosome Replication Lab, Clare 
Hall, CR-UK) (Stade et al., 1997). Dr. J. F. Diffley very kindly also 
provided the strain crmlA CRM1T539C, with the permission from Dr. M. 
Rosbash (Neville and Rosbash, 1999).
Two hybrid interactions
The coding sequence of all the six ELP genes was cloned in both 
'GAL4-activation domain'- and ’GAL4- DNA binding domain'-based vectors 
provided from the GAL4 Two-Hybrid Phagemid Vector Kit (Stratagene), 
using a combination of PCR amplification and sub-cloning from other
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vectors. In order to detect interactions, the plasmids were introduced in 
genetically modified yeast cells provided from the Matchmaker Library 
Construction A Screening Kit (Clontech). The interaction studies were 
done according to the manufacturer's recommendations.
Fluorescent activated cell sorting (FACS)
lxlO7 cells were collected for each sample, re-suspended in 70% 
ethanol, pre-chilled at -20°C and incubated fo r 30min at room 
temperature (cells could stay at this stage for several days at either 
room temperature or 4°C). When cells were ready for analysis they were 
washed twice with 1 ml 50 mM Tris-HCI pH 7.8, before they were re­
suspended in the same buffer containing 10 fx\ of RNAse A (SIGMA, 10 
mgr/ml). A fte r 2-4 hrs incubation at 37°C, cells were precipitated by 
centrifugation and re-suspended in 500 jul FACS buffer (200 mM Tris- 
HCI pH 7.5, 200 mM sodium chloride and 78 mM MgCfe) with the addition 
of 15 /d propidium iodide (1 mgr/ml, SIGMA). At this stage cells could 
also be stored at 4°C. Just before analysis, cells were sonicated for 
lOsec. Fluorescence from intercalated propidium iodide is measured by 
FACScan (Beckton-Dickinson).
Zymocin treatment of 5. cerevisiae cells
K. lactis cells were grown in rich medium for 2 days, harvested and 
200 ml of cell-free supernatant was mixed with 200 ml of 5. cerevisiae 
cells grown at mid-log phase, at a final concentration of 0.5-lxl06 
cells/ml. The S. cerevisiae cells were then left to grow for up to 6 hours 
after the mixing.
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2.5 Protein extraction
Native insect extracts
SF9 insect cells were transformed and processed according to the 
Bac-N-Blue baculovirus protocol (Invitrogen). For the production of crude 
protein extracts the transformed cells were harvested with a mild spin 
(2000 rpm, 5min, 4°C), washed firs t with PBS and then with Hypotonic 
buffer (20 mM Hepes (KOH) pH 7.5, 5 mM KCI, 1.5 mM MgC \ z ) .  After 
incubation on ice with the same buffer for 20min, cells were broken using 
a B pestle bounce homogenizer. To separate the cytosolic extract from 
nuclear pellet the broken cells were spun at 10000 rpm for lOmin, 4°C.
Denatured E. coli extracts
1 ml of E. coli cells was centrifuged at 14000rpm at room 
temperature for 1 minute. The cell pellet was re-suspended in 100 jj\ 3x 
Laemmli buffer per 1 unit of absorbance at 600nm. This was boiled for 5 
minutes, centrifuged and the supernatant retained. 10 //I of this extract 
was sufficient for visualising by Coomassie staining after SDS-PAGE.
Expression of recombinant GST and GST-E!o5 proteins in 
bacteria
In order to generate a GST-Elp5 fusion protein, the ORF of the 
ELP5 gene was cloned in the pGEX-3X vector (Amersham Bioscience), and 
the plasmid introduced in BL21 DE3 competent bacteria cells. Cells were 
grown at 37°C and induced with 1 mM IPTG for 3 hours. A fter cell re­
suspension in PBS (Phosphate buffer saline), lysozyme (50 mg/ml) was
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added, and the cell suspension was incubated for 30 min on ice, and then 
subjected to sonication. The extract was incubated for 1 hour at 4°C with 
Triton X-100 in a final concentration of 1%, and the soluble supernatant 
was collected a fte r a 10 min, 12000 rpm spin at 4°C. This soluble 
supernatant contained GST-Elp5, which was purified and immobilized on 
glutathione beads (Amersham Pharmacia) by incubation for 30 min at 
room temperature. The soluble GST control protein was produced in the 
same way, based on the expression from pGEX-3X vector.
Generation of an anti-Ktil2 antibody (Max Soeciaard)
The Ktil2 ORF was cloned in frame with the GST protein in pGEX- 
3X and the fusion protein expressed in BL21 DE3 by induction with 1 mM 
IPTG for 6 hours at 28°C. Subsequently, Max Soegaard, another PhD 
student in the laboratory, prepared and purified the GST-Ktil2 fusion 
protein. Cells were lysed in PBS by french press and inclusion bodies were 
solubilised by treatment of the pellet with 0.5 % Sarcosyl and sonication. 
GST-Ktil2 was purified on glutathione-sepharose (Amersham 
Biosciences) as described above. The recombinant fusion protein was 
used to immunize rabbits (Imgenex). The resulting antibody was used for 
Western blots at 1:1000 final dilution.
Rapid yeast whole cell extract preparation
Whole cell extracts were prepared as was described elsewhere, 
from the indicated strains (Kushnirov, 2000).
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2.6 Biochemical methods
Antibody couolina to Protein A beads
400 fj\ of 50% protein A slurry (Pharmacia) were re-suspended in 
15 ml PBS, centrifuged at 3000rpm and washed a further two times in 
PBS. The beads were then transferred to a 1.5 ml Eppendorf tube. 0.625 
ml purified 12CA5 antibody solution (stock concentration 1.6 mg/ml, a 
final ratio of 5 mg antibody to 1 ml beads) was added and binding allowed 
for 2 hrs at room temperature with agitation. A fter centrifugation at 
3000rpm the supernatant was discarded and the beads washed into 15 ml 
PBS, and then with a further 2x 15 ml PBS. A borate buffer was 
prepared from 0.1 M boric acid and 0.1 M sodium borate solutions, which 
were mixed in a ratio of 7:4, to give a buffer with pH 9.0. The beads 
were washed twice in 15 ml of this buffer. 0.5 g dimethylpimedilate 
(stored desiccated at -20°C) was dissolved in 50 ml 0.1 M sodium borate. 
The resulting solution was checked to ensure the pH was above 8.5, and 
then 15 ml was added to the washed beads and coupling was allowed to 
occur for 3 hour at room temperature in a tube fixed onto a rotating 
wheel. A fter this time, the beads were pelleted and re-suspended in 25 
ml 200 mM Ethanolamine pH 8 . This step was repeated once more and 
then the beads were incubated at room temperature for 4 hours with 
rocking. Finally the beads were washed three times in PBS and re­
suspended in PBS as a 50% slurry. Sodium azide was added at 0.02% final 
concentration and the beads stored for up to two weeks at 4°C.
In  vitro transcription/translation
The recombinant Elp4 and Elp6  proteins used for the in vitro pull 
down experiments were produced using the TnT T7-coupled wheat germ 
extract systems (Promega) according to the manufacturer's 
recommendations. The DNA template used was pBluescript I I  KS (+/-), 
into which the coding sequence of the two genes was cloned.
In  vitro pull down experiments
Immobilized, baculovirus-expressed histidine-tagged Elpl or Elp2  
and bacterially expressed GST or GST-Elp5 proteins were mixed with 
the product of in vitro transcription/translation (Elp4 or Elp6 ) reactions 
in a buffer containing 250 mM potassium acetate, 100 mM Hepes-KOH 
pH 7.6, 20% Glycerol, 0.1% NP40, lx  protease inhibitors and 4 mM B- 
Mercaptoethanol and incubated overnight with previously equilibrated in 
the above buffer Nickel agarose or GST beads. The next day, the beads 
were washed three times with the same buffer and the bound proteins 
were separated by PAGE on a 10% SDS gel. The Elp4 and Elp6  proteins 
showed weak, non-specific binding to Ni-agarose. Therefore, these beads 
were washed three times with the above buffer but containing 30 mM 
imidazole pH 7.5
Co-immunoprecipitation experiments
For holo-Elongator co-immunoprecipitation experiments, the yeast 
protein extracts that were used had previously subjected to Bio-Rex 
chromatography. 500 fjg protein of the appropriate elution fraction 
adjusted to 500 mM salt in buffer A (see Protein purification) was
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incubated with Sepharose A beads, which had been previously conjugated 
with 12CA5 antibody. The beads were washed three times with the same 
buffer, re-suspended in lx  SDS loading buffer and the bound proteins 
were subjected to SDS-PAGE.
Large scale yeast Elonoator and Ktil2 purification
DNA-free soluble whole cell extract subjected to cation-exchange 
chromatography on Bio-Rex 70 (Bio-Rad) essentially as described 
previously (Winkler et al., 2001). Briefly, for every 90 mg of protein to 
be loaded onto the column, 1 g of Bio-Rex 70 (Bio Rad) was prepared by 
swelling and washing in Buffer A1200 (40 mM Hepes-KOH pH 7.6,1 mM 
EDTA, 1 mM dithiothreitol, 20% (v/v) glycerol containing 1200 mM 
potassium acetate) three times. The resin was then re-dissolved in AO 
(the number following buffer name denotes concentration of potassium 
acetate in milli Molar units) and equilibrated with 3-5 column volumes of 
Buffer A150. Protein was loaded onto the column in a buffer of 
comparable salt concentrations and eluted stepwise with increasing 
amounts of salt (150 mM, 300 mM, 600 mM, and 1200 mM KOAc), at a 
rate of 2  column volumes per hour. Fractions were collected in 1/10 
column volume volumes and either applied to the next column or quick- 
frozen in liquid nitrogen and stored at -80°C. The vast majority of 
Elongator and K til2  were eluted in the fraction containing 600 mM KOAc. 
Typically, 50 ml of this fraction was incubated with 0.8 ml of protein A- 
Sepharose CL4B-12CA5 monoclonal antibody resin (1-3 mg of antibody/ml 
of resin) overnight at 4 °C. The resin was collected by gravity flow in a 
column holder and washed extensively with buffer A containing 600 mM
KOAc and equilibrated in A containing 300 mM KOAc. Bound proteins 
were then eluted in three washes with 1 ml of buffer A containing 
300 mM KOAc and 2 mg/ml HA peptide (KKKRILKMYPYDVPDYARIL) for 
15 min at 30 °C. These fractions were pooled and subjected to Nickel 
agarose chromatography as described previously. Bio-Rex 70 resin could 
be regenerated by a 3-column volume wash of 0.5 M KOH and intensive 
rinsing with H2O until the pH dropped to pH 7.5. Then, it can be stored 
at 4°C in 40 mM HEPES, pH 7.6,1 mM EDTA, 0.02% sodium azide.
Get filtration chromatography
Gel filtration analysis was performed using a Superose 6  column 
connected to a BIOLOGIC FPLC chromatography system (Bio-Rad). The 
buffer used was 2% glycerol, 250 mM Potassium Acetate pH 7.6, 0.1% 
NP-40, lx  protease inhibitors. The column was run at a flow rate of 30 
//l/min and the protein containing fractions (8 -2 0 ) were analysed by 
western blotting. Size markers (Pharmacia) were dissolved in the same 
buffer and run under the same conditions, immediately before and after 
each sample.
Nickel Agarose Chromatography
Typically, 0.5 ml Nickel Agarose (Qiagen) was firs t washed with 
Buffer H before the protein was loaded. Protein was incubated from 5 
hrs to overnight with the resin, which was then washed with 5-10 column 
volumes of Buffer H. Subsequently, the resin was washed with 5 column 
volumes of buffer H including 10 mM imidazole, pH 7.5, followed by 5 
column volumes of buffer H, 50 mM imidazole, pH 7.5. The affinity 
column was then eluted f irs t 3 times with 1 column volume of buffer H,
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100 mM imidazole, pH 7.5 and then 5 times with 1 column volume of 
Buffer H, 500 mM imidazole, pH 7.5. All the fractions were quick-frozen 
under liquid nitrogen and stored at -80°C.
Buffer H
Glycerol 10% (v/v)
HEPES, pH 7.6 40 mM
2-mercaptoethanol 4 mM
Potassium Acetate pH 7.6 300 mM 
Triton X-100 0.1%
Protease Inhibitors (final concentrations: 1 mM PMSF, 10 jug/ml 
Leupeptin, 1 jug/ml Pepstatin A, 10 mM Benzamidine HCI, all from 
SIGMA)
Chromatin immunoprecipitation assay (CHIP)
Strains were grown in YPD media to a density of 1-1.5 x 107 cells 
per ml and fixed in 1% formaldehyde for 30 min at room temperature. 
Cells were lysed in FA lysis buffer (50 mM Hepes pH 7.5,140 mM NaCI, 1 
mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, lx  protease 
inhibitors) and chromatin was fragmented by extensive sonication 
(average fragment size always <500 bp). Whole cell extract from 1 x 107 
cells was used for immuno-precipitations (incubation at 4° C overnight). 
Reactions were cleared by centrifugation at maximum speed in a 
microcentrifuge for 15 min, before 15 i j \ of Protein A slurry (equilibrated 
in FA lysis buffer containing 1 mg/ml bovine serum albumin and 1 mg/ml 
DNA) was added to the supernatant, and the mix was then incubated for 
2 hours. Subsequently, the Protein A washed successive with buffers FA,
FA500 (50 mM Hepes pH7.5, 500 mM NaCI, 1 mM EDTA, 1% Triton X- 
100, 0.1% sodium deoxycholate, lx  protease inhibitors), LiCI (10 mM Tris- 
HCI, pH 8 , 250 mM LiCI, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM 
EDTA, lx  protease inhibitors) and TE containing 100 mM sodium chloride, 
each one for 5 min. The beads were then re-suspended in Elution buffer 
(100 mM Tris-HCI pH 7.8, 10 mM EDTA and 1% SDS-sodium dodecyl 
sulfate) and incubated fo r 10 min at 37°C. The elution was repeated once 
more and the DNA was precipitated by centrifugation after incubation 
with 2.5 volumes cold 100% Ethanol and 1/10 of volume 3M sodium 
acetate pH 5 either 1 hr at -80 °C or overnight at -20 °C. The 
precipitated DNA was re-suspended in TE. 1/30 of immunoprecipitated 
and 1/20,000 of input DNA was used for analysis using a real-time PCR 
machine. For the experiments shown, results were normalised according 
to the amount of input DNA, or the amount of non-specific 
immunoprecipitated DNA. For real-time PCR experiments the results 
were analyzed by Microsoft Excel programme.
In  vitro histone acetvltransferase assay (HA T assay)
Histone acetyltransferase reactions (30 //I) were carried out in 
buffer containing 10 mM Hepes-KOH (pH 7.6), 5 mM MgCfe, 10 mM 
sodium-butyrate, 5 mM DTT, 5% glycerol, 0.25 mg/ml BSA, and 0.25 ijC\ 
(1 Ci = 37 £Bq) [3 H]acetyl-CoA (0.25 mCi/ml, 2-10 Ci/mmol). As a 
substrate, reactions contained 1 0  fjg of core histones commercially 
available, or 5 yg synthetic peptide mimicking the firs t 32 (H2A), 
33 (H2B), 28 (H3), or 27 (H4) amino acids of the histone amino-terminal
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tails. Reactions were carried out fo r 45-60 min at 30°C. To quantitate 
the amount of [3 H] acetate transferred onto the substrate, the 
reactions were stopped onto P81 paper or GF/C glass microfiber filters 
(Whatman). Filters were washed three times in 50 mM sodium carbonate 
(pH 9.2), once in ethanol, allowed to dry, and subjected to scintillation 
counting. Alternatively, reactions were terminated by addition of SDS- 
sample buffer followed by SDS/PAGE using pre-cast 16.5% Tris-Tricine 
peptide gels (Bio-Rad). A fte r staining of the histones with Coomassie 
blue, the gels were dried and subjected to f  luorography.
2.7 RNA-based methods
Total RNA extraction from yeast
For the detection of ELP3 mRNA, total RNA was isolated from an 
equal number of 5. cerevisiae cells from the indicated strains, using the 
RNAeasy mini k it (QIAGEN) according to the manufacturer's 
recommendations. For the detection of 28S and 18S RNA, the gel was 
stained with EtBr in a final dilution of 1:10000 in water.
Northern blot analysis
The preparation of a 2% gel for electrophoresis and the transfer 
of RNAs to a Hybond-N nylon membrane (Amersham) was based on 
Sambrook et al. (Sambrook J, 1989). The probe was a PCR product from 
the coding region of ELP3 gene (Table 2 .2 ), which was labelled using the 
Ready-to-Go bNA labelling beads from Amersham, according to
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manufacturer's recommendations. Finally, hybridization of the membrane 
with the probe was performed using the ExpressHyb kit from Clontech.
RNA immunoprecipitation assay (RIP)
RNA immunoprecipitation was performed essentially as described 
for ChIP (Kristjuhan et al., 2 0 0 2 ), but with some important modifications. 
Briefly, cells were fixed in 1% formaldehyde fo r 30 min at room 
temperature, lysed in FA lysis buffer (50 mM Hepes-KOH, pH 7.5, 140 
mM NaCI, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 
protease inhibitors) containing RNAse inhibitor (RNASIN (Promega)); 50 
U/500 //I buffer), and then nucleic acids were fragmented by extensive 
sonication. Before immunoprecipitation, the extract was treated with 
DNAse (400-500 units RNAse-free DNAse I  (Sigma) per 500 fj\ extract) 
in 25 mM MgCl2 , 5 mM CaCl2 , 3 p\ RNASIN for 10 min at 37°C. Nuclease 
digestion was stopped by the addition of EDTA to 20 mM. Whole cell 
extract from 1 - 2  x 1 0 8 cells was typically used for immuno-precipitations, 
but this varied depending on the abundance of the transcript to be 
probed for. Immuno-precipitation was performed by adding the relevant 
antibody to the DNAse-treated extract and incubating at 4° C overnight. 
Reactions were cleared by centrifugation at maximum speed in a 
microcentrifuge for 15 min, before 15 //I of Protein A slurry (equilibrated 
in FA lysis buffer containing 1 mg/ml bovine serum albumin and RNAse 
inhibitor) was added to the supernatant, and the mix was then incubated 
for 2 hours. All subsequent precipitate washes and the final elution were 
performed as fo r ChIP (Kristjuhan et al., 2002), except that buffers 
contained RNAse inhibitor (50 U RNASIN/500 fj\ buffer). The eluate
fraction was adjusted to 200 mM NaCI, before addition of 20 \ig 
Proteinase K and incubation at 42°C for 1 hr and then at 65° for 5 hrs to 
overnight. The reactions were extracted with an equal volume of acid- 
equilibrated (pH 4.8) phenohchloroform 5:1. Sodium acetate, pH 5 at final 
concentration 0.3 M, 20 jjg glycogen and ice-cold absolute ethanol at final 
concentration ~70% were added to the aqueous layer before 
precipitation at -80° fo r 1-2 hrs. The reaction was centrifuged at 
maximum speed in a microcentrifuge for 15 min and the precipitate 
washed with ice-cold 70% Ethanol. RT-PCR was typically performed on 
freshly prepared RNA using either a one-step reaction protocol as 
instructed by the manufacturer (Roche 'Titan' kit) or a real-time PCR 
machine. Anti-Myc antibody 9E10 (or 9E11) was used to precipitate myc- 
tagged Elp3, or Elpl. RT-PCR samples were separated on a 6 % 
acrylamide/bis (19:1) TBE gel and visualized with Sybr Green (Cambridge 
Bioscience) at 1/10.000 dilution. For real-time RT-PCR experiments, 
analysis was carried out using the ABI Prism 7000 Sequence Detection 
System in combination with TaqMan Reverse Transcription Reagents 
(Applied Biosystems N808-0234) and the results were processed using 
the Microsoft Excel programme. In  contrast to ChIP, the amount of 
input RNA required to give a suitable RT-PCR signal (logarithmic range) 
differs from transcript to transcript in the same RIP assay, because 
transcript levels can d iffe r dramatically from gene to gene. This often 
precludes the use of multiplex RT-PCR.
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2.8 Microscopy
GFP staining
Living cells were collected by centrifugation at 10,000^ for 5 s, 
washed once with PBS re-suspended in a small volume of PBS containing 
10 jugr/ml DAPI (SIGMA) and observed microscopically on poly-lysine 
coated slides. In case of observing fixed cells, the cell pellet was re­
suspended in 1 ml of pre-chilled at -20 °C methanol, by vortex and 
incubated at room temperature fo r 6 min. They then pelleted again as 
previously and re-suspended in 1 ml pre-chilled acetone, by vortex. The 
sample could be stored at this point in dark in -20 °C. In order to 
visualize the sample, cells were spun down and re-suspended again in 2 0  jul 
acetone. 1 0  of those were placed on poly-lysine-coated slides and 
smeared forth and back across the slide with the side of a pipette tip 
until dried. 4 ii\ of DAPI/glycerol (0.3 ^gr/ml DAPI in 50% glycerol) were 
placed on sample and covered with coverslip. At this point the sample is 
ready to visualized or can be stored at 4°C in dark. Sample images were 
taken and processed by a combination of Zeiss Axioplan microscope and 
appropriate filte r  sets, digital camera (HAMAMATSU C4742-95), and 
Openlab 2.0.8 application (Improvision).
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List of primary Antibodies Dilution for
Western blot
Rabbit Polyclonal Elpl 1:500
Rabbit Polyclonal Elp2  1:250
Rabbit Polyclonal Elp3 1:2000
Rabbit Polyclonal Elp4 1:1000
Rabbit Polyclonal Elp6  1:1000
Rabbit Polyclonal Ktil2 1:1000
Rabbit Polyclonal 9110-100 (HA, Abeam) 1:2000
Rabbit Polyclonal Medl (kind g ift from
Dr. Bjorklund 5.) 1:2000
Mouse Monoclonal 4H8 1:1000
Mouse Monoclonal 8WG16 1:1000
Mouse Monoclonal H14 (Covance) 1:1000
Mouse Monoclonal 9E10 or 9E11 1:1000
Anti-GST (Goat, Amersham Pharmacia) 1:1000
Anti-Tubulin (Rabbit, Oncogene) 1:100
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List of secondary Antibodies (SIGMA) Dilution for
Western blot
Anti-mouse IgG 1:10000
Anti-rabbit IgG 1:10000
(1:20000 for Elp3, 4, 5 and 6  primary Abs)
Anti-goat IgG 1:10000
Table 2.1 List of primary and secondary antibodies 
used for Western blot
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LIST OF OLIGONUCLEOTIDES
Name Sequence (5*—►S') Use for
Elp4Ade5' CATTGTATAACAAATTCGGCTCCCAAA
TATCGCATGTACCATGCGGCATCAGAG
CAG
ELP4 K/O
Elp4Ade3* AAAAGCATGCCGTATATTTCCCATAAA 
TTGAACCAT ATTCCTT ACGCATCTGTG 
CGG
ELP4 K/O
Elp5Kan5* GCTCCAACCCAAGCT A TTGCTACAGGT 
AGAACAAGAT AT ACAGCTGAAGCTTC 
GTACGC
ELP5K/0
Elp5Kan3' AATCTGGAAGCACTCACT ATTT ACCAT 
CAGAAAGATGAAATACGACTCACTATA 
GGGAGACC
ELP5 K/O
Elp6Trp5* ACCGTCCAGAACCTCCACAAAAATAAC 
TAAATACACA \ 1 1ATGCGGCATCAGAG 
CAG
ELP6 K/O
Elp6Trp3* TACGAGAATCAATGTGCCTCGT ATAT A
ATCTTATCATTATCTTACGCATCTGTGC
GG
ELP6 K/O
Elp4His5* GGCCGGGGTACCGGGGCTGCCGCTGGGA
AACTCTG
HisHA tagged 
Elp4
Elp4His3‘ CCGGCCGGATCCATAGTCTAAAGA
TATCTTGGTCT
HisHA tagged 
Elp4
100
Ktil2k/o5* GGGTAAAGGGACCTTGTAAAACTTTT
GAAAAAACTCCGGTTCTGCTGCTAGT
KTI12 K/O
Ktil2k/o3* CGTCTTGCCATTTACCTYCTGAT ATT AA 
TCACATGTATACCTCGAGGCCAGAAGAC
KTI12 K/O
GST-Ktil2 5 CGGTCGACGGATCCAGATGCCACTGGTG
CTTTTTACGGG
GST-tagged
Ktil2
GST-Ktil2 3 GCTCGATCCGAATTCAAGTTTTTGTTA
AGATAATCAGCG
GST-tagged
Ktil2
Ktil2HisHA5‘ GGCCTGGGGT ACCAGACAACGCTTGCT A 
AACA111GGT
HisHA tagged 
Ktil2
Ktil2HisHA3‘ CCGGACCGGATCCATTCAAGTTTTTGTT
AAGATAATCAG
HisHA tagged 
Ktil2
Ktil2(6HA)5*
or
Ktil2(18Myc]
CCGC1 1 1 1CGCTGATT ATCTT AAGAAAA 
A CTTGAA TTCCGGTTCTGCTGOTAGT 
5*
6 HA and 
18Myc tagged 
Ktil2
ELP3-pFA6a-
F2
ATGGTAAACTAGGATATGAACTAGACG 
GTCCAT ACATGTCGAAAAGAATTCGGA 
TCCCCGGGTTAATTAA
GFP-
tagged
Elp3
ELP3-pFA6a-
R1
CTGCTTGGA AAA CCGGCCATGTCGGCG 
GCACAT AAAAGTTCT ATTT ACCTGAAT 
TCGAGCTCGTTTAAAC
GFP
tagged
EId3
pl38 ATGCTTCTCGAGATGGCCAGTTCGTCAC
ATAAC
Cloning 
of ELP5 
in pBS
pi 39 TCT AGAGTCGACTT AAAGGGATCCTCAT 
AATG
Cloning 
of ELP5 
in pBS
kapl20 5' GATGAGCATCCTCAGTCAAGATGAATA
AAATAATCTCTCCAAATAAGCCTCCGGT
TCTG
KAP120
K/O
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kapl20 3' AAAGATACCACTGTAATGTTGTTAGTCGAA
AAGAC
KAP120
K/O
GAL4BDEIpl 5 ' GGCTCAGGAATTCATGGTTGAACATGACAA 
GAGTGGGTCAAAGAGGC
Cloning 
of ELP1 in 
two-hybrid 
vector
GAL4BDEIp2 5 GGCTCAGGAATTCATGGTGGAATGT ATCAC1 
CCCGAAGCCATTTTTA
Cloning 
of ELP2 in 
two-hybrid 
vector
GAL4BDEIp3 5 GGCTCAGGAATTCATGGCTCGTCATGGAAAA
GGCCCAAAAACTAACA
Cloning 
of ELP 3 in 
two-hybrid 
vector
GAL4BDELP5 IYGGCTCAGGA ATTCATGGCCAGTTCGTCACA1 
AACCCTGTCATTCTTT
' Cloning 
of ELP5 in 
two-hybrid 
vector
pl32 TCTAGAGTCGACTCAAAAATCAACAATATG
ACTC
Cloning of 
ELP1 in 
two-hybrid 
vector
pi 34 TCTAGAGTCGACCTATTCATATGCTAATGA
GTATATAC
Cloning of 
ELP2 in 
two-hybrid 
vector
pl36 ATGCTTCTCGAGATGTCA 1 1 VCGTAAAAG 
AGG
Cloning of 
ELP4 in 
two-hybrid 
vector
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3137 TCT AGAGTCGACTT AATAGTCTAAAGAT A 
TCTTG
Cloning of 
ELP4 in 
two-hybrid 
vector
3139 TCT AGAGTCGACTT A A AAGGGATCCTCAT 
ATG
Cloning of 
ELP5 in 
two-hybrid 
vector
pl41 T CT AGAGTCGACTT AGCGATAAAAT AGT 
11 \GTTG
Cloning of 
ELP6 in 
two-hybrid 
vector
p60EXP. C-t CGGCCCGTCGACTT AAATTCTTTTCGACA 
TGTATGG
Cloning of 
ELP3 in 
two-hybrid 
vector
p60seql ATGGCTCGTCATGGAAAAGG Elp3 probe 
for Nor­
thern blot
p60seq7 GGCTACCACTGCAATACCCGA Elp3 probe 
for Nor­
thern blot
adhlprom real 
time fw TGCTATCAAGTATAAATAGACCTGCAATT ChIP
adhlprom real 
time rv GTGCAGAAAAAGAAACAAGGAAGAA ChIP
GAL1-D1-REAI
-F I
. GATCCTTCTGTGTCGGACTGG RIP
GAL1-D1-REAI
-R1
. GGAGCACTGGCAAACCTTTC RIP
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adhl late orf 
real time fw TTAGTCGGTGGTCACGAAGGT ChIP
adhl late orf 
real time rv TTCCAGCCCTTAACGTTTTCA ChIP
fbal prom real 
time fw GCTTCAATTACGCCCTCACAA ChIP
fbal prom real 
time rv CC&TTAGACAACATGAGGGAT AAA ChIP
BAT1-REAL 
-D l-F
TTGGCGACAAAAAATTGGGT ChIP
BAT1-REAL
-D l-R
TGGGCCGAACAACCATAGAT ChIP
SSA4-REAL-
Dl-F
TACATTG&AGCCAGTGGAAAAAGTT ChIP
SSA4-REAL-
Dl-R
TCACCCGTT AAGATGGCAGCCTGTA ChIP
CHR4-REAL-F CTGGCTTAAACCAGCACTATGTATA ChIP
CHR4-REAL-R CCAAACAACTATSTAGGACATATTT 
TTACA
ChIP
Table 2.2 Oligonucleotide sequences
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LIST OF YEAST STRAINS
Reference/
S. cerevisiae
W303-1A MATa (Thomas and Rothstein, 1989)
W303-1B MATa (Thomas and Rothstein, 1989)
JSY 100 \AATa elplA:LEU2 (Otero et al., 1999)
js y  1 1 8 MATa elp2A::LEU2 This study
jsyi30 MATa elp3A::LEU2 (Wittschieben et al., 1999)
JSY672 MATa elp4A::ADE2 (Winkler et al., 2001)
JSY784 MATa elp5A::KAN (Winkler et al., 2001)
JSY786 MATa elp6A::HIS3 (Winkler et al., 2001)
JSY787 MATa elplA::LEU2 elp4A:: 
ADE2
(Winkler et al., 2001)
JSy489 MATa ELPl(HiSi0-HA):: TRP1 (Winkler et al., 2001)
JSY666 MATa ELP4(HiSi0-HA):: TRP1 This study
JSY662 MATa elp2A::LEU2 
ELPl(HiSin-HA):: TRP1
This study
JSY964 MATa elp3A::LEU2 
ELPl(His10-HA ):: TRP1
This study
JSY965 MATa e/p4A*.*ADK
ELPl(HiSi0-HA):: TRP1
This study
JSY973 MATa elp5A::KAN
ELP4(HiSi0-HA ):: TRP1
This study
JSY974 MATa elp6A::HIS3
ELP4(HiSi0-HA ):: TRP1
This study
JSY754 MATa ELPl(MyC18)::HIS3 This study
JSY969 MATa elp3A::LEU2 
ELPl(MyC18)::HIS3
This study
J5V777 MATa ELP3(MyC18)::HI53 (Gilbert et al. 2002)
J5y968 MATa elp2A::LEU2 
ELP3(MyCi8)::HIS3
This study
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JSY975 MATa elp4A::AbE2 
ELP3(MyC18)::HIS3
This study
JSY95 MATa ktil2A::URA3 This study
JSY142 MATa gcn5A'-:HIS3 [Kristjuhan et al., 2 0 0 2 )
JSY 144 MATa elp3A::LEU2 gcn5A:: HI53 (Kristjuhan et al., 2002]
JSY970 MATa ktil2A::URA3 
Elpl(MyC18)::HIS3 This study
J5Y960 MATa KTI12(HA6)::HIS3 This study
JSY993 MATa KTI12(MyC18)::URA3 This study
JSY996 MATa KTI12(HiSio'HA)::TRP1 This study
JSY994 MATa elp2A::LEU2
KTT12(M yCi*):: UR A 3
This study
JSY995 MATa elp3A::LEU2
KTI12(M yC18):: UR A 3
This study
JSY1001 MATa ktil2A::URA3 gcn5A::HIS3 This study
JSY963 MATa kapl20A::HIS3 
ELP3(GFP):: TRP1
This study
JSY978 MATa xpolA::LEU2 ELP3(GFP)::TRP1 
* pKW457(xpol-l)::HIS3 This study
JSY976 MATa crmlA::LEU2 ELP3(GFP)::TRP1 
+ pD(T-«Aiir539^ This study
JSY569 MATa deflA::URA3 (Woudstra et al., 2002)
MGSC 102 MATa rad26A::HIS3 (Woudstra et al., 2002)
JSY624 MATa deflA::URA3 rad26A::HIS3 (Woudstra et al., 2002)
JSY676 MATa deflA::URA3 elp3A::LEU2 (Reid J., 2004)
JSY991 MATa ktil2A::URA3
gcn5A::HI53 elp3A::LEU2
This study
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JSY992 MATa ktil2A::URA3 gcn5A::HI53 
hos2A::TRPl hdalAr.KAN This study
> MATa xpolA::LEU2
* pKW457(xpol-l)::HIS3 (Stade et al., 1997)
> MATa crmlA::LEU2
+ dDC-CRMI T539C (Neville and Rosbash. 1999)
> MATa radl4A::LEU2 (Woudstra et al., 2002)
> MATa radlA Kind g ift from Dr. L. Prakash
> MATa rad 10A Kind g ift from Dr. L. Prakash
Reference/
Strain Mating type ________________Source
K. lactis
IFO 1267 MATa (toxic) Kind g ift from Prof. Michael J. R. Stark
MBK 801 MATa (non toxic) Kind g ift from Prof. Michael J. R. Stark
Tabic 2.3 List of yeast strains
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CHAPTER 3
YEAST HOLO-ELONGA TOR: STRUCTURE- 
FUNCTION ANALYSIS AND LOCALIZATION
STUblES
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3.1 Introduction
Yeast Elongator complex was initially isolated from yeast 
chromatin as a three subunit complex associated with the hyper- 
phosphorylated elongating form of RNA polymerase I I  (Otero et al., 
1999). The three proteins were named Elpl, Elp2 and Elp3, 
respectively, and were also found to form a complex in the absence of 
RNA polymerase I I .  Further studies with soluble, chromatin-free 
fractions from cells expressing a double affinity-tagged Elpl protein 
showed that the true form of Elongator is a six-subunit complex, 
named holo-Elongator. The three additional Elongator proteins were 
named Elp4, Elp5 and Elp6  (Winkler et al., 2001).
Holo-Elongator can be disrupted into two sub-complexes by 
anion exchange chromatography (Winkler et al., 2001). Core Elongator 
consists of Elpl, Elp2  and Elp3 and the small sub-complex consists of 
the three remaining proteins (Elp4, Elp5 and Elp6 ). Disruption during 
chromatography can possibly explain why the small sub-complex was 
not found associated with the “elongating" form of RNA polymerase 
I I ,  since the initial purification scheme included a monoQ column 
(Otero et al., 1999). The six-subunit complex but not the core 
complex, posses histone acetyl-tranferase activity against mainly 
histone H3, suggesting that the small sub-complex is indispensable for 
this function (Winkler et al., 2002). More recently, holo-Elongator was 
shown to bind RNA in vitro and in vivo (Gilbert et al., 2004).
Although the above data clearly suggest a role fo r the 
Elongator complex in the nucleus, a number of localization studies have 
created controversy over the last few years. Thus, two independent 
studies in yeast and one in mammalian cells showed that the majority
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of Elongator is found in the cytoplasm, whereas another one clearly 
showed Elongator to primarily be in the nucleus in mammalian cells 
(Fichtner et al., 2002; Hawkes et al., 2002; Kim et al., 2002; Pokholok 
et al., 2002). Finally, a more recent study suggested that yeast Elpl 
has a nuclear localization signal, which can locate GFP to the nucleus 
(Fichtner et al., 2003).
I t  is well established that a number of transcription factors, 
from yeast to man, shuttle between these two compartments rather 
than continuously occupying the nucleus. The firs t nuclear transport 
receptor that was identified, capable of both importing and exporting 
proteins, was the importin/exportin-p family member Crml (also called 
exportin 1/Xpolp) (Neville and Rosbash, 1999). Crml has now been 
identified as the nuclear export signal (NES) receptor for a variety of 
proteins, which include transcription factors, kinases and the 
cytoskeletal component actin (Neville and Rosbash, 1999). These 
proteins belong to a family of proteins containing leucine-rich NESs. 
These signals are short sequences (~10 amino acids) with critically 
spaced hydrophobic residues that are essential for export activity. 
Crml-dependent export is the only well studied export mechanism in 
5. cerevisiae (Neville and Rosbash, 1999). Other members of the 
importin-p family in 5. cerevisiae are called karyopherins. Like Crml, 
these other factors act as receptors for both imported and exported 
cargoes. A non-essential gene, encoding the Kapl20 protein, was shown 
recently to play a role in mediating the export of the 60S ribosomal 
subunit (Stage-Zimmermann et al., 2000). Deletion of the S. 
cerevisiae KAP120 gene was shown to confer sensitivity towards the 
toxin zymocin, a phenotype which is also characteristic of e/pA 
mutants. The interpretation of this result was that Kapl20 might play
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a role in nucleocytoplasmic distribution of Elongator (Fichtner et al., 
2003).
The aim of the experiments described in this chapter was to 
confirm biochemically and genetically that Elongator exists as six- 
subunit complex in cells, map important interactions among its 
subunits, identify possible roles for them in the identified functions 
of the complex, and explore the possibility that Elp3 actively shuttles 
from the cytoplasm to the nucleus.
3.2 Purification of holo-Elongator following the Elp4 
protein
I f  Elongator indeed consists of six subunits, it should be 
possible to isolate this complex by purification of any Elp protein 
tagged with the epitope used previously for Elpl (Winkler et al., 2001). 
Based on the fact that holo-Elongator is composed of two sub­
complexes, we considered it relevant to isolate Elongator from cells 
expressing a tagged version of one of the components of the small 
sub-complex. A haploid strain expressing a tagged version of the Elp4 
protein was therefore constructed. The endogenous chromosomal copy 
of ELP4 was modified so that the full-length of Elp4 would be fused to 
a tag encoding a carboxyl-terminal decahistidine stretch and a HA 
epitope. A schematic representation of this Elp4 molecule is depicted 
in Fig. 3.1A. A fter genetic verification that the tag did not interfere 
with Elp4 function (these cells, in contrast to elp4A mutants, were not 
temperature sensitive), the soluble fraction of whole cell extracts 
from these cells was isolated. The three step purification scheme that 
was followed is shown in Fig. 3.IB. The firs t step was Bio-Rex 70
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chromatography. The proteins eluted from this resin with moderate 
high salt concentration (600 mM potassium acetate) were loaded onto 
12CA5-conjugated Sepharose A beads. After overnight incubation and 
thorough washing, competition with 1 mg/ml HA peptide was used to 
elute the bound proteins, which were then incubated with Ni+-agarose 
beads. A fter washing, the bound proteins were eluted with 500 mM 
imidazole, yielding purified holo-Elongator (Fig. 3.IB lane 1). As can be 
seen, however, the three small subunits were super-stoichiometric 
(Fig. 3.IB compare lane 1 with 3). Interestingly, when the affinity 
column (HA) was washed with 2 M NaCI, only the three smaller 
subunits, Elp4, Elp5 and Elp6  co-purified, suggesting that holo- 
Elongator can be disrupted into two sub-complexes by high salt (lane 
(2)). Therefore, we can conclude that holo-Elongator behaves 
biochemically as a fragile six-subunit complex, which is particularly 
unstable under high salt conditions.
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HisHA
B
HHHHHHHHHHYPYDVPDTA
Yeast soluble 
fraction  
from  Elp4-H isH A  
cells
I
Bio-Rex 70
I
12CA5 a ffin ity  
resin
I
Ni*-agarose
Elp4-HisHA
Elp5
Elp6
(1) (2) (3)
Figure 3.1. Purification of Elp4-HisHA from soluble yeast extract.
A, Schematic representation of HisHA-tagged Elp4 protein. 9, 
Purification scheme and silver staining. Lane (1) is holo-Elongator 
eluted from Nr-agarose following the purification of Elp4-HisHA 
protein. Note that tagged Elp4 migrates at the same position as Elp3. 
Lane (3) is holo-Elongator obtained from the purification of Elpl- 
HisHA protein (Winkler et al., 2001) and is used as a control. High salt 
treatment of Elp4-HisHA bound to 12CA5 affinity resin resulted in 
disruption of the two sub-complexes (lane (2)). The asterisk indicates 
an irrelevant contaminant.
3.3 Genetic evidence that holo-Elongator is a six-subunit 
complex
To investigate genetically whether all the six co-purified
subunits function in the same cellular process, phenotypic analysis of
cells carrying deletions in the genes encoding the three smaller
Elongator subunits was performed. The three deletion mutants were
constructed and tested for growth in the presence of high salt (1 M
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NaCI) and at high temperature (39°C). Fig. 3.2A, B, shows tha t the 
three mutants were as sensitive as the elplA  cells under these 
conditions. Moreover, the double mutant elp lA /e lp4A  cells did not 
show any additional growth defect. Similar results were also observed 
in experiments under a number of other conditions (performed by 
others), which fu rth e r supported the idea that all the six Elongator 
subunits are involved in the same biochemical pathway in the cell.
A
yPD yPD+1 M NaCI
W303
elplA
elp4A
elp5A
elp6A
elplA/elp4A
w303
Figure 3.2. Phenotypic analysis of elpA mutant cells. A, Drop test 
assay to compare the growth of wild type and elpA mutants in the 
presence or absence of high salt. B, Comparison of growth of wild type 
and elpA mutants on YPD plates at 30°C and 39°C.
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3.4 The Elp3 protein levels are greatly reduced in elpl A 
mutants
A common feature among multi-subunit complexes is that the 
absence of one of the subunits affects the stability of the others. In 
order to investigate whether this also applies to holo-Elongator, the 
protein levels of different Elongator subunits in wild type and all the 
elpA mutant cells were monitored. Unfortunately, our antibodies 
against the Elpl and Elp2  proteins were unable to consistently detect 
these proteins in yeast whole cell extracts, precluding us from 
extending the studies to these proteins as well.
Whole cell extracts from wild type and all the elpA mutant cells 
were subjected to immunoblotting and antibodies against the Elp3, 
Elp4, Elp5 and Elp6  proteins were used for the detection of the 
respective Elongator subunits. The expression levels of a-tubulin 
protein were used as loading control. Fig. 3.3A shows that, the protein 
levels of all the three small subunits, Elp4, Elp5 and Elp6  (middle and 
lower panels) were similar in wild type and elpA mutant cells. In 
contrast, the Elp3 protein levels appeared to be somewhat reduced in 
all elpA mutants and the protein was not even detectable in elplA 
cells. However, independent biochemical studies from cells lacking 
ELP1 showed that a small amount of Elp3 could be detected by 
immunoblotting analysis a fte r several steps of concentration and 
purification (Max Soegaard, PhD student in the lab), suggesting that 
very small amounts of Elp3 may remain in those cells. Northern blot 
analysis revealed that the ELP3 gene is normally transcribed in mutant 
e/pA cells, apart from elp3A, as expected (Fig. 3.3B). This indicated 
that the stability of Elp3 protein requires Elpl.
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Elp3 
a - tubulin
Elp4
Elp5 
a-tubulin
Elp6
a-tubulin
B
ELP3
28S
185
n—
_____
Northern blot
Ethidium bromide 
staining
Figure 3.3. Stability and expression of Elongator subunits. A, The
presence of Elp3 (upper panels), Elp4 and Elp5 (middle panels), and 
Elp6 (lower panels) in wild-type and elpA mutant yeast cells was 
examined by Western blotting, using anti-Elp antibodies. Detection of 
a-tubulin was used as a loading control. Note that the relevant Elp4 
band in the d iffe ren t cell types is the lower one. The reduced mobility 
of the Elp4 protein in the control lane with pure Elongator (“purified" 
lane) is due to the HisHA tag. B, mRNA levels of the ELP3 gene in the 
indicated elpA mutants examined by Northern blotting. Ethidium
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bromide staining of 28S and 18S subunits of rRNA was used as a 
loading control.
3.5 Protein-protein interactions among Elongator subunits
To investigate protein-protein interactions in the Elongator 
complex, co-immunoprecipitation experiments from different elpA 
deletion strains were performed. For these experiments, whole cell 
extracts (WCEs) were prepared from cells expressing a tagged 
version of an Elongator subunit while lacking another one, for example 
from elp2A cells expressing Elpl-HisHA. The strains that were used 
are shown in Table 2 .2 . To construct these strains, single elpA 
deletion mutants were mated with cells expressing a tagged version 
(decahistidine stretch and a single HA epitope tag) of Elpl or Elp4. 
The diploid cells were induced to sporulate, and then tetrads were 
dissected. Spores with both markers (one obtained from the deletion 
of the ELP gene and the other from the tagged version of Elp) were 
selected. Whole cell protein extracts were prepared from these cells. 
At firs t, the whole cell extracts were pre-cleared on Sepharose A 
beads, and then loaded onto 12CA5-conjugated Sepharose A beads. 
However, western blot analysis with an antibody, which recognises the 
HA epitope, showed that only a small fraction of these single-HA 
tagged proteins (either Elpl or Elp4) was found on the beads, thereby 
precluding firm  conclusions fo r the co-immunoprecipitated Elp 
proteins. I t  was already known from previous large-scale purification 
studies that the 12CA5-conjucated Sepharose A beads are able to 
immunodeplete the single HA-tagged Elpl protein found in the elution 
fractions from Bio-Rex 70. Importantly, Elongator was found to elute
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as an intact six-subunit complex at moderate salt concentration from 
this weak cationic resin. Therefore, to enable high-efficiency 
immunoprecipitation and to increase specificity, extracts derived 
from the d ifferent strains were firs t subjected to small-scale 
chromatography on Bio-Rex and the 600 mM potassium acetate elution 
fractions were then loaded onto 12CA5-conjugated Sepharose A 
beads.
As shown in Fig. 3.4A, Elongator could under those conditions be 
specifically immunoprecipitated from wild-type cell extracts 
expressing tagged Elpl (right panel), but not from control cells that 
did not express a tagged Elongator protein (le ft panel). Remarkably, 
when the ELP2 gene was deleted, Elpl still interacted with the five 
remaining subunits, although the three smaller proteins Elp4, Elp5 and 
Elp6 appeared to be somewhat sub-stoichiometric (Fig. 3.4B, le ft 
panel). This experiment suggested that the Elp2 protein is not 
absolutely required fo r the integrity of the holo-Elongator complex, 
but may serve as a stabilisation factor between core Elongator, 
composed of Elpl, Elp2 and Elp3, and the “small" sub-complex 
composed of Elp4, Elp5 and Elp6.
When extracts from cells lacking the ELP3 gene were used, only 
Elpl was detected in the precipitates, which indicated that none of 
the remaining five subunits interacts strongly with Elpl (Fig. 3.4B, 
middle panel). I t  should be mentioned that the Elp2 protein levels 
seemed to be reduced in elp3A cells, something that was noticed in all 
the elpA mutants tested. Unfortunately, as mentioned above the 
stability of Elp2 in d ifferent mutant extracts could not easily be 
directly assessed by performing western blot analysis on whole cell 
extracts, because our anti-Elp2 polyclonal antibody was unable to
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consistently detect this protein in crude extracts. However, the 
remaining small amount of Elp2 that could be detected in Bio-Rex 
eluates was found not to co-immunoprecipitate with Elpl (Fig. 3.4B, 
Elp2 blot middle panel). Therefore, because a three-subunit Elpl-Elp2- 
Elp3 complex does exist as a stable entity (Otero et al., 1999), it can 
be concluded that Elpl and Elp2 both interact with Elp3 but not with 
each other. An additional conclusion is that none of the small subunits 
interacts strongly with Elpl. Thus Elp3 seems to be essential not only 
for catalytic function, but also for the integrity of the Elongator 
complex.
In the absence of Elp4, the Elpl protein could still interact with 
Elp3 (Fig. 3.4B, right panel). However, in this case the Elp2, Elp5 and 
Elp6 proteins could not be detected, even in the inputs. This can be 
explained in two ways: either these three proteins no longer co-elute 
with Elpl and Elp3 from Bio-Rex when Elp4 is absent, or deletion of 
the ELPA gene resulted in reduced Elp2, Elp5 and Elp6 protein levels. 
However, previous experiments (Fig. 3.3A middle and lower panels) 
showed that Elp5 and Elp6 protein levels were not decreased 
significantly in any of the elpA mutants. Therefore, it is reasonable to 
conclude that these two proteins do not directly contact Elpl or Elp3. 
In the case of the Elp2 protein, firm conclusions on its fate in elpAA 
extracts are not possible, because of the poor quality of the anti-Elp2 
antibody. However, because previous studies have shown that core 
Elongator (Elpl/2/3) exists on its own when separated biochemically 
from the "small" sub-complex (Winkler et al., 2001), the most likely 
possibility is that the ELPA deletion results in reduced Elp2 protein 
levels. This interpretation would in turn suggest that the presence of 
Elp4 is not necessary for the integration of Elp2 in core Elongator. In
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conclusion, Elp4 is required fo r stabilisation of Elp2 and the 
association of the small sub-complex Elp4/5/6 with Elpl.
NO TAG Elo1-HA
J- &
Eip6
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elp2A
Elp1-HA
elp3A elp4A
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Figure 3.4. Co-immunoprecipitation experiments of holo-Elongator 
subunits via E lp l-H A . A, Western blot analysis of the co- 
immunoprecipitations (co-ips) from cells with untagged or HA-tagged 
Elpl protein. The Elpl-HA protein is sufficient to specifically 
immunoprecipitate the whole Elongator complex (right panel). B, 
Extracts from the indicated deletion mutants were used for co-ips. 
The five-subunit complex immunoprecipitated from extracts of elp2A 
cells has sub-stoichiometric amounts of Elp4/5/6, suggesting that 
Elp2 is involved in ensuring the stable interaction of the two sub-
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complexes (le ft panel). Elpl and Elp2 interact directly with Elp3 but 
not with each other (middle and right panel). The small sub-complex 
does not interact directly with Elpl (middle panel).
Holo-Elongator was also specifically immunoprecipitated when 
extracts from wild type cells expressing Elp4-HA protein were used 
(Fig. 3.5 le ft panel). When extracts from e/p5A cells, expressing 
tagged Elp4, were tested Elp4, Elp6, and small amounts of Elp3 co- 
immunoprecipitated (Fig. 3.5, middle panel). This suggested that Elp4 
interacts directly and strongly with Elp6 and that neither of these 
two proteins interacts strongly with Elpl, Elp2 or Elp3, although a 
weak Elp4/6-Elp3 interaction was evident. The small amount of Elp2 
protein that could be detected was found in the flow through (Fig. 3.5, 
elp5A cells, Elp2 blot, upper band). This was not unexpected, since the 
majority of Elp3 was also found there. Based on the fact that Elpl 
interacts directly and strongly with Elp3, the majority of Elpl was also 
expected to be in the flow through. Instead, the Elpl was not even 
detected in the input, which indicated that ELP5 deletion might result 
in a reduction of Elpl protein levels, below the detection level of our 
anti-EIpl antibody. However, it  was obvious from the previous 
experiments with e/p3A cells that Elpl does not interact directly with 
Elp4, Elp5 or Elp6 (Fig. 3.4B, middle panel).
Finally, when extracts from elp6A cells carrying a tagged 
version of Elp4 protein were used, only a small amount of Elp3 was co­
precipitated, supporting the notion that these proteins interact, albeit 
weakly. The absence of a signal for Elpl and Elp2 can be explained as 
in the previous cases. However, in this case Elp5 was also not 
detected, even in the input. Previous experiments showed that the 
Elp5 protein levels are normal in all elpA deletion mutants (Fig. 3.3A,
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middle panels). This suggested that the Elp5 does not co-elute from 
the Bio-Rex column with Elp4, which allows the conclusion that Elp5 is 
incorporated into the small sub-complex in an Elp6-dependent manner.
Elp4-HA
Elp4-HA 
elp5S e lp6 i
Eip1 H r
Elp2 y g #
Elp3 F -  —*j I
Elp4
Figure 3.5. Co-immunoprecipitation experiments of holo-Elongator 
subunits via Elp4-HA. HA-tagged Elp4 protein can specifically co- 
immunoprecipitate the holo-Elongator complex (left panel). Extracts from 
the indicated deletion mutants were used. Elp4 and Elp5 interact directly 
with Elp6 but not with each other (middle and right panel). A weak 
Elp3/Elp4 interaction is also evident (right panel).
The above experiments provided evidence that there is a strong 
direct interaction between Elpl and Elp3, as well as between Elp4 and 
Elp6. They also suggested a direct strong interaction between Elp5 
and Elp6. Because core Elongator, consisting of Elpl, Elp2, and Elp3
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has previously been isolated (Winkler et al., 2001), the absence of 
Elp2 in Elpl-precipitates from elp3A cells also indicated that the 
interaction with Elp3 is required for the incorporation of Elp2 into 
core Elongator. Surprisingly, as far as the binary interactions between 
any individual protein in the Elp4/5/6 module and one of the three 
larger proteins are concerned, co-immunoprecipitation experiments 
only indicated a weak interaction between Elp4 and Elp3. This suggests 
that the formation of the six-subunit Elongator complex is based on 
the Elp3/Elp4 interaction, which might be strengthened when the two- 
sub-complexes are incorporated into one complex. However, the result 
from Fig. 3.4B (le ft panel) also indicated that upon formation of the 
holo-complex, Elp2 might also contribute to the stable interaction 
between the two sub-complexes.
3.6 Pair-wise Elongator protein interactions
To compliment the co-immunoprecipitation studies, in vivo pair­
wise interactions between individual Elongator proteins were examined 
by use of the yeast two-hybrid system. The genes encoding all the 
Elongator subunits were cloned in frame with the activation and the 
DNA-binding domains of the Go 14 activator, respectively, and a tester 
yeast strain was transformed with combinations of these 12 plasmids. 
In this particular strain, expression of the HIS3 and A0E2 genes is 
driven by a promoter, which contains Gal4-responsive elements (the 
promoter of the GAL1 and GAL2 genes in front of the H I53  and 
A0E2, respectively,). I f  the two proteins of interest interact directly, 
the activation domain of Gal4 will be recruited to the promoters of 
the above genes resulting in their transcriptional activation. This
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enables the cells to survive in the absence of histidine and adenine in 
their growth medium. In order to test whether each Gal4-Elp fusion 
was functional, the constructed plasmids were also introduced in the 
corresponding elpA mutants. For instance, the plasmid encoding an 
Elp4-Gal4AD fusion protein was introduced in elp4A cells and the cells 
were tested fo r growth at high temperature. In contrast to 
untransformed mutant cells, transformed cells were insensitive to 
high temperature, indicating that neither the activation nor the DNA- 
binding domain of Ga 14 interfered with the normal function of the 
Elongator protein in question.
All the possible combinations of pair-wise Elongator protein 
interactions were tested in both directions. Surprisingly, the only 
interaction detected was that of Elp4 and Elp6, in both directions 
(Fig. 3.6, the many negative results are not shown). Interestingly, this 
interaction was also observed in the co-immunoprecipitation 
experiments, fu rther strengthening the conclusion that a strong 
direct interaction exists between these two proteins. The absence of 
identification of other positive interactions may point to the 
limitations of two-hybrid analysis in detecting protein-protein 
interactions between subunits of multi-subunit complexes, as has also 
been the case for the yeast TFIIH complex (Feaver et al., 2000).
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Figure 3.6. Two-hybrid interactions. The reciprocal direct 
interaction between Elp4 and Elp6 is shown. Yeast cells transformed 
with the indicated plasmids (le ft) were grown on medium lacking 
adenine and histidine (right). The growth of cells is indicative of 
interaction. Positive and negative controls provided by the 
manufacturer were used for comparison.
Unfortunately, in this particular case the use of the two-hybrid 
system thus proved to be unhelpful in identifying the missing pieces in 
the "interaction map" puzzle. Therefore, I  sought to gain evidence for 
the remaining interactions in vitro, by performing pull down 
experiments, using either recombinant or in vitro transcribed- 
translated Elongator proteins (Fig. 3.7). Recombinant Elpl and Elp2 
proteins tagged with multiple histidines were expressed in insect cells, 
recombinant GST and GST-Elp5 proteins were expressed in bacteria, 
and the Elp4 and Elp6 proteins were in vitro transcribed-translated. 
Unfortunately, despite attempts in several expression systems, 
soluble recombinant, or in vitro transcribed-translated, Elp3 protein 
could not be obtained. The results from binary interaction studies are
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shown in Fig. 3.7. Neither Elpl nor Elp2 was found to interact directly 
with any of the smaller subunits (upper panels). However, Elp6 was 
shown to interact with an Elp5 fusion to GST and not with GST alone 
(lower panels). I t  is worth mentioning that this direct interaction was 
already suggested by the results from the co-immunoprecipitation 
experiments from elp6A cells (Fig. 3.5, right panel).
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Figure 3.7. In  vitro pull down experiments. Baculovirus expressed 
histidine-tagged Elpl or Elp2 were immobilised on Ni-agarose and 
incubated with in vitro transcribed/translated Elp4 or Elp6 (upper 
panels). Immobilised GST-Elp5 on GST-Sepharose was incubated with 
baculovirus expressed Elpl or Elp2-His, and in v itro  
transcribed/translated Elp4 or Elp6 (lower le ft panel). In  vitro 
transcribed/translated Elp6 was also incubated with immobilised GST 
(lower right panel). Elp6 interacts directly with GST-Elp5 but not with 
GST.
Taken together, these results make it possible to propose a 
model to describe the molecular architecture of the Elongator 
complex (Fig. 3.8). In the large core Elongator sub-complex, Elpl
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protein interacts with Elp3, but does not interact strongly with Elp2 in 
the absence of Elp3. This suggests a direct Elp2/Elp3 interaction. I t  
should be mentioned that studies with human Elongator showed a 
direct Elpl/Elp2 and Elpl/Elp3 but not Elp2/Elp3 interaction (Kim et 
al., 2002). On the other hand, the small sub-complex is formed based 
on direct interactions of Elp4 and Elp6, and of Elp6 and Elp5. 
Furthermore, a weak interaction between Elp3 and Elp4 was detected.
Figure 3.8. Model fo r the architecture of the yeast holo- 
Elongator complex. The six subunits are represented with oval shapes 
and the binary interactions are indicated with lines. Different colors 
are used depending on the assay that revealed each interaction: 
orange color for co-immunoprecipitations, blue color for in vitro pull 
down experiments and purple color for an interaction identified by 
both co-immunoprecipitations and two-hybrid analysis. The dotted 
arrows are used to denote that Elp2 might interact with any of the 
Elp4, Elp5 and Elp6 proteins in the context of holo-Elongator. Finally, 
the dashed line represents the identified interaction between Elpl 
and Elp2 in the human Elongator complex.
Moreover, the co-immunoprecipitation studies, suggested that the 
incorporation of the two sub-complexes into a holo-complex results in 
a possible interaction of Elp2 with components of the "small" sub­
complex and/or the stabilization of the weak Elp3/Elp4 interaction.
Core-Elongator
Elp4/5/6 module
Uncovered interactions between Elpl and the “small" sub-complex
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might also occur in the context of holo-Elongator complex. Finally, 
novel interaction surfaces between the two sub-complexes might be 
formed upon their assembly.
3.7 The WD40 repeat protein Elp2 is dispensable for the 
in vitro HAT activity of Elongator
I t  was already known from previous studies that the holo- 
complex and not core Elongator, composed of Elpl, Elp2 and Elp3, can 
acetylate histone H3 in vitro (Winkler et al., 2001). In order to 
dissect the role of the Elongator subunits for this activity, it was 
desirable to purify "mutant Elongator" forms, which included the 
catalytic Elp3 subunit, but lack one of the other components. However, 
the data from the interaction studies strongly suggested that 
Elongator is a fragile complex with a limited number of strong 
interactions among its subunits. Deletion of any one of the ELP genes 
thus more or less completely disrupted the Elongator complex. 
However, in cells lacking the ELP2 gene, the remaining five subunits 
still formed a complex. To investigate if this five-subunit complex 
retains HAT activity, it was purified and tested in in vitro HAT 
assays. This was particularly relevant because several HAT and HDAC 
complexes harbor subunits, which - like Elp2 - contain WD40 repeats 
(Roth and Allis, 1996; Vermaak et al., 1999). I t  has thus been 
suggested that WD40 repeats might be involved in contacting 
histones to facilitate the acetyl-transferase and de-acetylation 
reactions, respectively.
The purification scheme employed for isolating Elongator from 
elp2A cells was identical to that previously used for the purification
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of six-subunit Elongator complex (Fig. 3.1 A and Winkler et al., 2001). 
The Western blot analysis of Fig. 3.9A shows that the purified 
“mutant" complex from elp2A cells, obtained from two independent 
preparations, retained the five other Elongator subunits. However, 
the three smaller subunits as well as the Elp3 protein appeared to be 
somewhat sub-stoichiometric compared to the wild type complex. In 
order to be able to compare the HAT activity of the five-subunit 
complex with that purified from wild type cells, similar amounts of the 
catalytic subunit Elp3 were used in the HAT assays, with the 
consequence that other subunits, particularly Elpl, were present in 
larger amounts in the reactions containing “mutant" elp2A complex 
(Fig. 3.9A). Fig. 3.9B shows the result of the HAT assays comparing 
wild type and the two independently purified "mutant" complexes. 
Surprisingly, five-subunit Elongator lacking the Elp2 retained full in 
vitro HAT activity directed against histone H3. Adding recombinant, 
histidine-tagged Elp2 to the reactions did not dramatically affect the 
activity (the apparent stimulation of wild type complex activity- lane 1 
and 2- was due to loading differences). These data demonstrate that 
the WD40 repeat protein Elp2 is not required for Elongator's HAT 
activity in vitro.
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Figure 3.9. The WD40 repeat protein Elp2 is dispensable fo r the in 
vitro HAT activity of Elongator. A, Western blot analysis of purified 
Elongator from wild type and elp2A cells. Fractions from two independently 
purified complexes lacking the Elp2 are shown (elp2-l, elp2-2). B, In vitro 
HAT assay using the purified complexes from (A). The upper panel is a 
f  luorogram of 3H labelled histone H3 and the lower a coomassie staining of 
all four core histones used in the assay. Recombinant Elp2 (rElp2), 
expressed in insect cells, was added in the indicated reactions (2, 4, 6). 
The amount of rElp2 that was used was comparable with that of yeast Elp2 
in the wild type Elongator preparation, as judged by Western blot analysis 
and silver staining (not shown). Coomassie staining of core histones is shown 
as a loading control. The mutant form of Elongator derived from elp2A 
cells retains full HAT activity.
3.8 Elp3 is important for Elongator-RNA interaction in
vivo
I t  was recently shown that the Elongator complex binds to RNA 
in vitro and that it is in close vicinity of nascent pre-mRNA in vivo 
(Gilbert et al., 2004). These results indicated that Elongator is
+ rfclpz
H3
fluorogram
coomassie 
1 2 3 4 5 6
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associated with active genes in living cells. To investigate the subunit 
requirements for RNA-binding in vivo, RNA immunoprecipitation (RIP) 
experiments were performed and the amount of co- 
immunoprecipitated GAL1 mRNA from wild type, elp2A and elp4A cells 
expressing Myc-tagged Elp3 protein was compared (Fig. 3.10A). As 
shown previously (Gilbert et al., 2004), efficient cross-linking of Elp3 
protein to GAL1 mRNA was observed in wild type cells (Fig. 3.10A, 
compare 'Elp3-myc' to ‘no tag'). Interestingly, although the levels were 
somewhat reduced, RNA interaction with Elp3 was also observed in 
cells lacking Elp2 (a component of core Elongator) and Elp4 (a core 
component of the “small" Elongator sub-complex). This indicates that 
neither the “small" sub-complex, nor Elp2 play crucial roles in the 
association of Elongator (Elp3) with transcripts in vivo. Because Elp3 
levels are dramatically reduced in cells lacking Elpl (Fig. 3.3A upper 
panels), it was not relevant to compare the immunoprecipitated RNA 
from wild type and elplA cells. However, by tagging Elpl rather than 
Elp3, the importance of the Elp3 protein fo r Elongator-RNA 
interaction was investigated (Fig. 3.10B). Remarkably, Elpl-RNA 
interaction was dramatically reduced in the absence of Elp3 (Fig 
3.10B, upper panel), and this decrease was not due to changes in the 
expression level of the Elpl protein (Fig. 3.10B, lower panel). Taken 
together, these data indicate that the Elp3 protein plays a crucial role 
for the association of Elongator with RNA from active genes.
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Figure 3.10. Elp3, but not Elp2 and Elp4, is required for Elongator-RNA 
association in vivo. RNA-immunoprecipitation experiments using extracts 
from strains expressing 18myc-tagged Elongator subunits. RNA was 
quantitated using reverse transcriptase real-time PCR. Bars represent the 
average of two independent experiments. Error bars indicate variance. A, 
RIP experiments with the indicated strains expressing myc-tagged Elp3 or 
the untagged control. B, RIP experiments with the indicated strains 
expressing myc-tagged Elpl or the untagged control (upper panel). Lower 
panel shows the result of an Elpl-myc Western blot with loading control 
(Ponceau S-stained membrane section) to demonstrate that Elpl is stable in 
elp3A cells. The resolution of Elpl into two distinct bands has previously 
been described (Fichtner et al., 2003).
Load
3.9 Localization studies of yeast Elp3
The Elp3 protein has at least three independent stretches of 
leucine-rich hydrophobic sequences (52-66, 354-365, 454-462 aa). 
The latter of these is part of the conserved motif D of histone 
acetyl-transferase domain. As was mentioned previously (paragraph 
3.1) such hydrophobic sequences are typically critical fo r Crml- 
dependent nuclear export (Neville and Rosbash, 1999). Therefore, we 
reasoned that Elp3 might be recognized by Crml and be shuttled from 
the cytoplasm to the nucleus. I f  that was true, Elp3 should accumulate 
in the nucleus of cells when Crml function is abrogated. Since the 
CRM1 gene is essential, a CRMl temperature sensitive (ts) mutant 
strain was used, which was also expressing a GFP tagged Elp3 protein. 
Using this strain, the localization of the Elp3 protein in living cells 
growing at the permissive or the restrictive temperature was followed 
microscopically. As can be seen in Fig. 3.11 A, these ts mutant CRM1 
cells, either expressing or not expressing a GFP-tagged Elp3, grew 
normally at 30°C but died at 37°C, as was expected since the essential 
function of Crml is impaired at that temperature. Fig. 3.11B shows the 
GFP and DNA (DAPI) staining of ts CRMl cells at 30°C (permissive) 
and 37°C (restrictive temperature) expressing (lower panels) or not 
expressing (upper panels) the GFP-Elp3 protein. The vast majority of 
Elp3-GFP cells showed cytoplasmic GFP staining at both temperatures. 
A few cells showed co-localization of GFP and DNA at 37°C, suggesting 
an accumulation of Elp3 in the nucleus (Fig. 3.11C). However, these 
cells did not exceed the 5% of the total cell population, which cannot 
be considered significant.
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Figure 3.11. Elp3 is mainly cytoplasmic in CRM1 ts mutant cells.
A, Comparison of growth of wild type yeast cells with those carrying 
or not a CFP-tagged Elp3 and a temperature sensitive CRMl gene. 
CRM1 ts cells do not grow at 37°C. B, 6FP staining of untagged or 
Elp3-6FP tagged ts CRM1 cells. The majority of cells show cytoplasmic 
staining at both 30°C and 37°C. Note the apparently empty space (the 
nucleus) that is marked by red arrows on a GFP image. Yellow arrows 
indicate the DNA staining. C, In a few cells the Elp3-GFP staining (red 
arrows) co-localizes with DNA (DAPI staining, yellow arrows), 
suggesting an accumulation of Elp3 in the nucleus.
135
Additionally, when the ts CRM1 Elp3-GFP cells were firs t fixed 
and then examined microscopically, the GFP staining, though less 
intense, was not entirely excluded from the nucleus (DAPI staining, 
yellow arrows) even at 30°C (Figure 3.12, the red arrows indicate the 
nucleus of a cell on a GFP image, based on the comparison with the 
DAPI staining). Nevertheless, once more these ts mutant cells did not 
show any dramatic accumulation of the Elp3 protein in the nucleus.
ts CRMl Elp3-GFP 
GFP DAPI
30 °C
3 7°C
Figure 3.12. GFP and DAPI staining of fixed ts CRM1 cells 
expressing an Elp3-GFP fusion. Temperature sensitive CRAM cells 
expressing or not expressing the Elp3-GFP fusion protein were grown 
to mid-logarithmic phase at 30°C. Then, they were split and half of 
the population was fixed with methanol directly, whereas the other 
half was transferred for 1 hr at 37°C before fixing. After fixing, cells 
were stained with DAPI and studied microscopically for GFP and DNA 
staining. The yellow arrows mark the DAPI-stained DNA (nucleus), 
whereas the red arrows mark the nucleus of the same cell on the 
corresponding GFP image.
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Next, another mutant strain for the Crml protein was used, 
which expresses a Crml protein with a single point mutation 
(CRMU539C). This c r m l  alleles confer sensitivity to the 
Streptomyces metabolite Leptomycin B (LMB) (Neville and Rosbash, 
1999). A strain, which carries the E!p3-GFP fusion in the CRM1T539C 
background was constructed (the original strain was a kind g ift from 
Dr. John F. D iff ley). As expected, these cells could not grow on rich 
medium supplemented with LMB (100 ngr/ml) (Fig. 3.13A). The cells 
were left to grow for lh r in the presence or absence of LMB in liquid 
culture (sufficient time for the inhibition of Crml receptor according 
to (Neville and Rosbash, 1999)) before the localization of Elp3-GFP 
was examined microscopically. Again, Elp3-GFP was mainly cytoplasmic 
(Fig. 3.13B compare “no tag" and the upper panel of Elp3-GFP cells). 
However, as in the previous case with the ts CRM1 mutant strain, a 
small percentage of the LMB sensitive cells also showed prominent 
nuclear staining (middle and lower panels of Elp3-GFP cells). These 
experiments suggested that the Elp3 protein, which is mainly 
cytoplasmic, does not accumulate in the nucleus to any significant 
extend as a result of inactivation of the Crml import/export factor.
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Figure 3.13. LMB-dependent inhibition of Crml function is not 
sufficient fo r Elp3 accumulation in the nucleus. A, Growth of wild 
type, CRM1T529C untagged, and CRM1T539C Elp3-GFP tagged mutant 
cells at 30°C on a rich medium, in the absence or presence of LMB. B, 
GFP and DAPI (yellow arrows) staining of untagged or Elp3-GFP tagged 
living cells a fter incubation with LMB for lhr. The red arrows mark 
the corresponding position of the nucleus on a GFP image, based on the 
comparison with the DAPI staining.
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Finally, based on the observation from Fichtner et al. (2003), 
that deletion of the KAP120 confers resistance towards the toxin 
zymocin, I  sought to test the possibility that Kapl20 is important for 
the translocation of Elongator in and out of the nucleus. I f  this 
protein was indeed responsible for the proposed shuttling, nuclear 
accumulation of Elongator might be expected to occur in the kapl20A 
mutant cells. Thus, a strain, which expresses Elp3-GFP in the kapl20A 
background, was constructed, and the cells were examined 
microscopically, a fter fixation (Fig. 3.14). Again, the majority of Elp3- 
GFP staining was cytoplasmic. However, there was weak GFP staining in 
the nucleus (red arrows, compare to DAPI staining indicated by yellow 
arrows), but not at all different from the staining of Elp3-GFP in wild 
type cells, as shown in Fig. 3.12 (upper panel). Therefore, we can 
conclude that the Elp3 protein does not accumulate to a significant 
degree in the nucleus in the absence of Kapl20.
GFP DAPI
kap l20A  
Elp3-GFP
Figure 3.14. GFP and DAPI staining of fixed kapl20A Elp3-GFP 
cells, kapl20A mutant cells expressing the Elp3-GFP fusion protein 
were grown to mid-logarithmic phase at 30°C and then fixed with 
methanol, stained with DAPI and studied microscopically for GFP and 
DNA staining. The yellow and red arrows are used as previously.
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3.10 Discussion and conclusions
The experiments described in this Chapter represent the firs t 
comprehensive investigation of the structure-function relationship of 
yeast Elongator, a histone acetyl-transferase complex with a role in 
RNAPII transcription. The existence of six-subunit Elongator complex 
was confirmed biochemically and genetically and its detailed molecular 
architecture was revealed. Moreover, several lines of evidence 
suggested roles, or unexpected lack of roles, for individual Elongator 
subunits (Petrakis et al., 2004). Finally, the idea that Elongator 
shuttles continuously from the cytoplasm to the nucleus was tested.
Six-subunit holo-Elongator complex could be isolated following 
the purification of a tagged version of the Elp4 protein (Fig. 3.1). I t  
should be noted that no other polypeptides were found to co-purify 
with Elongator under these conditions. However, upon purification the 
"small" sub-complex was super-stoichoimetric compared to core 
Elongator (Elpl, Elp2 and Elp3), indicating that holo-Elongator is either 
more prone to disintegrate during purification when tagged on Elp4 or 
that the "small" sub-complex also exists as a separate entity with 
unknown function. During purification, it was also observed that holo- 
Elongator could be separated into two sub-complexes by high salt 
treatment (2 M NaCI, Fig. 3.1). This and the already known disruption 
of the complex by anion exchange chromatography (Winkler et al., 
2001), makes it reasonable to conclude that holo-Elongator is a fragile 
complex.
Genetic analysis using cells lacking any one of the six ELP genes 
or even a combination of two showed that these cells display the same 
phenotypes (Fig. 3.2). These include slow growth in the presence of
high salt and sensitivity to high temperature, suggesting participation
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of all the Elp proteins in the same cellular process. Moreover, 
Western blot analysis, where the protein levels of the Elongator 
subunits were detected in wild type and all the elpA mutant cells, 
revealed that the Elp3 protein is susceptible to degradation in the 
absence of the other holo-Elongator components, but in particular in 
the absence of Elpl (Fig.3.3). Structural interdependence among the 
components of multi-subunit complexes is a common feature of such 
complexes, and this finding also supports the idea that the six 
Elongator proteins form a complex in yeast cells.
One interesting issue that remains to be re-addressed is the 
composition of Elongator complex isolated from the chromatin salt- 
stable fractions of yeast whole cell extracts. Based on the available 
data, it seems likely that all the six subunits would be detected. 
However, an interesting speculation is that the "small" sub-complex 
functions as a "loading" factor of core Elongator on ternary 
complexes, and is therefore associated only with the soluble, DNA- 
free fraction of the complex.
Work by Schaffrath and co-workers using immunoprecipitation 
of tagged Elongator subunits and detection of a co-precipitated 
differently tagged subunit gave some information about subunit 
requirements for Elongator assembly (Fichtner et al., 2002; Frohloff 
et al., 2003). While the present work confirms and significantly 
extends the conclusions derived from these studies, there are also 
surprising contradictions. For example, Frohloff et al. (Frohloff et al., 
2003) detected the Elp3 protein in cells lacking ELP1, whereas the 
above results indicated that normal Elp3 stability in vivo requires ELP1 
(Fig. 3.3A). Likewise, these authors concluded that the structural 
integrity of the small Elp4/5/6 sub-complex requires the ELP4, ELP5,
141
and ELP6 genes, while this work showed that Elp4 can interact with 
Elp6 in the absence of ELP5 (Fig. 3.5, middle panel). The reasons for 
these differences are presently unclear.
Three different approaches were followed in order to identify 
interactions between the six Elongator subunits. The results are 
summarized in the proposed model of Fig. 3.8. Briefly, core Elongator 
is formed as a result of a direct interaction of Elpl and Elp2 with 
Elp3. A direct strong interaction of Elp6 with Elp4 and Elp5 is 
sufficient fo r the assembly of the ‘’small" sub-complex. The only 
detected interaction between subunits of the two sub-complexes, 
albeit weak, was between Elp3 and Elp4. We therefore favor the idea 
that interactions between subunits of the two sub-complexes 
primarily take place in the context of holo-Elongator. In support of 
this hypothesis the absence of Elp2 was shown to de-stabilize the 
interaction of the “small" sub-complex with Elpl and Elp3 (Fig. 3.4), 
though no direct binary interaction was detected between Elp2 and 
any of the Elp4/5/6 proteins.
I t  was shown previously for other multi-protein complexes that 
different subunits have distinct roles (Lewis and Reinberg, 2003; 
Sterner and Berger, 2000; Sudarsanam and Winston, 2000). I t  was, 
therefore, interesting to dissect the requirement of yeast Elongator 
subunits for the two identified functions of the complex, the in vitro 
HAT activity and the in vivo RNA-binding. In the case of the in vitro 
HAT activity, “mutant" complexes, which would include Elp3 but lack 
one or more of the other subunits, had to be purified to homogeneity 
and their activity compared with that of wild type six-subunit 
Elongator. However, in order for these studies to be relevant and 
possible, stable mutant Elongator forms had to exist in different elpA
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mutant cells. Unfortunately, the co-immunoprecipitation experiments 
described in Fig. 3.4 and 3.5, clearly showed that Elongator is a fragile 
complex, which typically dissociated when just one of its subunit 
proteins was absent. For the in vivo RNA-binding, the Elongator-RNA 
interaction in wild type and different elpA mutants was compared.
One of the hypothesis for the architecture of the Elongator 
complex was that the Elp2, a WD40 repeat-containing protein, would 
turn out to either be essential for the integrity of the Elongator 
complex, or be required fo r its HAT and RNA-binding activity. 
Surprisingly, in the elp2A mutant cells the remaining five Elp proteins 
were shown to still form a complex, indicating that the Elp2 protein is 
not crucial for the integrity of Elongator. I t  should be mentioned that 
data from Schaffrath and co-workers suggested that the role of the 
Elp2 protein might be to allow interactions with other proteins, such 
as Ktil2 (Fichtner et al., 2002).
Next, the “mutant" form of Elongator from elp2A cells was 
purified and tested fo r its ability to acetylate core histones in vitro. 
Fig. 3.9 shows that this complex retained the ability to acetylate 
histone H3, at levels comparable to that of wild type Elongator. This 
result indicated that the WD40 repeats of Elp2 are not crucial for 
the contacts between the complex and core histones that are 
presumably required to direct the catalytic activity of Elp3 to its 
substrate. Considering that the stability of Elp3 is Elpl-dependent 
(Fig. 3.3), this indicated that one, two or all the “small" subunits 
(Elp4/5/6) are necessary to form an active HAT with the dimer of 
Elpl/Elp3.
In contrast to the Elp2 protein, the Elp3 subunit appeared to 
play a crucial role fo r the integrity of holo-Elongator complex (Fig.
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3.4B). When it was missing, the "small" sub-complex did not associate 
with the Elpl protein. This is consistent with the finding that among 
the subunits of the two sub-complexes, only the Elp3 was found to 
interact weakly with Elp4 (Fig. 3.5).
Recently, Elongator was shown to interact co-transcriptionally 
with mRNA (Gilbert et al., 2004). Using extracts from different elpA 
mutants it was clear that the minimal "Elongator complex" capable of 
interacting with mRNA is the Elpl/Elp3 dimer (Fig. 3.10). In light of 
the fact that Elp3, but not the other subunits, is conserved from 
archeae to man (Wittschieben et al., 1999), it  was perhaps not 
surprising to find that this subunit is also crucial for the in vivo RNA 
binding of Elongator. I t  thus seems reasonable to expect that the 
fundamental functions of the Elongator complex be supplied by 
abilities intrinsic to Elp3, with the other subunits playing primarily 
function-augmentative or regulatory roles. I t  would be very 
interesting to know whether the HAT domain, located at the C- 
terminus (Wittschieben et al., 1999), or the SAM-binding domain, 
recently identified at the N-terminus of Elp3 (Chinenov, 2002), has 
any role in RNA binding of Elongator. Moreover, it  would be 
interesting to test whether Elongator, though not essential for the 
cell, has an additional auxiliary role for the stability of RNA during 
transcription, its accurate splicing, or even its translocation and 
further processing in the cytoplasm.
During the last few years, one controversial issue concerning 
Elongator is its sub-cellular localization. Genetic and biochemical data 
clearly suggested a role fo r Elongator in the nucleus (Gilbert et al., 
2004; Otero et al., 1999; Wittschieben et al., 2000; Wittschieben et 
al., 1999). However, two immune-localization studies failed to detect
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significant amounts of the yeast complex in the nucleus (Fichtner et 
al., 2002; Pokholok et al., 2002), whereas, Fichtner et al. (Fichtner et 
al., 2003) recently showed that the Elpl protein has an intrinsic 
nuclear localization signal, sufficient to direct the green fluorescent 
protein (GFP) from the cytoplasm to nucleus. Moreover, in the latter 
study (Fichtner et al., 2003), Schaffrath and co-workers suggested a 
model according to which nuclear retention of Elongator was mediated 
by a member of the importin p family (Kapl20), which might be crucial 
for the mechanism of action of the toxin zymocin (for details see at 
paragraph 1.3 of Chapter 1). Triggered by this suggestion I  sought to 
study whether Elongator shuttles actively from nucleus to cytoplasm 
via the action of an import-export receptor.
The best-studied receptor, the function of which has been 
linked to translocation of a number of d ifferent factors in 5. 
cerevisiae is the Crml protein (Neville and Rosbash, 1999). Therefore, 
if Crml mediates Elongator shuttling, Elp3 should accumulate in the 
nucleus when the function of Crml is impaired. Using different crml 
mutant strains, the localization of an Elp3-GFP fusion protein was 
studied under the microscope. Under all conditions tested, the great 
majority of detectable Elp3 was found in the cytoplasm. Only a few 
cells showed a clear nuclear signal. However, these did not represent a 
significant proportion of the whole population. Moreover, deletion of 
KAP120 did not result in any accumulation of Elp3 in the nucleus, in 
contrast to what was speculated by Fichtner et al. (Fichtner et al., 
2003). I t  should be mentioned that especially in the case of fixed 
cells, the Elp3-GFP signal was also evident in the nuclear region 
(according to a comparison with DAPI staining), though it was less 
intense than the cytoplasmic signal. This suggests the presence of a
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low amount of Elongator in the nucleus, which might be sufficient for 
its transcription-related functions. Nevertheless, the mechanisms 
governing Elongator localization in cells remain unclear. Therefore, it 
would be interesting fo r this study to be extended to investigating 
the role of d ifferent growth conditions, such as growth in the 
pre^szncz of the toxin zymocin, or under stress as well as the role of 
other import-export receptors in the cellular localization of Elongator 
complex. Finally, it  would be of great interest to uncover Elongator's 
possible cytoplasmic role (see also discussion in Chapter 5).
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CHAPTER 4
KTI12 ANb ELONGATOR: IN  VITRO ANb 
IN  VIVO STUblES OF THEIR RELATIONSHIP 
ANb IMPLICATIONS FOR ZYMOCIN ACTION
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4.1 Introduction
As mentioned in the Introduction (Chapter 1), the KTI12 and 
ELP genes were identified in a genetic screen for targets of the toxin 
zymocin in 5. cerevisiae cells (Frohloff et al., 2001). Studies from 
Schaffrath and co-workers suggested a physical interaction between 
Elongator and Ktil2 (Fichtner et al., 2002a). In this Chapter, the role 
of Ktil2 in the in vitro and in vivo function of Elongator is explored. 
Moreover, genetic and biochemical experiments, which test the 
possibility that the mechanism of zymocin action involves RNAPII 
degradation, are presented.
4.2 Physical association of Elongator and Ktil2
While Ktil2 was not found to associate with purified holo- 
Elongator (Winkler et al., 2001), Fichtner et al. have reported a 
physical interaction using immunoprecipitation assays at very low 
stringency (Fichtner et al., 2002a). In order to test the stability of 
the Ktil2-Elongator interaction, co-immunoprecipitation experiments 
were performed using extracts from cells expressing a 6-HA affinity 
tagged Ktil2 protein. Fig. 4.1 shows the western blot analysis of 
immunoprecipitations (IPs) with an anti-HA antibody using extracts 
from cells expressing untagged or tagged Ktil2. In the control IP 
from untagged cells, none of the Elongator proteins were 
immunoprecipitated (lane 3), while 6-HA tagged Kti 12 co- 
immunprecipitated significant amounts of Elp3 and Elp4 under low salt 
conditions (250 mM, lane 6). By contrast, under more stringent 
conditions (500 mM, lane 8), there was significantly less Elongator
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associated with Ktil2. However, both Elp3 and Ktil2 were clearly co­
depleted from the flow through also under these conditions (compare 
lane 4 and 7 of upper and middle panel), suggesting that Elp3 is 
washed o ff the beads by the 500 mM salt wash. Taken together, 
these data indicate that Elongator and Ktil2 interact in a salt-labile 
manner.
IN  FT IP IN  FT IP FT IP
fm  Ktil2(6HA)
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Figure 4.1. Co-immunoprecipitation of Elongator and K til2 .
Extracts from cells expressing untagged or 6xHA tagged Ktil2 were 
used for immunoprecipitation experiments, using an anti-HA antibody. 
Under low stringency conditions (250 mM salt), immunoprecipitated 
Ktil2(6HA) co-precipitate significant amounts of Elp3 and Elp4 (lane 
6). When higher salt concentration was used, significantly less 
Elongator was found in the precipitate (lane 8).
4.3 Purification of Ktil2 from soluble fraction of yeast 
whole cell extracts
Since Ktil2 was found to interact with Elongator, it was
interesting to test the possibility that these proteins might exist in
the same complex. The genomic KTI12 gene was, therefore, modified
so that the K til2  protein was expressed with a C-terminal
decahistidine-HA (single) tag. A fter genetic confirmation that the
epitope tag did not interfere with Ktil2 function, the modified Ktil2
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protein was purified from the soluble fraction of yeast whole cell 
extracts, by a mixture of conventional and affinity chromatography, 
following the same scheme that was used previously for holo-Elongator 
(Fig. 3.1 and Winkler et al., 2001). Fig. 4.2A shows a coomassie-stained 
gel of highly purified Ktil2 obtained from that purification. The ~43 
kDa protein was identified by mass spectrometry and found to be 
Ktil2. The 180 kDa was identif ied as the product of Y0L223C gene. 
This protein is a frequent irrelevant contaminant when the 
decahistidine-HA tag is used (Gilbert et al., 2003).
B anti-Ktil2
Ktil2-
HisHa
final bleed pre-bleed
1 2 3 1 2 3
GST-
K til2 f
K til2 -
HisHA
E'P3 f i t
E lp 4
anti-Elp3
anti-Elp4
Figure 4.2. Purification of soluble K til2  from yeast whole cell 
extracts. A, Coomassie stained gel of highly purified Ktil2. The 
protein indicated with asterisk is the irrelevant contaminant, encoded 
by the YDL223C gene. M indicates marker proteins. B, Western blot 
analysis using anti-Ktil2, anti-Elp3 and anti-Elp4 antibodies. The final 
anti-Ktil2 bleed, but not the pre-bleed, recognises the recombinant 
GST-Ktil2 protein (lane 3, le ft upper panel) and the purified yeast 
Ktil2-HisHA (lane 2, le ft upper panel). Highly purified native yeast 
Ktil2 does not contain Elp3, or Elp4 (lane 2, lower panels), and highly 
purified Elongator does not contain Ktil2 (lane 1, left upper panel).
Max Soegaard, another PhD student in the lab, raised a rabbit 
antibody against a GST-Ktil2 fusion protein (see Chapter 2). The final 
bleed but not the pre-bleed, recognised the highly purified Kti 12-
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HisHA protein from yeast (lane 2) as well as the recombinant G5T- 
Ktil2 protein (lane 3) (Fig. 4.2B le ft upper panel). Using this antibody, 
it was also shown that highly purif ied holo-Elongator complex does not 
contain even small amounts of Ktil2 (Fig. 4.2B left upper panel, lane 1). 
Conversely, highly purified yeast Ktil2 (lane 2 of le ft upper and lower 
panels) did not contain even small amounts of either Elp3 or Elp4 (Fig. 
4.2B lower panels, compare lane 1 where holo-Elongator is loaded with 
lane 2).
The method used to purify holo-Elongator and Ktil2 made it 
impossible to exclude the possibility of a weak salt-labile interaction 
between them. During the previously mentioned purification procedure 
the extract was subjected to moderate high salt (600 mM potassium 
acetate). As shown in Fig. 4.1, the interaction between Elongator and 
Ktil2 is not stable under those conditions. Therefore, I  sought to 
purify the Ktil2-HisHA protein from soluble yeast whole cell extracts 
under less stringent conditions (250 mM salt) (Fig. 4.3). In particular, 
as the majority of Ktil2 elutes from Bio-Rex with 600 mM salt, this 
eluate was split into two, half of which was further processed at 600 
mM salt, whereas the other was diluted to 250 mM prior to loading on 
12CA5-conjugated Sepharose A beads. The elution profile after the 
third step of the purification scheme (Ni-agarose) was followed by 
Western blot analysis. Ktil2 and Elp3 were found to co-elute only 
under low salt conditions (Fig. 4.3A, elution from Ni-agarose with 
increasing amounts of imidazole). However, in order to investigate 
whether Elp3 and Ktil2 were also in the same complex, the proteins in 
the 500 mM imidazole elution fraction were subjected to gel filtration 
chromatography. Fig. 4.3B shows a Western blot analysis of Elp3 and 
Ktil2-HA from the different elution fractions of the sizing column.
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Although the resolution of this gel filtration experiment is not very 
good, two observations can be made: (i) There is a good but not 
precise overlap of the elution profile for Elp3 and Ktil2 (Elongator 
peaks in lane 5, whereas Ktil2 in lane 6) and (ii) "Elongator-free" Ktil2
from its sequence (37 kDa). The fraction where Elongator peaks (lane 
5) also contains significant amounts of Ktil2, suggesting that under 
low stringency conditions a fraction of Ktil2 associates with 
Elongator. Finally, the elution of "Elongator-free" Ktil2 at molecular 
size >37 kDa suggested that either Ktil2 multimerises or that it co­
elutes with other unidentified proteins under those conditions. 
Alternatively, the weak complex between the different proteins might 
be dissociating during the course of the experiment, resulting in their 
slight separation.
Figure 4.3. K til2  co-elutes with Elongator under low salt 
conditions. A, Western blot analysis of Elp3 and Kti 12 following the 
elution from Ni-agarose. The numbers indicate the mM of imidazole 
that was used fo r the elution. IN , input (Ni-agarose load), FT, Ni- 
agarose flow through, W, wash. Note that Elp3 is represented by the 
lower band on the blot. The upper band of lane M50" is of unknown 
origin. B, Western blot analysis for Elp3 and Ktil2 obtained from every 
second elution fraction of the sizing column. The arrows at the top 
indicate the elution of protein markers.
Interestingly, under low salt conditions, the elution fractions 
from 12CA5 beads (2nd step of the purification scheme) also contained
(lane 7) elutes as a protein of higher molecular weight than predicted
A B
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Elp3 r Elp3 
K til2 - 
H Af i  Ktil2
______
1 2 3 4 5 6 7 8 9  10
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the Rpbl subunit of RNA polymerase I I  and the Medl subunit of the 
Mediator complex, in a salt-dependent manner (Fig. 4.4A, compare 
fractions A at 600 mM and 250 mM). Moreover, all the three proteins 
(Ktil2, Rpbl, Medl) seemed to co-elute even after the last step of 
purification (Ni-agarose) (Fig. 4.4B, lanes "50" and "500"). Although an 
interaction between Ktil2 and RNA polymerase I I  has been described 
previously (Fichtner et al., 2002b), the observed interaction with the 
Mediator subunit Medl was novel and potentially interesting.
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Figure 4.4. K til2 , RNA polymerase I I  and Mediator co-elute 
under low salt conditions. A, Western blot anlaysis following the 
second step of purification (binding on 12CA5 beads). Ktil2 co-elutes 
with Rpbl and Medl only under low stringency conditions (compare the 
blots for Rpbl and Medl from elution A at 600 mM with the ones from 
elution A at 250 mM). B, Western blot analysis for Ktil2, Medl and 
Rpbl obtained from the elution of Ni-agarose. The numbers indicate 
the concentration of imidazole (in mM) used for the elution. C, 
Extracts from cells expressing HisHA-tagged or untagged Ktil2 were 
subjected to three-step purification. The blot represents a 
comparison of the elution profile of the indicated proteins from Ni- 
agarose with increasing amounts of imidazole. D, The proteins found in 
the 500 mM elution from (B) were subjected to sizing column 
chromatography. Western blot analysis for Rpbl, Medl and Ktil2- 
HisHA obtained from every second elution fraction of the sizing 
column. The arrows indicate the elution of the indicated marker 
proteins.
However, it  is often observed that a large multi-subunit 
complex, such as Mediator, binds non-specifically on different resins
under low salt conditions. So, to further test the possibility that
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Mediator interacts with Ktil2, the same three-step purification 
scheme was followed in parallel with extracts from cells expressing an 
untagged or a HisHA tagged Ktil2 protein. Figure 4.4C (middle and 
upper panel) shows a Western blot analysis of the Ni-agarose elution 
fractions from both tagged and non-tagged cells following the 
Mediator subunit, Medl. As can be seen, Medl was found to elute from 
HA-beads even in the absence of HA-tagged Ktil2 (Fig. 4.4C upper 
panel, the elution from the 12CA5 beads was loaded on Ni-agarose, 
therefore indicated by IN), suggesting that the protein also binds 
non-specifically. However, the elution of Medl from Ni-agarose was 
somewhat Ktil2-dependent. When Ktil2 was not tagged, most of Medl 
was in the flow through and the rest was in the wash and low-imidazole 
elutions (Fig. 4.4C upper panel). In  contrast, when cells were 
expressing a Ktil2-HisHA protein, some Medl was found in the flow 
through but the rest eluted in high imidazole, partly overlapping with 
the elution of Ktil2 (Fig. 4.4C, compare middle with lower panel). This 
difference, though not very prominent, supports the idea that there is 
a weak interaction between Ktil2 and the Mediator complex.
Finally, the 500 mM imidazole elution fraction from Ni-aagrose 
shown in Fig. 4.4B, was analyzed by gel filtration chromatography. The 
elution profile of the sizing column clearly showed that Ktil2 did not 
co-elute with either RNA polymerase I I  or Mediator (Fig. 4.4D), 
suggesting that these proteins do not form a stable complex, but 
merely interact.
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4.4 Genetic and functional interaction of Ktil2 and Gen5
The results above indicate that Elongator and Ktil2 interact in 
vitro. I f  Ktil2 is also a functional partner of Elongator in the cell, it 
should interact genetically with Gcn5, as Elongator does. The genetic 
interaction between Ktil2 and the HAT subunit of the SAGA complex, 
Gcn5, was therefore tested. The gcn5A elp3A double mutant displays 
a number of severe growth defects, such as temperature sensitivity 
(37°C) (Wittschieben et al., 2000). Therefore, a gcn5A ktil2A  double 
mutant was constructed and its growth at 37°C was tested. Fig. 4.5A 
shows that the gcn5A ktil2A  mutant cells are also sensitive to high 
temperature (37°C). Moreover, the triple mutant lacking KTI12, GCN5 
and ELP3 showed the same sensitivity as the gcn5A elp3A, as judged 
by the sensitive drop test of Fig. 4.5B, suggesting that Ktil2 and Elp3 
participate in the same genetic pathway. Interestingly, additional 
deletion of two genes encoding histone de-acetylases (HOS2 and 
HOA1) from gcn5A ktil2A  cells restored the sensitivity to elevated 
temperature to wild type levels (Fig. 4.5C). Thus, as previously shown 
fo r elp3A gcn5A hos2A hdalA (Wittschieben et al., 2000), ktil2A  
gcn5A hos2A hdalA are also capable of growing at 37°C, providing 
further evidence for a functional interaction between Ktil2 and Elp3.
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Figure 4.5. Genetic interaction between K til2  and Gcn5. A, C,
Cells from the indicated strains were streaked on YPD plates and 
grown for 3-5 days at 30°C or 37°C, as indicated. B, Serial dilutions of 
cells from the indicated strains were spotted on YPD plates and left 
to grow for 3-5 days at 30°C or 37°C.
Kristjuhan et al. (2002), previously showed that the severe 
growth phenotypes of the elp3A gcn5A double mutant cells correlates 
with hypo-acetylation of histone H3 in the coding region of a number 
of d ifferent genes. Inspired by this study, the possibility that the
gcn5A k til2A  double mutant cells also display hypo-acetylation of
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specific histone H3 lysines was investigated. ChIP assays were 
performed, testing the levels of acetylation at lysine 27 of histone 
H3, in wild type, ktil2A , gcn5A, gcn5A ktil2A  and elp3A gcn5A cells. 
The graph of Fig. 4.6A shows that, deletion of KTI12 gene alone 
results in a 50% reduction of acetylation of lysine 27 in the coding 
region of the BAT1 and SSA4 gene. In cells lacking only the GCN5 
gene, the acetylation levels of lysine 27 was 13% and 9%, respectively, 
of that in wild type cells (Fig. 4.6B). Most significantly, the gcn5A 
ktil2A  and elp3A gcn5A double mutants displayed another two- to 
three- fold reduction of the acetylation level of histone H3 lysine 27, 
compared to the gcn5A single mutant cells (Fig. 4.6B). This result 
suggested that deletion of the KTI12 gene results in reduced 
acetylation and, that in a gcn5A background, k til2  mutation confers a 
further reduction of acetylation in the coding region of certain genes, 
which is comparable with that observed upon deletion of the ELP3 
gene in the same background. This result is in agreement that Ktil2 
has a role in regulating the in vivo HAT activity of Elongator.
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Figure 4.6 gcn5A k til2 A  double mutant cells display reduced 
acetylation of lysine (K) 27 of histone H3 in the coding region of 
certain genes. A, Deletion of the KTI12 gene results in a moderate 
reduction of acetylation compared to wild type cells. B, Cells lacking 
the GCN5 gene retain only 13% and 9% of the acetylation of K27 of 
histone H3 in the coding region of BAT1 and 55A4 gene, respectively. 
Deletion of either KTI12 or ELP3, in the gcn5A background, results in 
an additional 2- to 3-fo ld reduction of the acetylation level of lysine 
27. The resu lts  shown are averages of th ree  independent 
experiments.
4.5 Ktil2 is dispensable for the in vitro HAT activity 
and the in vivo RNA binding of Elongator
Based on the  described physical, genetic and functional 
interaction between Elongator and K til2 , it  was relevant to study 
whether K til2  has an e ffe c t on the in vitro HAT and the in vivo RNA 
binding activ ity o f Elongator. Therefore, in vitro HAT assays were 
performed using highly purified Elongator with or without the addition 
of increasing amounts of the highly purified K til2 (depicted in Fig. 
4.2). As expected, holo-Elongator acetylated histone H3, whereas 
K til2  had no HAT activ ity on its own (Fig. 4.7A, compare lane 1 with 
lanes 4, 5). No obvious dramatic e ffec t (stimulatory or inhibitory) was
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detected when increasing amounts of Ktil2 were added in the 
presence of Elongator (Fig. 4.7A, compare lane 1 with lanes 2, 3), 
suggesting that purified Ktil2 does not regulate Elongator’s HAT 
activity in vitro.
In order to test whether Ktil2 is required for Elongator's in 
vivo RNA binding, RNA immunoprecipitation experiments were 
performed with wild type or k til2 A  mutant cells (Fig. 4.7B, upper 
panel). Immunoprecipitation with an antibody recognizing the Myc 
epitope from cells expressing Myc-tagged, but not untagged, Elpl was 
found to effic iently co-immunoprecipitate mRNA derived from 
transcription of the GAL1 gene. In the absence of KTI12 gene, the 
levels of RNA bound to Elpl were slightly reduced, but Elpl clearly 
retained its ability to bind GAL1 mRNA, suggesting that Ktil2 has 
little, if any, role in Elongator's RNA-binding activity. In Fig. 4.7B, the 
middle panel is a Western blot analysis, which shows that the Elpl 
protein levels in ktil2A  cells were similar to those in wild type (the 
lower panel is a Ponceau S stained membrane used as a loading 
control). Taken together, these results suggest that the Ktil2 protein 
is dispensable fo r the integrity, the in vitro HAT activity and the in 
vivo RNA binding activity of Elongator. However, our data also suggest 
that Ktil2 regulates Elongator's HAT activity in vivo, presumably via a 
direct interaction.
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Figure 4.7 K til2  does not a ffect the in vitro  HAT activity or the 
in vivo RNA binding of Elongator. A, In  vitro  HAT assays using 
highly purified Elongator and/or Ktil2. The upper panel is a fluorogram 
of 3H labelled histone H3 and the lower panel is a coomassie staining 
of the core histones th a t were used as a substrate. In  lane 1 and 2, 
approximately 2.8 pmoles of Elongator were used, whereas in lane 3 
only 2 pmoles. In  lane 2 and 4, 2.8 pmoles of purified K til2 were used. 
In  lane 3 and 5, the amount of Kti 12 was 5.6 pmoles. Note tha t in lane 
3 the reduced acetylation of H3 coincides with the reduced amount of 
purified Elongator tha t was used. B, RNA immunoprecipitation (RIP) 
from wild type cells carrying non-tagged or Myc-tagged Elpl, and from 
k til2 A  cells expressing Myc-tagged Elpl protein. The middle panel is a 
western blot analysis o f the extracts tha t were used fo r the RIP, 
using an anti-Myc antibody. The lower panel is a Ponceau S stained 
membrane used as a loading control of the Western blot. The 
resolution of E lpl into a double band has been described previously 
(Fichtner et al., 2003).
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4.6 Ktil2 is recruited to DNA independently of Elongator
I t  was previously suggested by Fichtner et al. (Fichtner et al., 
2002b) that Ktil2 is recruited to the promoter and not the coding 
region of the AbHl gene. In an attempt to study whether Elongator is 
crucial fo r this recruitment, chromatin immunoprecipitation assays 
were performed using extracts from wild type, elp2A and elp3A cells, 
expressing a tagged (Ktil2-Mycl8), or un-tagged Ktil2 protein. The 
input and immunoprecipitated DNA was amplified using real-time PCR. 
The promoter of the AbH l gene was clearly significantly enriched in 
the Ktil2-Myc precipitates compared to precipitates from non-tagged 
wild type cells (Fig. 4.8A). Surprisingly, though, other genomic regions, 
such as the coding region of the AbH l gene, the promoter of the 
FBA1 gene and even the non-transcribed region of chromosome 4 were 
also found to be enriched in these precipitates (Fig. 4.8B). I t  should 
be mentioned that this applied to all the genomic regions that were 
tested. This surprising observation suggests that Ktil2 is more or less 
globally associated with chromatin rather than specifically with the 
promoter of a gene as suggested by the results of Fichtner et al. 
(Fichtner et al., 2002b).
The use of cells lacking either the ELP2 or ELP3 gene was 
relevant fo r two reasons: (i) it  was suggested by Fichtner et al. 
(Fichtner et al., 2002b) that Elp2 might interact with Ktil2, and (ii) 
Elp3 is crucial fo r the integrity of Elongator (Fig. 3.4). Importantly, 
deletion of either of those genes had no significant effect on the 
recruitment of Ktil2 to the tested genomic regions (Fig. 4.8C). I t  
should be mentioned that the expression level of Kti 12 was not 
affected by the deletion of either ELP2 or ELP3 gene (data not
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shown). Therefore, these results suggest that K til2  is recruited to 
chromatin in an Elongator- and gene-independent manner.
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Figure 4.8 K til2  is recruited to several regions of genomic DNA.
A, Chromatin immunoprecipitation with an anti-Myc antibody (9E11) 
using ex-tracts from  cells expressing un-tagged or Myc-tagged Ktil2. 
The immunoprecipitated DNA was quantitated by real-time PCR with 
normalization to  the amount o f to ta l input DNA ("Relative DNA 
binding"). B, Immunoprecipitation of Ktil2-M ycl8 to d iffe ren t regions 
of the genome. ORF stands fo r "open reading frame". C, Deletion of 
ELP2 or ELP3 gene does not a ffe c t the recruitment of K til2  to DNA. 
Chromatin immunoprecipitation using extracts from wild type, elp2A 
and elp3A cells. Specific primers fo r the promoter and the coding 
region of ADHl gene (ORF), the promoter of FBAl gene, and the non­
transcribed region of chromosome 4 were used fo r the amplification 
of DNA from Myc-immunoprecipitates.
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4.7 Interplay between different factors in zymocin's 
mechanism of action
The KTI12 and all the ELP genes were isolated in a genetic 
screen fo r mutations rendering Saccharomyces cerevisiae cells 
insensitive to the toxin zymocin (Frohloff et al., 2001). I t  was also 
reported that deletion of a number of different transcription-related 
factors confers hyper-sensitivity, thereby linking toxin function with 
transcription. In  particular, gcn5A cells were found to be even more 
sensitive than wild type cells (Kitamoto et al., 2002). Therefore, it was 
interesting to test the e ffect of the deletion of GCN5 gene on the 
killer toxin insensitivity of k til2 A  and elp3A cells (Fig. 4.9). As 
expected, single mutant gcr\5A cells showed great sensitivity towards 
the toxin (Kitamoto et al., 2002). Interestingly, however, deletion of 
either ELP3 or KTI12 in the gcn5A background completely suppressed 
this sensitivity, supporting the view that both Elongator and Ktil2 are 
primary mediators of zymocin action (Fig. 4.9).
elp3A ktil2A
w.t elp3A ktil2A gcn5A gcn5A gcn5A
non killer K. tact is cells 
5. cerevisiae cells
killer K. lactis ce\\s 
5. cerevisiae cells
Figure 4.9 Deletion of ELP3 or KTI12 suppresses the killer toxin 
sensitivity of gcn5A cells. Killer eclipse assays; killer or non killer K. 
lactis cells (red arrows) were grown o/n on a YPD plate at 30 °C. The 
next day, 5. cerevisiae cells (blue arrows) from the indicated strains 
were spotted in the vicinity of the K. lactis cells. Toxin-sensitive wild 
type and hypersensitive gcn5A cells show an eclipse-like growth. Both
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elp3A and ktil2A  mutant cells are insensitive. Deletion of either ELP3 
or KTI12 completely suppresses the sensitivity of gcn5A cells.
The following set of experiments was inspired by the studies of 
Woudstra et al., (2002). In these studies the yeast homologue of the 
human CSB protein, Rad26, was purified from the chromatin fraction 
of yeast cell extracts. Rad26 was found to interact with another 
polypeptide, called Defl (Woudstra et al., 2002). The phenotypes of 
cells lacking DEF1 are consistent with a role for this factor in the 
DNA damage-response. In contrast to wild-type cells, which degrade 
the RNA polymerase I I  in response to UV, defl A cells were unable to 
do so. Based on their results, Woudstra et al. suggested that RNA 
polymerase I I  stalled at a DNA lesion triggers a coordinated rescue 
mechanism that requires the Rad26-Defl complex, and that Defl 
enables ubiquitination and proteolysis of RNAPII when the lesion 
cannot be rapidly removed by Rad26-promoted DNA repair.
Strikingly, Jablonowski and Schaffrath (2002) observed that 
the protein level of the un-phosphorylated form of RNAPII was 
reduced in response to zymocin. Moreover, based on other results 
these authors proposed that this form of the enzyme might be stalled 
in the early coding region of transcribed genes in response to zymocin. 
My next experiments were based on the hypothesis that zymocin- 
stalled RNA polymerase I I  might be degraded as a “rescue" 
mechanism, in a manner reminiscent of the DNA damage-response, and 
that Defl might have a role also in this process. One prediction of this 
model was that deflA  cells would be expected to be very sensitive to 
the toxin. Indeed, the eclipse assays of Fig. 4.10A shows that defl A 
cells are extremely zymocin sensitive, much more than wild type cells. 
Deletion of the gene, which encodes the biochemical partner of Defl,
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Rad26, showed wild type sensitivity. Interestingly, the double mutant 
deflA rad26A cells were as sensitive as the single deflA  mutant cells, 
suggesting a Rad26-independent role for Defl in zymocin's mechanism 
of action. Additionally, when the ELP3 gene was deleted in a deflA  
background, the cells were zymocin insensitive suggesting that the 
role of Elp3 in zymocin action precedes that of Defl.
The above genetic data, which suggest a possible involvement of 
Defl in the cellular response to zymocin, raised the question of 
whether other factors participating in cellular response to UV might 
also play a role in zymocin toxicity. The zymocin sensitivity of a 
number of d ifferent deletion mutants for genes involved in DNA 
repair was tested. Deletion of either RAD16 or RAD18, which encode 
proteins with roles in global genome repair and damage 
tolerance/post-replication repair pathways, respectively, conferred 
wild type sensitivity in killer eclipse assays (data not shown). 
Interestingly, however, radl4A cells were killer-toxin insensitive (Fig. 
4.10B). Radl4 and its human homologue, XPA, recognise damaged DNA 
and are key components in the nucleotide excision repair pathway 
(Prakash and Prakash, 2000). However, cells with deletion of genes 
that encode other members of the same pathway, like RADI and 
RADIO, behaved like wild type cells, indicating a possible NER- 
independent role fo r Radl4 (Fig. 4.10B). Intriguingly, the d e flA  
radl4A double mutant cells displayed wild type toxin sensitivity (Fig. 
4.10B), suggesting that in the absence of both Radl4 and Defl the 
toxin still functions, possibly by using an alternative pathway.
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Figure 4.10 Killer eclipse assays testing the sensitivity of DNA 
repair-related mutant cells in zymocin's mechanism of action. A,
Killer eclipse assays showing that d e flA  mutant cells are extremely 
sensitive towards zymocin. rac/26A cells display wild type sensitivity, 
whereas the sensitiv ity of d e f lA  rad26A  double mutant cells 
resembles that o f the d e f l A  cells. Moreover, deletion of ELP3 
suppressed the sensitivity of d e f l A  cells. B, Mutants of NER-related 
factors tested fo r  zymocin sensitivity (rad lA , radlOA and radl4A). 
rad l4A  cells are insensitive, whereas rad lA  and radlOA cells display 
wild type sensitivity. Deletion of bE Fl in rad l4A  cells re-stored wild 
type sensitivity.
4.8 The effect of zymocin on RNA polymerase I I
Inspired by the genetic data, which showed that elp3A cells are 
insensitive to zymocin while d e flA  cells are extremely sensitive (Fig. 
4.10A), we decided to investigate whether the level of sensitivity 
correlated with the protein levels of the un-phosphorylated form of 
RNA polymerase I I .  We hypothesized that zymocin might lead to
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Elongator-dependent stalling of elongating RNAPII, which might 
result in its Def 1-dependent degradation. Wild type, elp3A and deflA 
5. cerevisiae cells were mixed with cell-free supernatants of over­
grown K. lactis cells, secreting or not secreting zymocin, and left to 
grow fo r up to 6 hours, as described in Chapter 2 (Materials and 
methods). FACS analysis showed that both wild type and deflA  cells 
were arrested in the G1 phase in the presence of zymocin, whereas 
elp3A cells were unaffected (data not shown). Similar results are also 
represented on the graph of Fig. 4.11A, where the growth of the 
different cell types, in the presence or absence of zymocin, is plotted. 
I t  is obvious that the wild type cells grew much slower in the presence 
of zymocin, while the growth of elp3A cells was unaffected. More 
importantly, the d e flA  cells were almost completely unable to grow 
after the addition of zymocin-containing medium. These rates of 
growth thus correlated exactly with the results of the eclipse assays 
(Fig. 4.10A).
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Figure 4.11 Zymocin e ffect on growth rate and protein levels of 
un-phosphorylated Rpbl in d ifferent cell types. A, Wild type, 
elp3A and deflA  cells were grown in the presence or absence of 
zymocin, and their growth rate was plotted on a diagram. The number 
of cells is indicated in 106. B, Western blot analysis using extracts 
from the cells that were used for the growth rate assay. The upper 
panel is a Western blot analysis for un-phosphorylated Rpbl (8WG16
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antibody) and the lower a coomassie stained gel, used as a loading 
control for the Western blot.
Then, extracts from the same cell types were used to examine 
the protein levels of un-phospshorylated Rpbl, in the presence or 
absence of zymocin. In wild type cells, significant reduction in the 
Rpbl protein a fte r six hours treatment with zymocin was observed 
(Fig. 4.11B, compare the Rpbl band of lane 3 with that of lane 5, 
versus the loading control). As expected, the levels of un- 
phosphorylated Rpbl were more or less unaffected by the presence of 
zymocin in elp3A  cells (compare lane 8 with 10 of Fig. 4.11B). 
Interestingly, there was no detectable Rpbl in defl A cells treated for 
6 hours with zymocin (lane 15), indicating that degradation of RNAPII 
in this case is even more dramatic than in wild type cells. I t  should be 
mentioned that the same dramatic reduction was also observed for 
the Elp3 protein levels in de fl A cells treated fo r six hours with 
zymocin (data not shown). In  any case, this result again correlated 
with the increased sensitivity of d e fl A cells. Therefore, it can be 
concluded that the presence of zymocin in wild type, or deflA  cells 
results in reduced levels of the un-phosphorylated form of Rpbl and 
the extent of the reduction correlates with the level of sensitivity 
towards the toxin.
4.9 Discussion and conclusions
KTI12 and all the ELP genes were isolated in a genetic screen 
for mutations rendering Saccharomyces cerevisiae cells insensitive to 
zymocin (Frohloff et al., 2001). Subsequently, Schaffrath and co­
workers showed that Elongator interacts with Kti 12 in co-
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immunoprecipitation experiments. However, the integrity of the six- 
subunit Elongator complex remains intact when the Ktil2 protein is 
missing (Fichtner et al., 2002a). Ktil2 was also shown to interact with 
RNAPII, in particular with the serine 5 phosphorylated form (Frohloff 
et al., 2003). Furthermore, ktil2A  mutant cells displayed phenotypes 
that are very similar to elpA mutants, including sensitivity to 6-AU. 
These observations indicated that Ktil2 might be a functional partner 
of Elongator.
The results presented in the f irs t part of this Chapter 
represent the firs t comprehensive analysis of the interaction between 
Elongator and Ktil2 and the possible role for this interaction in vivo 
and in vitro. Using co-immunoprecipitation assays the previously 
reported interaction between Elongator and Ktil2 was confirmed. 
However, this interaction was stable only under low salt conditions 
(Fig. 4.1). This observation suggests that Elongator interacts with, but 
is not stably associated with, Ktil2. Moreover, yeast Ktil2 was 
purified as a single protein from the soluble fraction of extracts 
under stringent conditions, whereas under low stringency a sub­
population of Elongator seemed to co-purify with a substantial amount 
of Ktil2 (Fig. 4.2, Fig. 4.3). However, the stoichiometry of this 
complex is unknown. The highly purified yeast Ktil2 protein presented 
in Fig. 4.2 did not have any e ffect on the in vitro histone acetyl- 
transferase activity of Elongator under the conditions tested (Fig. 
4.4). In addition, deletion of KTI12 gene did not affect the in vivo 
RNA binding of Elongator (Fig. 4.4). These results indicated that the 
Ktil2 does not directly regulate the in vitro HAT activity or the in 
vivo RNA binding of Elongator.
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Genetic studies, on the other hand, suggested a functional 
interaction between Ktil2 and Gen5 reminiscent of that between Elp3 
and Gcn5 (Fig. 4.5), supporting the idea that Ktil2 affects in vivo 
Elongator function. Thus, the ktil2A  gcn5A double mutant displayed 
increased sensitivity to high temperature (37°C), a characteristic 
previously reported fo r elp3A gcn5A cells (Wittschieben et al., 2000). 
Moreover, the acetylation levels of lysine 27 of histone H3 in the 
coding region of the BAT1 and SSA4 gene (two of the genes that 
showed reduced acetylation in elp3A gcn5A cells (Kristjuhan et al., 
2002)) were examined in ktil2A  gcn5A cells. Fig. 4.6 shows that the 
concomitant deletion of KTI12 and GCN5 resulted in a reduction of 
the acetylation levels comparable to that observed upon deletion of 
both ELP3ar\d GCN5. Since Ktil2 interacts with Elongator, this result 
is most easily understood if  there is a defect in the in vivo HAT 
activity of Elongator in the absence of the KTI12 gene. I t  should be 
mentioned that this is the firs t time that a possible in vivo functional 
relationship between Elongator and Ktil2 has been demonstrated. To 
obtain more support for a regulatory role of Ktil2 in the in vivo HAT 
activity of Elongator, it  would be of great interest if point mutations 
could be identified that disrupt the interaction between Elongator and 
Ktil2. I f  Ktil2 regulates the in vivo HAT activity of Elongator by 
direct protein-protein interactions, these mutations should have the 
same effect as deletion of the entire KTI12 gene on the acetylation 
levels of the previously mentioned genes.
In sharp contrast to data obtained by Fichtner et al. (Fichtner 
et al., 2002b), who reported recruitment of Ktil2 protein only to the 
promoter of the AbHl gene, the ChIP experiments presented in this 
Chapter suggest that the Ktil2 is present in several regions along the
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genome, such as coding regions and even un-transcribed sequences. 
Moreover, the presence of Ktil2 in these regions was independent of 
Elongator. This was a surprising result. One obvious explanation is that 
Ktil2 is a component of chromatin. I t  has recently been shown that 
activation of the GAL1 gene results in reduced histone DNA contacts 
(nucleosome loss) at the gene (Kristjuhan and Svejstrup, 2004). I f  
Ktil2 associates with chromatin (rather than being a DNA-binding 
protein), galactose induction would also be expected to result in 
reduced detection of Ktil2 protein in the coding region of GAL genes. 
This idea is currently under investigation.
In the second part of this Chapter, the mode of action of the 
killer toxin zymocin was investigated. In particular, the idea that 
zymocin action involves degradation of RNAPII was tested. Zymocin is 
secreted from K. lactis cells and results in the arrest of wild type 5. 
cerevisiae cells in the G1 phase of the cell cycle. Work from 
Schaffrath and co-workers suggested that RNA polymerase I I -  
dependent transcription is impaired in the presence of zymocin. 
Moreover, it  was shown that the protein levels of the un- 
phosphorylated Rpbl subunit are dramatically reduced (Jablonowski 
and Schaffrath, 2002). In  the same report, chromatin 
immunoprecipitations were used to study the recruitment of RNAPII 
to the ADH1 gene in the presence or absence of zymocin. I t  was 
suggested that zymocin results in reduction of the un-phosphorylated 
form of RNA polymerase I I  at the promoter, and that it is instead 
stably bound at the beginning of the gene. The proposed 
interpretation of these results was that in the presence of zymocin 
the un-phosphorylated form of RNAPII is stalled in the beginning of 
the gene (Jablonowski and Schaffrath, 2002).
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Elongator seems to be one of the primary targets of zymocin 
and a pre-requisite of its function in 5. cerevisiae cells, since any 
tested combination of deletion mutants that include an ELP3 deletion 
show the same lack of sensitivity that is observed in single elp3A 
mutant cells. Most likely, the same is true for Ktil2 (Fig. 4.9).
Inspired by the model proposed by Jablonowski and Schaffrath 
(2002), I  speculated that zymocin-induced stalled RNAPII might be 
subjected to degradation in a way similar to that by which RNAPII, 
stalled on damaged DNA, is thought to be removed (Woudstra et al., 
2002). Based on this idea, the toxin sensitivity of deflA  cells was 
tested. Def 1 is the only protein known to specif ically be involved in the 
degradation of RNAPII in the presence of UV-induced damage 
(Woudstra et al., 2002). According to the above speculation, deflA  
cells would be expected to be very sensitive to zymocin, because they 
would accumulate stalled RNAPII without the ability to degrade it. In 
the same way, rad26A cells were expected to be less sensitive than 
wild type cells, and the deflA  rad26A double mutant to regain wild 
type toxin sensitivity. Figure 4. 10 shows that deflA  cells were indeed 
very toxin sensitive. However, the rad26A cells displayed wild type 
sensitivity and the deflA  rad26A double mutant cells behaved like the 
de flA  cells. Although the possibility that zymocin's way of action 
involves an alternative mechanism independent of degradation of 
RNAPII cannot be excluded, the above results might suggest a novel, 
Rad26-independent, role for Defl in zymocin's mechanism of action.
A surprising result was obtained from the Western blot analysis 
examining the change in protein levels of the un-phosphorylated form 
of Rpbl in response to zymocin in different cell types. Interestingly, 
Rpbl protein levels decreased 6 hours after treatment with zymocin in
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wild type cells. In agreement with the insensitivity in the killer eclipse 
assays, the Rpbl protein levels were unaffected in elp3A cells. 
Intriguingly, and in apparent disagreement with the above speculation 
about the possible role of Defl in zymocin action, the amount of un- 
phosporylated Rpbl was not stabilized, but rather dramatically 
reduced, in deflA  cells (Fig. 4.11). In fact, after six hours there was 
no detectable Rpbl in de flA  cells. This observation suggests that 
zymocin results in reduced levels of un-phosphorylated RNAPII, which 
in turn results in impaired RNAPII function (other proteins also 
showed reduced levels after 6 hours treatment). Additionally, these 
results have uncovered a new Defl-independent RNAPII degradation 
pathway, which is detrimental for growth in the presence of zymocin.
However, the possibility of a secondary effect of zymocin on 
Rpbl protein expression cannot be excluded (in the absence of 
transcription, protein production will eventually cease). One way to 
distinguish between increased protein degradation and decreased 
protein production, would be by showing that in wild type and deflA  
cells the rate of degradation of RNAPII is increased in the presence 
of zymocin and cyclohexamide, compared to that in the presence of 
cyclohexamide alone (which inhibits translation). I t  might also be 
informative to investigate the effect of zymocin on Rpbl protein 
levels in a proteasome-def icient strain. I f  the proteasome is involved 
in degradation of RNAPII in response to zymocin, these cells might be 
toxin-sensitive, and retain normal Rpbl protein levels in the presence 
of the toxin. Finally, it should be mentioned that 1.5 hrs after the 
treatment with zymocin, the Rpbl protein levels were comparable to 
those of untreated cells in both wild type and deflA  cells (compare 
lanes 2 and 4 and lanes 12 and 14, respectively, of Fig. 4.11B).
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Therefore, if  zymocin action involves stalling of RNAPII, ChIP 
analysis of RNAPII in the absence and presence of zymocin at this or 
even later time points might prove useful. Much work remains to be 
done before we can hope to understand the complex mechanisms 
underlying the e ffect of zymocin on Elongator, transcription, and cell 
growth.
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CHAPTER 5
DISCUSSION AND FUTURE DIRECTIONS
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The experiments described in the previous two Chapters were 
designed to address key questions about the composition, the 
interactions, and the in vitro and in vivo role of Elongator complex in 
yeast 5. cerevisiae. Elongator was initially purified from the insoluble 
chromatin fraction of yeast extracts as a component of a novel 
complex, which includes the hyper-phosphorylated form of RNA 
polymerase I I  known to be engaged in transcript elongation (Otero et 
al., 1999). Based on this interaction and genetic evidence, it was 
suggested that Elongator participates in RNA polymerase I I  
transcript elongation (Fellows et al., 2000; Otero et al., 1999; 
Wittschieben et al., 1999). Initially, it was thought that Elongator 
consists of three subunits. However, further biochemical studies using 
the soluble fraction of yeast extracts uncovered a more complex form 
of Elongator, consisting of six subunits (Krogan and Greenblatt, 2001; 
Li et al., 2001; Winkler et al., 2001). The same studies suggested that 
Elongator can be disrupted into two sub-complexes; core Elongator, 
composed of the three subunits found initially in the chromatin 
fraction of extracts, and the “small" sub-complex composed of the 
three new proteins identified using the soluble fraction of extracts 
(Krogan and Greenblatt, 2001; Li et al., 2001; Winkler et al., 2001).
The results presented in Figures 3.1 and 3.2 of Chapter 3 
further support the notion that the true form of Elongator is a six- 
subunit complex. In  particular, all the six subunits were found to 
stably associate following the purification of one tagged subunit from 
each sub-complex (Elpl or Elp4; Fig.3.1). Additionally, deletion mutants 
for any of the genes encoding the six Elongator subunits were shown 
to confer the same growth defects, such as sensitivity to high 
temperature and high salt (Fig. 3.2 and (Fellows et al., 2000; Otero et
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al., 1999; Wittschieben et al., 1999)). Moreover, deletion of two ELP 
genes, one encoding a subunit of core Elongator (ELP1) and another 
encoding a subunit of the “small" sub-complex (ELP4), did not show any 
additional defect, suggesting that these proteins are implicated in the 
same genetic pathway in the cell (Fig. 3.2).
In an attempt to gain insight into Elongator's molecular 
architecture, three d iffe ren t approaches were utilized; co- 
immunoprecipitation assays, yeast two-hybrid interactions and in vitro 
pull down experiments. To better understand the results of co- 
immunoprecipitation experiments from d iffe rent elpA deletion 
mutants, the stability of Elongator proteins in these mutants was 
studied. Interestingly, the Elp3 protein was found to be de-stabilized 
when the Elpl subunit was missing (Fig. 3.3). That is not surprising, 
since the protein-protein interaction studies showed a strong, direct 
interaction between these two subunits, suggesting that Elp3 is more 
susceptible to degradation when its “partner" is absent (Fig. 3.4). The 
same protein-protein interaction studies also showed a direct 
interaction between Elp4 and Elp6 (Fig. 3.5, 3.6) and between Elp5 and 
Elp6 (Fig. 3.7). Surprisingly, only a weak interaction between Elp4 and 
Elp3 was observed (Fig. 3.5). Although no direct interaction was 
observed, there were indications that Elp2 also has a role in stabilising 
the interaction between the two sub-complexes (Fig. 3.4). However, 
the fact that Elp2 was not found to play a major role in the formation 
of the holo-Elongator complex was surprising, since it includes eight 
WD40 repeats, motifs previously shown to participate in protein- 
protein interactions. All the identified interactions among the 
Elongator subunits are summarised in the Fig. 3.8
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So far, there is no direct in vitro evidence connecting the 
function of Elongator complex with transcript elongation in yeast. In 
contrast, human Elongator complex was shown to facilitate transcript 
elongation through chromatin (Hawkes et al., 2002; Kim et al., 2002). 
Interestingly, this reaction was dependent on the presence of acetyl- 
CoA, thus correlating the identified histone acetyl-transferase 
activity of Elongator with transcript elongation. Moreover, a number 
of other studies have uncovered an important role of Elongator's HAT 
activity in vivo (Kristjuhan et al., 2002; Wittschieben et al., 2000). For 
example, it was shown that combined elimination of Elp3 and Gcr\5 
HAT activity conferred severe growth defects to cells (Wittschieben 
et al., 2000). This was also the case when deletion of the GCN5 gene 
was combined with the deletion of either ELP1 or ELP2 (Wittschieben 
et al., 2000). These defects were shown to correlate with reduced 
occupancy of RNA polymerase I I  and overall reduced acetylation 
levels of histone H3 in the coding region of several genes (Kristjuhan 
et al., 2002). The interpretation of these results is that Elongator 
contributes to transcription by acetylating histone H3 of several 
actively transcribed genes, but that its function is redundant with 
that of Gcn5.
Elongator can also acetylate core histones and nucleosomes in 
vitro (Winkler et al., 2002). The catalytic subunit is the Elp3 protein 
and the main target of the activity is histone H3. However, little  was 
known about the role of the other subunits in that function. Winkler 
et al. showed that biochemically isolated yeast core Elongator is not 
active as a HAT (Winkler et al., 2002). The same was shown for the 
human core Elongator complex (hEIpl, hElp2, hElp3) (Hawkes et al., 
2002). In contrast, the six-subunit holo-Elongator complex was active.
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This suggested that the "small" sub-complex is required for the HAT 
activity of Elongator. To learn more about the role of the individual 
subunits, "mutant" forms of Elongator complex lacking at least one of 
the subunits, had to be purified and tested in HAT assays in vitro. 
Unfortunately, that was not generally possible because my 
experiments showed that Elongator is a fragile complex, which 
typically dissociates when one of its subunit proteins is absent (Fig. 
3.4, 3.5). The only exception was when the Elp2 protein was missing 
(Fig. 3.4). The co-immunoprecipitation assays of Fig. 3.4 clearly 
suggested that in the elp2A cells, the remaining five Elp subunits still 
form a complex. This complex was therefore purified and compared to 
Elongator from wild type cells in HAT assays (Fig. 3.9). These 
experiments suggested that the Elp2 protein is dispensable for the 
HAT activity of Elongator. I t  is possible that the WD40 repeats of 
Elp2 are necessary for interaction with other proteins, such as Ktil2, 
as was suggested by Fichtner et al. (2002b).
Recently, Elongator was shown to have another activity; it binds 
to RNA both in vitro and in vivo. Thus, using a modified chromatin 
immunoprecipitation assay, RNA immunoprecipitation (RIP), Gilbert et 
al. showed that Elp3, like RNAPII, could be cross-linked to nascent, 
un-spliced pre-mRNA in vivo, and that it is found along the entire 
length of the transcript (Gilbert et al., 2004). As expected, Elpl was 
also found to cross-link to RNA (Fig. 3.10). In an attempt to uncover 
possible roles for the individual subunits in that RNA association in 
vivo, different elpA deletion mutants were used, and the efficiency of 
Elp3 or Elpl in associating with RNA was compared with that in wild- 
type cells. Deletion of either ELP2 or ELP4 did not have any major 
effect on Elp3-RNA interaction. Considering that the Elp5 and the
Elp6 do not interact with core Elongator in elp4A cells (Fig. 3.4), the 
above result also suggested that the “small" sub-complex is 
dispensable for the binding of Elp3 to RNA in vivo. However, deletion 
of ELP3 was shown to dramatically reduce Elongator-RNA interaction 
in vivo (Fig. 3.10). Therefore, Elp3 may have three different roles: 
critical component fo r the integrity of holo-Elongator, catalytic 
subunit fo r the histone acetyl-transferase activity, and major 
contributor to RNA binding in vivo.
As mentioned previously, Elp3 has two distinct motifs: the HAT 
motif and the SAM domain. I t  would, therefore, be of great interest 
to explore the role of each domain for all the previously mentioned 
functions. Point mutations, which eliminate the histone acetyl- 
transferase and the potential histone de-methylase activity, could be 
introduced and their e ffect on any of the three mentioned roles of 
Elp3 could be tested. Finally, it would be extremely interesting to test 
the possibility that Elp3 has a histone de-methylase activity, as 
proposed by Chinenov (2000). That can be achieved either by in vitro 
histone methyl-transferase assays/de-methylase assays, or by 
detecting a possible effect of deletion of ELP3 gene on the levels of 
the already known targets for lysine or arginine methylation. Genetic 
interactions with the SET-domain containing yeast genes would also be 
indicative for this function. Unpublished work in the Svejstrup 
laboratory has so far failed to uncover convincing evidence of a role 
for Elp3 in histone de-methylation.
Although convincing evidence fo r a role fo r Elongator in the 
nucleus has been obtained, most of the localization studies so far 
clearly suggested that it is found mainly in the cytoplasm, especially in 
yeast (Fichtner et al., 2002b; Hawkes et al., 2002; Kim et al., 2002;
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Pokholok et al., 2002). Recently, however, Elpl was proposed to have a 
nuclear localization signal (Fichtner et al., 2003). In  an attempt to 
address the question of cellular localization, the idea that Elongator 
continuously shuttles from the cytoplasm to the nucleus and back was 
tested (Fig. 3.11-3.14). In particular, the effect of the inactivation of 
two factors (Crml and Kapl20) involved in protein nuclear 
import/export on the localization of Elp3 was studied. I f  one of these 
factors had a role in transferring Elongator (Elp3) from the cytoplasm 
to the nucleus, elimination of its import function should result in 
accumulation of Elongator (Elp3) in the nucleus. Unfortunately, no 
significant accumulation of Elp3 in the nucleus was detected in either 
case. However, fu rther studies to delineate the localization of 
Elongator under d ifferent conditions would be of great interest. 
Recently, using GFP staining, Huh et al. (2003) identified 
approximately 4800 copies of Elp3 in 5. cerevisiae cells, predominantly 
found in the cytoplasm (Huh et al., 2003). Identification of a 
cytoplasmic function fo r Elongator would seem to be of great 
importance as well. An intriguing possibility is that it  also has a role in 
acetylating the newly synthesized histones, thereby participating in 
maintaining the chromosome-wide acetylation levels of the yeast 
genome.
Finally, the significance of the genetic interaction between 
Elongator and a number of d ifferent elongation factors should be 
addressed (Kong et al., submitted). This could potentially open up the 
way of identifying other so fa r unknown transcription-related 
functions of the yeast Elongator complex.
The second part of the thesis focuses on the physical and 
functional connection between Elongator and Ktil2. Ktil2 was
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previously shown, by co-immunoprecipitation experiments, to interact 
with Elongator, but having no role in maintaining the integrity of the 
six-subunit holo-Elongator complex. In particular, Fichtner et al. 
(Fichtner et al., 2002b) suggested that Elp2 might be the subunit that 
Ktil2 interacts with in the Elongator complex. Others, however, have 
reported that purification of Ktil2 from yeast cell extracts resulted 
in the isolation of a different and seemingly unrelated protein complex 
(Krogan and Greenblatt, 2001).
The results presented in Chapter 4 showed that Elongator 
interacts with Ktil2, but that this interaction is not stable at high salt 
concentrations (Fig. 4.1). Moreover, purification of Ktil2 from the 
soluble fraction of yeast extracts, under moderate salt conditions, 
resulted in its isolation with another polypeptide (Fig. 4.2). However, 
the other protein was found to be a common contaminant when 
12CA5/Ni-agarose tandem purification is used as purification 
procedure (Gilbert et al., 2003). Under low salt conditions, Ktil2 was 
found to co-elute after three purification steps along with Elongator, 
RNA polymerase I I  and Mediator complex (Fig. 4.3, 4.4). However, 
further characterization suggested that Ktil2 is not in a complex with 
RNA polymerase I I  and Mediator (Fig. 4.4). Nevertheless, Ktil2 was 
found in Elongator-containing fractions (Fig. 4.3). I t  seems that Ktil2 
associates with Elongator in a salt-sensitive complex. I t  should be 
mentioned that core Elongator (Elpl, Elp2 and Elp3) - and not holo- 
Elongator - was recently suggested to co-purify with another protein 
called K till (Fichtner et al., 2003). The importance of this purification 
and the possibility that Elongator can form a salt-labile complex with 
both K till and Kti 12 requires further investigation. I t  is worth 
mentioning that Ktil2 has also been suggested to localize mainly in the
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cytoplasm, whereas K till was found to occupy both the cytoplasm and 
the nucleus (Fichtner et al., 2002b; Fichtner et al., 2003). The fact 
that Ktil2 clearly is localized in the nucleus as judged by chromatin 
immunoprecipitation assays (Fichtner et al., 2002a), shows that 
cellular localization data obtained by immuno- or GFP-localization 
should be regarded with caution. The precise relationship between 
these proteins and their function in cells is an important issue that 
merits further investigation.
The results of Fig. 4.5, 4.6 and 4.7 present the f irs t 
comprehensive in vitro and in vivo analysis of functional interaction 
between the Elongator and Ktil2. In particular, the purified yeast 
Ktil2 was used in in vitro HAT assays to test whether it stimulates (or 
inhibits) Elongator's ability to acetylate histone H3 (Fig. 4.7). 
Additionally, the ability of Elpl to cross-link to RNA in cells lacking 
the KTI12 gene was studied (Fig. 4.7). In both cases, Ktil2 found not 
to affect Elongator function. In contrast to that, Ktil2 was shown to 
interact genetically with Gcr\5, in a way similar to that of Elp3 (Fig. 
4.5). Moreover, deletion of both KTI12 and GCN5 resulted in 
reduction of the acetylation levels of specific lysines in the coding 
regions of some genes, resembling the phenotype of the double mutant 
elp3A gcn5A cells (Fig. 4.6). Thus, these experiments suggest a 
regulatory role for Ktil2 in Elongator's in vivo HAT activity. In the 
future, it would be interesting to investigate whether Kti 12 interacts 
genetically with the same elongation factors that Elongator was shown 
to interact with (Kong et al., submitted fo r publication). Finally, it 
should be noted that according to the data of Fig. 4.8, Kti 12 could be 
cross-linked to DNA in a gene- and Elongator-independent manner.
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Though the significance of this result is currently unknown, it might 
point towards an Elongator-independent role for Ktil2 in the cell.
In the last part of Chapter 4, some preliminary experiments 
concerning the mechanism of action of the zymocin toxin in 5. 
cerevisiae cells are presented (Fig. 4.9, 4.10, 4.11). These studies, as 
well as others, suggest that Elongator and Ktil2 are mediators of 
zymocin's effect in the cell (Fichtner et al., 2002a; Frohloff et al., 
2001). In fact they seem to be the main targets of the toxin, working 
upstream in the pathway of zymocin action. This is the most likely 
explanation for the finding that the otherwise very sensitive gcn5A 
cells become insensitive when either the ELP3 or the KTI12 gene is 
also deleted (Fig. 4.9).
Schaffrath and co-workers previously observed that the 
presence of zymocin correlates with stalled, un-phosphorylated RNA 
polymerase I I  in the early coding region of transcribed genes 
(Jablonowski and Schaffrath, 2002). Moreover, they reported a 
reduction in the total cellular amount of that form of the enzyme as a 
result of zymocin treatment. One interpretation of these results 
would be that zymocin results in persistently stalled RNA polymerase 
I I ,  which is then recognized by “recovery" machinery resulting in 
RNAPII being degraded. This mechanism is reminiscent of the 
proposed role for Defl protein during transcript elongation in the 
presence of DNA damage (Woudstra et al., 2002).
In vivo studies in yeast suggested that Defl has a role in UV- 
induced ubiquitination and subsequent degradation of RNA polymerase 
I I .  In particular, d e flA  mutant cells are un-able to degrade RNA 
polymerase I I  in response to UV. With these results in mind, it was 
obvious to test whether Defl had any role in zymocin's mechanism of
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action. Interestingly, defl A mutant cells were found to be much more 
sensitive to the toxin than wild-type cells (Fig. 4.10). The increased 
sensitivity was shown to correlate with the rate of growth in a culture 
medium after toxin addition (Fig.4.11). I f  the role of Def 1 in response 
to zymocin was similar to that proposed fo r the response to UV- 
irradiation, RNA polymerase I I  should become degraded in a Defl- 
dependent manner in response to zymocin treatment. However, the 
opposite turned out to be true: in the presence of zymocin the level of 
RNAPII was indeed dramatically decreased, but RNAPII degradation 
was much more pronounced in deflA  cells than in wild-type cells (Fig. 
4.11). This result suggests that, if  the mechanism of zymocin action 
indeed involves proteolysis of RNA polymerase I I ,  this degradation 
does not require Defl.
For the future, it  needs to be tested whether the reduction of 
RNA polymerase I I  level is a direct  consequence of RNAPII stalling, 
or whether it is an indirect effect of another so far unknown mode of 
zymocin action. Additionally, it  seems relevant to study whether 
zymocin results in ubiquitination of RNA polymerase I I ,  as happens in 
response to UV. Moreover, the effect of zymocin on cells with other 
defects in the protein degradation pathways (such as components of 
the ubiquitination machinery), should be studied genetically and 
biochemically. Finally, whether zymocin directly results in stalled RNA 
polymerase I I  could also be tested by in vitro transcription assays, 
where the effect of purified zymocin and the role of Elongator in its 
function could be monitored.
In summary, this study has described the molecular 
architecture of the six-subunit Elongator complex. Moreover, several 
lines of experimental approaches were pursued to shed light on the
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possible roles of the individual Elongator subunits. Finally, a physical 
and functional connection between Elongator and Ktil2 was delineated. 
In the future, it will be interesting to further dissect the role of 
Elongator in the transcription cycle and chromatin modification, and to 
explore the level at which Ktil2 is regulating Elongator's activity.
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E longator is a histone acetyltransferase com plex th a t 
associates w ith  the elongating form  o f R N A  polym erase 
I I .  We p u rifie d  E longator to  v irtu a l hom ogeneity v ia  a 
ra p id  three-step procedure based la rg e ly  on a ffin ity  
chrom atography. The p u rified  factor, holo -E longator, is 
a lab ile  six-subunit facto r composed o f tw o d iscrete sub­
complexes: one com prised o f the previously id e n tifie d  
E lp l, E lp2, and E lp3 proteins and another com prised o f 
th ree novel polypeptides, term ed E lp4, E lp5, and E lp6. 
D isrup tion  o f the yeast genes encoding the new  E longa­
to r proteins confers phenotypes ind istingu ishable from  
those previously described fo r the o th er elp  m utants, 
and concom itant d isruption  o f genes encoding p ro teins  
in  e ith e r subcom plex does not confer new  phenotypes. 
Taken together, o ur results ind icate  th a t holo -E longator 
is a fu nctio n al e n tity  in  vitro  as w e ll as in  vivo. M etazoan  
hom ologues o f E lp l and E lp3 have previously been re ­
ported . We cloned the hum an hom ologue o f yeast E LP4  
and show th a t th is  gene is ub iqu itously expressed in  
hum an tissues.
The form of RNA polymerase II (RNAPII)1 responsible for 
transcript elongation is fundamentally different from the form 
that enters a promoter to form a preinitiation complex (1, 2). 
During initiation, RNAPII is hypo-phosphorylated and associ­
ated with the functionally conserved Mediator complex, a mul­
tisubunit factor required for regulation of transcription (3, 4). 
The association of RNAPII with Mediator and the general 
transcription factors is severed during promoter clearance, 
triggered by TFIIH-mediated hyperphosphorylation of the car­
boxyl-terminal repeat domain (CTD) of the largest RNAPII 
subunit (5-7). During elongation, hyperphosphorylated yeast 
RNAPII is associated with the Elongator complex. Elongator 
binds directly to RNAPII, at least partly via the CTD, and the 
interaction is stabilized by CTD hyperphosphorylation (8).
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Elongator was biochemically isolated as a component of elon­
gating RNAPII from salt-stable chromatin but can also be 
isolated as a discrete, three-subunit complex when starting 
from the DNA-free soluble fraction of a whole cell extract (8). 
The genes encoding the Elongator subunits have been identi­
fied and shown to play a role in transcription elongation in vivo: 
ELP1 encodes a protein without discemable motifs (8), 
whereas Elp2 has multiple WD40 repeats (9), and Elp3 has 
histone acetyltransferase (HAT) motifs (10). The identification 
of a highly conserved HAT associated w ith elongating RNAPII 
suggests a mechanism for modification and remodeling of chro­
matin during transcript elongation. Recombinant Elp3 indeed 
has HAT activity in a gel-based HAT assay, and mutations in 
the sequence encoding the predicted acetyl-CoA binding pocket 
of the protein significantly reduce th is activity (11). Impor­
tantly, when the same point mutations are introduced in yeast, 
they confer phenotypes th a t are virtually identical to those 
resulting from deletion of either of the ELP  genes, indicating 
tha t the catalytic activity of the Elp3 protein is essential for 
Elongator function. The in vivo function of Elp3 is overlapping 
with tha t of the prototype HAT, Gcn5, the catalytic subunit of 
SAGA/ADA (12). In  the absence of both Elongator and SAGA 
HAT activity, cells are sick and unable to grow under a large 
variety of conditions. These phenotypes can be suppressed by 
concomitantly deleting the genes encoding two histone deacety- 
lases (HDACs), indicating functional redundancy between 
HDACs as well and supporting the notion th a t maintenance of 
a certain overall acetylation level in a cell may be important for 
cell viability and growth (11). Elongator function, such as HAT 
activity, is required for normal activation of a number of genes, 
indicating th a t Elongator is involved in creating a chromatin 
structure th a t is amenable to efficient transcription (8, 10).
To further our understanding of Elongator function, we iso­
lated the complex from extracts of yeast cells in which the gene 
encoding E lp l had been modified to express a double affinity- 
tagged version of the protein. This tag  made it possible to 
rapidly purify Elongator to virtual homogeneity under mild 
conditions. Here we show th a t the purified factor is a six- 
subunit complex, comprised of two discrete, three subunit sub­
complexes th a t easily dissociate. We have identified the three 
novel proteins of the complex, as well as a hum an homologue of 
one of the encoding genes, and provide evidence tha t holo- 
Elongator is the functional entity of Elongator in vivo.
EXPERIMENTAL PROCEDURES
Expression o f Tagged E lp l—A  sequence encoding a (His)10-HA 
epitope tag followed by a transcription termination signal was created 
by polymerase chain reaction using primers 5'-AGCTGACTAGTCAT- 
CACCATCACCATCACCATCACCATCACTATCCATGTTCCTGACTA- 
TGCCTAATTCCGGGCGAATTTCTTATG-3' and 5 '-GTTCTGAGCTCT-
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T a b le  I 
List o f yeast strains used
Name Description Reference/Source
W303-1A MATa, leu2-2, 112, h is3 -ll, 15, trpl-1, ade 2-1 canl-100 Thomas and Rothstein (25)
W303-1B MATa, leu2-2, 112, h is3 -ll, 15, trpl-1, ade 2-1, canl-100 Thomas and Rothstein (25)
JSY100 As W303-1A, but e\plA :LE U 2 Otero et al. (8)
JSY671 As W303-1A, but elp4A:ADE2 This study
JSY785 As W303-1A, but elp5A: JCAN This study
JSY537 As W303-1A, but ELPl(His,0-HA)::TRP2 This study
JSY788 As W303-1B, but elplA:LEU2 This study
JSY670 As W303-1B, but elp4A:AD£2 This study
JSY784 As W303-1B, but elp5A: JCAN This study
JSY786 As W303-1B, but e\p6A:HIS3 This study
JSY787 As W303-1B, but elplA:LEU2 elp4A: ADE2 This study
BJ2168 MATa, prcl-407, prbl-1122, pep4-3, leu2, trpl, ura3-52, gal2 J o n es(26)
JSY549 As BJ2168, but ELPl(His;0-HA): :TPP7 This study
TACGCCAAGCTTGCATGCCGGT-3' and plasmid pAS2-l (CLONT- 
ECH) as a template. The resulting sequence was inserted between the 
Spel and Sacl sites of pRS304 (13) to yield vector pSE.HISHA-304. Part 
of the ELP1 open-reading frame was amplified using primers 5'-GCT- 
ACACTCGAGACAAGATAATGAGCCTTTACGCCG-3' and 5'-TGTGA- 
CACTAGTAAAATCAACAATATGACTCTTAGGG-3' and cloned into 
pSE.HISHA-304 using theX hol and Spel sites yielding plasmid pELPl- 
HISHA-304. After transformation of the protease-deficient Saccha- 
romyces cerevisiae strain BJ2168 (Table I), a TRP+ clone was isolated in 
which the 3'-end of the ELP I gene was replaced, resulting in expression 
of an Elpl-(His)10-HA fusion protein (Elpl-HisHA; strain JSY549). To 
ensure that the (His)l0-HA epitope tag did not interfere with Elpl 
function, the same integration was performed in the W303 strain bac­
kground, making it possible to do phenotypic analysis and comparison 
with wild type and elp l A cells.
Protein Purification—DNA-free soluble whole cell extract (typically 
from 0.8-1.0 kg of yeast paste) was prepared from strain JSY549 and 
subjected to cation-exchange chromatography on Bio-Rex 70 (Bio-Rad) 
essentially as described previously (8). Protein was stepwise eluted 
with buffer A (40 mM Hepes-KOH pH 7.6, 1 mM EDTA, 1 mM dithio- 
threitol, 20% (v/v) glycerol) containing 150 mM, 300 mM, 600 mM, and 
1200 mM KOAc. The vast majority of Elongator eluted in the fraction 
containing 600 mM KOAc. Typically, 50 ml of this fraction was incu­
bated with 0.8 ml of protein A-Sepharose CL4B-12CA5 monoclonal 
antibody resin (1-3 mg of antibody/ml of resin) overnight at 4 °C. The 
resin was collected by gravity flow in a column holder and washed 
extensively with buffer A containing 600 mM KOAc and equilibrated in 
A containing 300 mM KOAc. Bound proteins were then eluted in three 
washes with 1 ml of buffer A containing 300 mM KOAc and 2 mg/ml HA 
peptide (KKKRILKMYPYDVPDYARIL) for 15 min at 30 °C. These 
fractions were pooled and diluted with an equal volume of buffer (40 mM 
Hepes-KOH pH 7.6, 300 mM KOAc, 20% (v/v) glycerol) and allowed to 
bind to 0.4 ml Ni2+-NTA-agarose (Qiagen) at 4 °C overnight with mix­
ing. The resin was collected in a column holder and washed with 2 ml 
of buffer A containing 300 mM KOAc. After washing with 2 ml of the 
same buffer containing 300 mM KOAc and 10 mM imidazole, bound 
protein was eluted in 1 ml of the same buffer containing 300 mM 
imidazole. Fractions were dialyzed against buffer A containing 100 mM 
KOAc and stored in small aliquots at -8 0  °C.
Gel filtration was carried out on a SMART chromatography system 
(Amersham Pharmacia Biotech). A portion of the eluate from the an- 
ti-HA immunoaffinity column was applied via a 25-p.l sample loop onto 
a Superose 6 PC1.6/30 column (Amersham Pharmacia Biotech) collect­
ing 50-p.l fractions. Aliquots (1 and 5 pi, respectively) were analyzed by 
immunoblotting and staining with silver nitrate. Different Elongator 
(sub)complexes were obtained by anion-exchange chromatography us­
ing an AKTA-FPLC (Amersham Pharmacia Biotech). Anti-HA eluate 
fractions 1-3 were pooled (~2 ml), diluted with buffer B (25 mM Tris- 
HAc, pH 7.8, 1 mM EDTA, 1 mM dithiothreitol, 20% glycerol) to a final 
concentration of 150 mM KOAc and loaded onto a Mono Q HR5/5 FPLC 
column (Amersham Pharmacia Biotech). The column was washed with 
2 volumes of buffer B containing 150 mM KOAc and developed with a 
10-column volume linear gradient from 150 to 1500 mM KOAc collecting 
0.35-ml fractions. Elongator subcomplexes eluted between 1000 and 
1450 mM KOAc. Aliquots were analyzed by immunoblotting (1 /xl) and 
staining with silver nitrate (5 p.1).
Protein Identification—Gel-fractionated proteins were digested with 
trypsin, and the mixtures were fractionated on a Poros 50 R2 RP 
microtip (14). Resulting peptide pools were then analyzed by matrix- 
assisted laser desorption/ionization reflectron time-of-flight (MALDI-
reTOF) MS using a Reflex III instrument (Briiker Franzen; Bremen, 
Germany) and by electrospray ionization (ESI) MS/MS on an API 300 
triple quadrupole instrument (PE-SCIEX; Thornhill, Canada), modified 
with an ultrafine ionization source (15). Selected mass values from the 
MALDI-TOF experiments were taken to search a S. cerevisiae subset of 
the protein non-redundant data base (NR; NCBI, Bethesda, MD) using 
the PeptideSearch (16) algorithm. MS/MS spectra were inspected for y" 
ion series to compare with the computer-generated fragment ion series 
of the predicted tryptic peptides.
Preparation o f Antibodies—To produce antibodies recognizing Elp4, 
Elp5/Ikil, and Elp6, peptides encompassing an amino-terminal cys­
teine residue followed by the final carboxyl-terminal 19 amino acids of 
the corresponding predicted open-reading frames were synthesized. 
Each of these peptides was coupled via its amino-terminal cysteine 
residue to Keyhole Limpet Hemocyanin (Calbiochem) by m-maleimido- 
benzoyl-N-hydroxysuccinimide ester (Pierce) cross-linking and used to 
immunize rabbits (Murex). For immunoblotting, the anti-Elp4, -Elp5, 
and -Elp6 antibodies and their respective prebleeds were used at a final 
dilution of 1:1000.
Yeast S trains and Phenotypic A nalysis—All S. cerevisiae stains used 
for genetic analysis (Table I) were congenic with strain W303 and grown 
and manipulated as described previously (8,10). To analyze killer toxin 
sensitivity, yeast strains were transformed with plasmid pNW064 en­
coding the killer toxin y-subunit under control of the inducible G all-10  
promoter (17). Dilutions of the indicated yeast strains were spotted onto 
SD (-ura  -trp) medium containing 2% glucose or galactose as 
indicated.
Expression A nalysis o f H um an E lp 4 —A full-length human Elp4 
cDNA clone was obtained from the NEDO sequencing project (clone 
KAT08960, GenBank™ accession number AK000505). The entire open- 
reading frame of human Elp4 was amplified by polymerase chain 
reaction using primers pl23 5'-GAAGATCTCCATGGCGGCAGTGGC- 
AACCTG-3' and pl24 5 '-GAAGATCTCTAGAAGTCCAGGTGCTTCTT- 
GCC-3' and radiolabeled with random hexamers. This probe was 
hybridized to a human multiple tissue Northern blot according to the 
manufacturer’s guidelines (CLONTECH). As a control, the blot was 
probed with a human j3-actin cDNA (CLONTECH).
RESULTS
Purification o f Elongator from Soluble Whole Cell Extracts— 
Previously, we purified the Elongator complex from the DNA- 
free, soluble fraction of a whole cell extract through five to six 
conventional chromatography steps (8). To facilitate the puri­
fication of Elongator and the subsequent analysis of its compo­
sition and enzymatic activities, we constructed a haploid S. 
cerevisiae strain  expressing a tagged version of the gene encod­
ing the largest subunit of Elongator, ELP1. The endogenous 
chromosomal copy was replaced w ith a gene encoding full- 
length E lp l fused to a carboxyl-terminal decahistidine stretch 
and a HA epitope tag  (Fig. 1A). After verification th a t the tag 
did not interfere w ith E lp l function in vivo (data not shown), 
we purified Elongator using an efficient three step procedure 
including two high affinity chromatography steps (Fig. IB). 
First, soluble whole cell extract was loaded onto Bio-Rex 70 
cation-exchange resin. Bound proteins were eluted with buffer 
containing 300 m M , 600 m M , and 1200 m M  potassium acetate 
(KOAc), respectively. Essentially all Elongator was collected in
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Fig. 1. P urifica tio n  o f E longator com plex. A, schematic diagram 
of tagged Elpl consisting of full-length Elpl fused to a decahistidine 
stretch and an HA epitope tag. B, diagram of the purification scheme. C, 
immunoblot analysis of fractions from the anti-HA immunoaffinity 
column. Elpl protein was detected using rat monoclonal antibody 3F10 
(Roche Molecular Biochemicals) recognizing the HA epitope. D, protein 
staining with silver nitrate of Elongator-containing fractions from the 
anti-HA immunoaffinity resin and the Ni2+-NTA-agarose column. Elp 
proteins are indicated. Numbers on the left indicate the positions of the 
molecular size markers.
the 600 mM KOAc eluate and subsequently applied onto an- 
ti-HA immunoaffinity resin. Analysis by immunoblotting 
showed that virtually all Elpl-HisHA from the Bio-Rex 70 
fraction bound to this column and could be eluted by competi­
tion with excess peptide containing the HA epitope (Fig. 1C). 
Interestingly, protein silver staining showed that, in addition 
to Elpl, Elp2, and Elp3, three additional proteins with appar­
ent molecular weights of 50, 35, and 30 kDa eluted from the 
immunoaffinity column (Fig. ID). These three proteins did not 
bind to the immunoaffinity resin in the absence of tagged Elpl 
(data not shown), indicating that they interact specifically with 
Elpl. Moreover, when the eluates from the anti-HA immuno­
affinity resin were subjected to Ni2+-agarose affinity chroma­
tography, the three additional proteins also co-eluted with the 
previously defined Elongator subunits, providing further evi­
dence that the interaction is specific (Fig. ID). We designated 
these putative novel Elongator subunits Elp4, Elp5, and Elp6, 
respectively.
Identification o f Three N ovel Elongator Subunits Elp4, Elp5, 
and E lp6—Peptide mass fingerprinting using MALDI-reTOF 
mass spectrometry (14, 16, 18) was used to identify the 50-, 35-, 
and 30-kDa protein bands. We identified the 50-kDa band as 
the product of the previously defined open-reading frame 
YPL101W on chromosome XVI (predicted molecular weight M r 
51.2) and named this gene ELP4. The p35/Elp5 protein was 
identified as the product of open-reading frame YHR187W 
(chromosome VIII, predicted molecular weight M r 35.2). Inter­
estingly, this gene was previously identified as the insensitive 
to killer toxin 1 gene, IKI1, which was identified in the same 
genetic screen as ELP1 /  IKI3 and whose inactivation renders 
yeast cells insensitive to pGKL killer toxin (19). F in a l ly , the 
30-kDa protein band was found to correspond to the open- 
reading frame YMR312W on chromosome XIII (predicted mo­
lecular weight M r 30.6), which we termed ELP6. The predicted 
molecular weights of the identified open-reading frames corre­
spond well with the apparent molecular masses in all three 
cases. Analysis of the three amino acid sequences by data base 
searching did not reveal any obvious domain structure or ho­
mology to proteins with known function.
To verify the identity of the 50-, 35-, and 30-kDa protein 
bands, polyclonal rabbit antibodies directed against the carbox­
yl-terminal 19 amino acids of Elp4, Elp5, and Elp6 were gen­
erated and tested for reactivity toward purified Elongator by 
immunoblotting. These antibodies, but not the corresponding 
preimmune sera, specifically recognized p50/Elp4, p35/Elp5, 
and p30/Elp6, respectively, in the Elongator preparation, con­
firming the identification of these proteins as components of 
the complex (Fig. 2A).
To establish that Elp4, Elp5, and Elp6 are bona fide subunits 
of Elongator, the purified complex was analyzed by gel filtra­
tion chromatography. All six Elongator proteins exactly co­
eluted from this resin as judged by protein silver staining and 
immunoblot analysis using antibodies directed against Elpl, 
Elp3, Elp4, Elp5, and Elp6 (Fig. 2B). This experiment shows 
that Elp4, Elp5, and Elp6 are indeed subunits of Elongator and 
indicates that Elongator is a stoichiometric complex composed 
of six subunits.
Elongator Is Composed o f Two Subcomplexes—Previously, 
we identified Elongator as a three-subunit complex (8). Careful 
analysis of protein fractions obtained from these earlier puri­
fications showed that proteins with apparent molecular 
weights corresponding to Elp4, Elp5, and Elp6 eluted from 
Mono Q slightly later than Elpl, Elp2, and Elp3 (data not 
shown). We reasoned that Elongator complex might be dis­
rupted by anion-exchange chromatography on Mono Q, or by 
high salt concentration. Indeed, when affinity-purified six sub­
unit Elongator was loaded onto Mono Q and eluted with in­
creasing salt, three different forms of the complex could be 
identified (Fig. 3). First, six subunit holo-Elongator eluted at 
<1100 mM KOAc. Second, the previously identified form of 
Elongator composed of Elpl, Elp2, and Elp3 (core Elongator) 
was detected, and, finally, fractions highly enriched in Elp4, 
Elp5, and Elp6 were obtained. We also observed that Elongator 
was disrupted in the presence of 2 M NaCl (data not shown). We 
conclude that Mono Q chromatography and/or high salt con­
centration can disrupt the Elongator complex, explaining our 
failure to previously identify the three smallest subunits. 
These findings indicate that Elongator is composed of two 
subcomplexes: one comprising the three largest subunits, and
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Fig . 2. Identification of the Elp4, EIp5, and Elp6 proteins by 
immunoblotting, and analysis of purified Elongator com plex by 
gel filtration. A, protein staining with silver nitrate and immunoblot 
analysis of purified Elongator using antibodies directed against the 
carboxyl termini of Elp4, Elp5, and Elp6, respectively. B, fractions from 
the anti-HA immunoaffinity column were subjected to Superose 6 gel 
filtration chromatography. Fractions were analyzed by 10% SDS-poly- 
acrylamide gel electrophoresis and stained with silver nitrate (top 
panel) or antibodies directed against Elongator proteins (bottom pan­
els). Numbers on the right of the silver stained gel indicate the positions 
of the molecular size protein markers. Numbers at the bottom of the 
figure indicate the migration of globular molecular size markers during 
gel filtration.
the second composed of the three newly identified proteins, 
Elp4, Elp5, and Elp6.
Disruption of ELP4, ELP5, and ELP6 Genes Results in Typ­
ical Elp Phenotypes—To analyze the role of ELP4, ELP5, and 
ELP6 in vivo, we disrupted one copy of the respective entire 
open-reading frames in diploid yeast cells, which were subse­
quently induced to sporulate. After dissection of the resulting 
tetrads, we noted the appearance of small colonies, which oc­
curred in a 2:2 ratio and co-segregated with the marker used
Fig. 3. R esolution  o f d ifferen t form s o f E longator by Mono Q 
anion-exchange chrom atography. Fractions from the anti-HA im­
munoaffinity column were loaded onto a Mono Q FPLC column and 
eluted with a linear salt gradient. Fractions were analyzed by 10% 
SDS-polyacrylamide gel electrophoresis and stained with silver nitrate 
(top panel) or detected by antibodies directed against Elongator pro­
teins (bottom panels).
(data not shown). This is reminiscent of the phenotype we 
previously observed in e lp l A., elp2A, and elp3  A cells (8-10). The 
identification of two genes encoding Elongator components, 
ELP1 /IK I3  and ELP5/IKI1, as genes whose inactivation cause 
insensitivity to pGKL killer toxin (19), prompted us to investi­
gate whether disruption of the remaining four ELP  genes also 
render cells insensitive to the killer toxin derived from the 
yeast Kluyveromyces lactis. Therefore, we conditionally ex­
pressed the y killer toxin subunit intracellularly using a galac- 
tose-inducible promoter (17). As shown in Fig. 4A, all elp A 
mutant strains grew normally on medium containing glucose 
where the killer toxin was not expressed. However, upon ex­
pression of killer toxin on galactose-containing medium, wild 
type cells were unable to grow, whereas all elp A mutants were 
insensitive to killer toxin. The mechanism of killer toxin de­
pends on the histone acetyltransferase activity of Elongator, as 
inactivation of the complex in an elp3  strain carrying a point 
mutation in a residue important for the catalytic activity of 
Elp3 also resulted in insensitivity to killer toxin.
Other phenotypes we observed for elp4A, elp5A, and elp6A 
cells were an inability to grow at 39 °C (Fig. 4B) and salt 
sensitivity (Fig. 4C), which were previously observed for e lp l A, 
elp2A, and elp3A  mutants (8-10). In addition, e lp l A elp4A 
double mutants cells displayed phenotypes virtually identical 
to those of the single mutants, such as growth rate, and sensi­
tivity to elevated temperature and high salt (Fig. 5 and data 
not shown), as previously observed for all combinations of 
e lp l A, elp2A, and elp3A  mutations (9). Taken together, these 
results indicate that ELP1 through E LP6  are all non-essential 
genes whose products also form a functional entity in vivo.
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Fig. 4. Phenotypic analysis of elp4A, elp5A, and elp6A  yeast 
cells. A, all elp mutants are insensitive to K. lactis killer toxin. Cells 
carried plasmid pNW064 (17) containing the killer toxin y subunit gene 
under control of a galactose-inducible promoter. Serial dilutions of the 
indicated mutant cells were plated on SD (-ura -trp) medium contain­
ing 2% glucose or galactose as indicated and allowed to grow for 2-3 
days at 30 °C. B, temperature sensitivity. Cells were grown on YPD for 
2—4 days at the indicated temperature. C, sensitivity to high salt 
concentration. Serial dilutions of the indicated mutant cells were 
dropped onto YPD or YPD containing 1 m NaCI and grown for 2-3 days 
at 30 °C.
Identification of Elp4 Homologues in Higher Eukaryotes—  
Further data base searching using the predicted amino acid 
sequence of ELP4 as a query identified significant homology 
with several open-reading frames from a variety of higher 
eukaryotes, including human and mouse (Fig. 6A). No clear 
domain structure could be identified on the basis of these 
homologies. Interestingly, however, the putative human and 
mouse Elp4 proteins are encoded by the human and mouse 
PAXNEB gene, respectively, which is localized on human chro­
mosome lip  13 (mouse chromosome 2), a region implicated with 
human disease (20). PAXNEB is expressed in a variety of 
human tissues as determined by Northern blot analysis (Fig. 
6B) and indicated by the presence of multiple expressed se­
quence tags (ESTs) derived from different tissues in the data 
base. The ubiquitous expression pattern suggests a general role
elpiA
elp4A
e/pfA e/p4A
Fig. 5. P henotypic analysis o f e l p l  e lp 4  double m utant cells. A,
temperature sensitivity. Wild type, single, and double mutant cells 
were grown on YPD for 2 -4  days at 30 °C, 37 °C, or 39 °C. B, sensitivity 
to high salt. Serial dilutions of the indicated mutant cells were dropped 
onto YPD or YPD containing 1 m NaCI and grown for 2 days (YPD) or 3 
days (YPD +1 m NaCI).
for Elp4 in higher eukaryotic cells. In addition, the identifica­
tion of human and other higher eukaryotic homologues of Elp4 
further supports the notion that Elongator is structurally con­
served from yeast to man.
DISCUSSION
In the present study we isolated Elongator complex by uti­
lizing a rapid purification procedure based largely on affinity 
chromatography. Our findings can be summarized as follows: 
Elongator consists of six subunits; the three identified previ­
ously, and a novel discrete subcomplex composed of three pro­
teins, termed Elp4, Elp5, and Elp6. We have named the novel 
factor holo-Elongator, to distinguish it from the core-factor 
(Elpl, Elp2, and Elp3) that we isolated previously. holo-Elon­
gator is a labile complex that can be dissociated into its two 
three-subunit subcomplexes by treatment with high salt or by 
anionic chromatography. We have identified the genes encod­
ing the three new subunits and shown by genetic analysis that 
strains lacking any one of these genes have phenotypes that are 
indistinguishable from those of the previously characterized 
elp strains. Finally, we have cloned the human homologue of 
yeast ELP4 and shown that it is ubiquitously transcribed.
holo-Elongator Is a Functional Unit—In vivo, two of the 
proteins in the Elp4/Elp5/Elp6 module, Elp5 and Elp6 have 
been shown to interact in a large scale two-hybrid screen (21). 
We found that deletion of any gene encoding a component of 
holo-Elongator results in similar phenotypes and that concom­
itant deletion of more ELP  genes fails to confer a new pheno­
type. In this respect, Elongator seems fundamentally different 
from other transcription-related multisubunit complexes, such 
as Mediator, Swi/Snf, Rsc, ADA, and SAGA. Mutation of genes 
encoding subunits of these complexes often confer very differ­
ent phenotypes, indicating that these factors are at least partly 
composed of subcomplexes or components with different spe­
cialized (gene-specific) functions. Additionally, some of the 
components of these factors, such as Gcn5 (a component of both 
ADA and SAGA) and Arp7/9 (components of both Swi/Snf and 
Rsc) perform functions in more than one factor, which likely 
contributes to diversified phenotypes (12, 22). Based on these 
observations and the above-mentioned fundamental difference 
between Elongator and other multisubunit factors, it may be 
argued that the products of the E LP  genes are likely to only 
exert their function together, in the context of Elongator. In 
agreement with this, we have failed to observe other proteins 
than the six holo-Elongator subunits after affinity purification 
from a strain expressing epitope-tagged Elp4 (TP and JQS,
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Fig. 6. ELP4 is a ub iquitously ex­
pressed gene w hose product is con­
served in h igher eukaryotes. A, pre­
dicted amino acid sequence of the protein 
encoded by ELP4 and alignment with se­
quences from various species using Clust- 
alX (24). M.m., Mus musculus, Q9ER73; 
H.s., Homo sapiens, Q9NX11; D.m., Dro­
sophila melanogaster, Q9VMQ7; C.e., 
Caenorhabditis elegans, Q18195; S.p., 
Schizosaccharomyces pombe, Q9USP1; 
S.c.,S. cerevisiae. Conserved residues are 
shaded in light gray, identical residues in 
dark gray, and residues identical in all 
species are highlighted. Yeast Elp4 is 26% 
identical/41% similar to human Elp4 
(PAXNEB) over the entire sequence. Oth­
erwise, homology between these proteins 
range from 21% identical and 41% similar 
(S.c. and D.m.) to 26%/43% (S.c. and S.p.) 
and 30%/49% (D.m. and H.s.). B, expres­
sion pattern of human ELP4 (PAXNEB) 
in the indicated tissues as determined by 
Northern blot analysis in comparison 
with the actin control.
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data not shown). It may also be significant that a point muta­
tion resulting in loss of Elp3 HAT activity also confers the full 
elp phenotype. This indicates that the most important function 
of holo-Elongator lies in its capacity as a HAT.
Elongator A s a Putative Target for K. lactis K iller Toxin—  
ELP1 is identical to IKI3, and the newly identified ELP5  gene 
is identical to 1K11. We found that the interesting and intrigu­
ing insensitivity to expression of the K. lactis  killer y-toxin is a 
phenotype shared by all the elp strains. While this work was in 
progress, Frohloff et al.{23) reported the identification of mu­
tants from a killer toxin screen virtually identical to the IKI 
screen and named their isolated mutants TOT  (for toxin tar­
get). From this screen, TOT1, 2, and 3 were found to be iden­
tical to ELP1, ELP2, and ELP3, respectively. The authors also 
found that the protein product of IK11 /  TOT5, as well as the 
product of a gene isolated in another killer toxin screen, 
KTI12ITOT4  (killer toxin insensitive 12), could be co-immuno-
precipitated with Elongator proteins, indicating that all the 
gene products isolated so far as intracellular effectors of the 
killer toxin interact. Our identification of Ikil/Tot5 as a com­
ponent of holo-Elongator (Elp5) provides an explanation for the 
Ikil/Tot5-Elongator interaction observed by Frohloff et al. (23). 
By contrast, extensive analysis by mass spectrometry did not 
provide any evidence for the presence of K til2  in highly puri­
fied Elongator preparations. Because the k t i l2  / tot4  mutant 
was shown to have phenotypes strikingly similar to those of elp 
mutants (23), however, it is likely that this protein plays a role 
in Elongator function. Importantly, expression of KTI12  /  TOT4 
from multicopy plasmids, but not similar overexpression of 
E L P 1/T O T 1, E L P 2 /T O T 2 , E L P 3 /T O T 3 , or E L P 5/T O T 5, con­
fers y-toxin resistance (23). Taken together, these findings thus 
suggest that Ktil2/Tot4 is not a component of Elongator, but 
rather influences its activity. This possibility is presently un­
der investigation.
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Elongator Is Conserved among Eukaryotes—Human homo­
logues of ELP1 and ELP3 have been identified by searching the 
data bases (8, 10). In support of the notion that the structure 
and function of holo-Elongator is highly conserved among eu­
karyotes, we identified a human homologue of the yeast ELP4 
gene, which has previously been submitted to the data bases 
and named PAXNEB. This gene is ubiquitously expressed, and 
is located in a region on chromosome 11 that has been impli­
cated in human disease. Heterozygous deletion of the l ip  13 
region gives rise to WAGR syndrome: Wilm’s tumor, Aniridia, 
genitourinary abnormalities, and mental Retardation. Most of 
these abnormalities are due to deletion of the well studied 
disease genes, PAX6 and WT1, but the cause(s) of the mental 
retardation remains to be identified. Other disease-related loci, 
such as those associated with loss of heterozygosity in breast 
and bladder cancers, also map to this region (Ref. 20 and 
references therein). We are presently isolating human Elonga­
tor with the aim to explore the molecular structure and func­
tion of Elongator in metazoans.
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The m olecular arch itectu re o f six-subunit yeast holo- 
Elongator com plex was investigated by the use o f im m u- 
n op recip itatio n , tw o-hybrid  in te rac tio n  m apping, and  
in  vitro  studies o f b in ary  in teraction s betw een in d iv id ­
u al subunits. S urprising ly, E lp2 is dispensable fo r the  
in te g rity  o f the holo-E longator com plex, and a p u rifie d  
five-subunit elp2A  E longator com plex re ta in s  h istone  
acetyltransferase a c tiv ity  in  vitro. These resu lts in d i­
cate th a t the W D40 repeats in  E lp2 are req u ired  n e ith e r 
fo r subunit-subunit in teractions w ith in  E lon g ato r n or 
fo r E longator in te rac tio n  w ith  histones d u rin g  catalysis. 
E lp2 and E lp4 w ere larg e ly  dispensable fo r th e associa­
tio n  o f E longator w ith  nascent R N A  tra n s crip t in  vivo. In  
contrast, E longator-R N A  in te rac tio n  requ ires th e E lp3  
p ro te in . Together, these d ata  shed lig h t on the struc- 
tu re-fu n ction  re la tion sh ip  o f th e E lon g ato r com plex.
The Elongator complex was first identified as a component of 
a hyperphosphorylated RNA polymerase II (RNAPII)1 holoen- 
zyme isolated from yeast chromatin (1). One of the subunits of 
Elongator, Elp3, contains domains conserved among histone 
acetyltransferases (HATs) (2), and Elongator has HAT activity 
directed against histone H3 and to a lesser extent H4 in vitro 
(3), raising the possibility that Elongator acetylates histones 
during RNAPII transcript elongation.
Elp3 HAT activity is essential for Elongator function in vivo 
as point mutations that abolish the catalytic function of Elp3 in 
vitro also confer the full range of elp phenotypes (4). elp phe­
notypes include temperature sensitivity at 39 °C, salt sensitiv­
ity, and slow adaptation to growth on carbon sources such as 
galactose (1, 5). elp cells are also sensitive to caffeine, Cal- 
cofluor White, and 6-azauracil (6, 7). Significantly, in all cases 
tested, elp phenotypes correlate with a failure of the m utant 
cells to activate, in a timely manner, the genes required for 
growth under the new conditions (1).
An elp deletion in combination with the deletion of different 
genes encoding transcription factors confers synthetic pheno­
types. Thus, elp3 in combination with rpb9 (encoding an RNA-
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J. Q. S.). The costs of publication of this article were defrayed in part by 
the payment of page charges. This article must therefore be hereby
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3801; E-mail: j.svejstrup@cancer.org.uk.
1 The abbreviations used are: RNAPII, RNA polymerase II; HAT, 
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PII subunit) is lethal (8), as is the combination of an elp3 and 
ctk l mutation (CTK1 encodes a subunit of the CTD kinase, 
CTDK1) (9). Cells expressing a conditional allele of SPT16 
(encoding the largest subunit of yeast FACT-CP complex) also 
display a synthetic phenotype in combination with elp3 m uta­
tion (10). Recent data have shown th a t Elongator also geneti­
cally interacts w ith Mediator, Rad6 ubiquitin ligase, P afl com­
plex, and Rpd3-Sin3 complex.2 Finally, combining the mutation 
of elp3 with gcn5 (encoding the catalytic subunit of the SAGA- 
ADA HAT complexes) confers severe growth defects, which are 
not seen in either of the single m utants (4). Significantly, the 
gcn5 elp3 double m utan t has reduced levels of histone H3 
acetylation in several genes compared w ith the single m utants, 
and low levels of acetylation in the coding region of these genes 
correlates with reductions in gene transcription. By contrast, 
low levels of acetylation in the promoter of genes does not 
correlate with reduced transcription nor with reduced pro­
moter occupancy by the TATA-binding protein (11). Recent 
experiments using RNA-immunoprecipitation have shown that 
Elongator is indeed present in the coding region of active genes 
in vivo (12).
The Elongator complex was first thought to consist of three 
subunits, named E lp l, Elp2, and Elp3 (now called core Elon­
gator) (1), but la ter purification of the complex from a yeast 
strain  expressing epitope-tagged E lp l has shown th a t the ac­
tive complex, holo-Elongator, consists of six subunits (E lp l-  
Elp6) (13-15), which are organized in two three-subunit sub­
complexes (13, 15). Significantly, deletion of any one of the 
{ELP) genes encoding these six subunits confers more or less 
identical phenotypes, and new phenotypes are not detected 
upon concomitant deletion of two or three ELP  genes (5, 13). 
These data suggest a tight functional connection between the 
proteins comprising the Elongator complex. Consistent with 
this idea, holo-Elongator, but not core Elongator, has HAT 
activity even though both complexes contain the catalytic Elp3 
subunit (13).
Here we investigate the molecular architecture of Elongator 
complex and show th a t the only ELP  gene th a t can be deleted 
without significant loss of Elongator integrity is ELP2. Surpris­
ingly, an Elongator complex lacking Elp2 even retains the 
ability to acetylate histones in vitro. We also show tha t the 
association of Elongator w ith nascent RNA in vivo requires 
Elp3 but not Elp2 or Elp4.
EXPERIMENTAL PROCEDURES
Yeast S trains and Phenotypic A nalysis—All Saccharomyces cerevi­
siae stains used for genetic analysis (Table I) were congenic with strain 
W303 and were grown and manipulated as described previously (1, 4).
2 S. E. Kong, M. S. Kobor, N. J. Krogan, J. F. Greenblatt, and J. Q. 
Svejstrup, unpublished results.
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T a b le  I 
Yeast strains
Strain Genotype Reference/source
W303-1B MATa Thomas and Rothstein (23)
JSY 100 MATa elplA :LE U 2 Otero et al. (1)
JSY 118 MATa elp2A:LEU2 This study
JSY130 MATa elP3A:LEU2 Wittschieben et al. (2)
JSY672 MATa elp4A:ADE2 Winkler et al. (13)
JSY784 MATa elP5A:JKAN Winkler et al. (13)
JSY786 MATa elp6A:HIS3 Winkler et al. (13)
JSY489 MATa ELPl(H is 10-HA)::TRP1 Winkler et al. (13)
JSY666 MATa ELP4(His10-HA)"TRPl This study
JSY662 MATa elp2A:LEU2 E L Pl(H isI0-HA)::TRPl This study
JSY964 MATa elp3A:JLEU2 ELPHHis10-HA)::TRPl This study
JSY965 MATa elp4A:ADE2 E LPl(H is10-HA)::TRPl This study
JSY973 MATa elp5A: JCAN ELP4(Hisw-HA)::TRPl This study
JSY974 MATa elp6A :m S 3  ELP4(Hisw-HA):-.TRPl This study
JSY754 MATa ELP1 {MYCia)::HIS3 This study
JSY969 MATa elP3A:LEU2 ELP1 (MYCls)::HIS3 This study
JSY777 MATaELP3(MYC I8)\HIS3 Gilbert et al. (12)
JSY968 MATa elp2A:LEU2 ELP3(MYCia)::HIS3 This study
JSY975 MATa elp4A: ADE2 ELP3(MYCls)::HIS3 This study
Expression of Tagged Proteins in Vivo—For the construction of the 
Elp4-HisHA strain, part of the ELP4 open reading frame was amplified 
using primers 5'-GCCGGGGTACCGGGGCTGCCGCTGGGAAACTCT- 
G-3' and 5'-CCGGCCGGATCCATAGTCTAAAGATATCTTGGTCT-3' 
and cloned into pSE.HISHA-304 (16) using the Kpnl and BamHI sites 
to produce plasmid pELP4-HISHA-304. After yeast transformation, a 
TRP+ clone was isolated in which the 3'-end of the ELP4 gene was 
replaced, resulting in expression of an Elp4-(His)10-HA fusion protein. 
To ensure that the (His)10-HA epitope tag did not interfere with Elp4 
function, phenotypic analysis was performed.
Protein Purification—The procedure for purification of Elongator 
from the elp2A Elpl-HISHA  strain has been described elsewhere (12).
Yeast Whole Cell Extract Preparation and Western Blot Analysis— 
Whole cell extracts were prepared as was described elsewhere (17) from 
the indicated strains. The antibody against a-tubulin was a mouse 
monoclonal from Oncogene and was used in a final dilution of 1/100 for 
immunoblotting. The antibodies against Elpl, 2,3,4,5,  and 6 were used 
as described previously (1, 2, 5, 13).
RNA Preparation—For the detection of ELP3 mRNA, total RNA was 
isolated from an equal number of S. cerevisiae cells from the indicated 
strains using the RNAeasy mini kit (Qiagen) according to the manufac­
turer’s recommendations. The probe was a PCR product from the coding 
region of the ELP3 gene. For labeling, Ready-to-Go DNA labeling beads 
from Amersham Biosciences were used according to the manufacturer’s 
recommendations. Hybridization of the membrane with the probe was 
performed using the ExpressHyb kit from Clontech. For the detection of 
28 and 18 S RNA, the gel was stained with EtBr in a final dilution of 
1/10,000 in water.
Co-immunoprecipitation Experiments—For Holo-Elongator co-im- 
munoprecipitation experiments, proteins from the first Bio-Rex chro­
matography step were used (13). 500 pg  of protein adjusted to 500 mM 
salt in buffer A (12) was incubated with Sepharose A beads, which had 
been previously conjugated with 12CA5 antibody. The beads were 
washed three times with the same buffer and resuspended in l x  SDS 
loading buffer, and the bound proteins were subjected to SDS-PAGE.
Two-hybrid Interactions—The coding sequence of all of the genes 
encoding the Elongator proteins were cloned in both “GAL4-activation 
domain*- and “GAL4-binding domain”-based vectors provided from the 
GAL4 two-hybrid phagemid vector kit (Stratagene). To detect interac­
tions, the plasmids were introduced in genetically modified yeast cells 
provided from the Matchmaker Library Construction & Screening Kit 
(Clontech). The interaction studies were done according to the manu­
facturer’s recommendations.
Expression of Recombinant GST and GST-Elp5 in Bacteria—To gen­
erate a GST-Elp5 fusion protein, the open reading frame of the ELP5 
gene was cloned in the pGEX-3X vector (Amersham Biosciences), and 
the plasmid was introduced in BL21 DE3 competent bacteria. Cells 
were grown at 37 °C and induced with 1 mM isopropyl- 1-thio-/3-D-galac- 
topyranoside for 3 h. After cell resuspension in phosphate-buffered 
saline, the cell suspension was incubated for 30 min on ice with ly- 
sozyme (50 mg/ml) and then subjected to sonication. The extract was 
incubated for 1 h at 4 °C with Triton X-100 in a final concentration of 
1%, and the soluble supernatant was collected after a 10-min 12,000 
rpm spin at 4 °C. This soluble supernatant contained GST-Elp5, which
was purified and immobilized on glutathione beads (Amersham Bio­
sciences) by incubation for 30 min at room temperature. The soluble 
GST control protein was produced in the same way.
In Vitro Transcribed I T ranslated Proteins—The recombinant Elp4 
and Elp6 proteins used for the in vitro  pull-down experiments were 
produced using the TnT T7-coupled wheat germ extract systems (Pro- 
mega) according to the manufacturer’s recommendations. The DNA 
template used was pBluescript II KS (±), into which the coding se­
quence of the two genes was cloned. Details are available on request.
In Vitro Pull-down Experim ents—Immobilized baculovirus-ex- 
pressed histidine-tagged Elpl or Elp2 and bacterially expressed GST or 
GST-Elp5 proteins were mixed with the product of in vitro transcrip­
tion/translation (Elp4 or Elp6) reactions in a buffer containing 250 mM 
potassium acetate, 100 mM Hepes-KOH, pH 7.6, 20% glycerol, 0.1% 
Nonidet P-40, l x  proteinase inhibitors, and 4 mM /3-mercaptoethanol 
and incubated overnight. The beads were washed three times before the 
bound proteins were separated by PAGE on a 10% SDS gel. The Elp4 
and Elp6 proteins showed weak nonspecific binding to nickel-agarose. 
Therefore, these beads were washed three times with the above buffer 
but containing 30 mM imidazole.
Other Assays—Histone acetyltransferase reactions (15 pi) were car­
ried out as described (3). RNA immunoprecipitation experiments were 
carried out as described by Gilbert et al. (12).
RESULTS
In a multisubunit protein complex, the stability of an indi­
vidual subunit can be dependent on the presence or integrity of 
the other subunits. We examined the am ount of individual 
Elongator subunits present in extracts derived from different 
elp deletion strains. Fig. 1A (top panels) shows the results of an 
analysis where whole cell extracts were immunoblotted and 
probed with anti-Elp3 antibodies. As a loading control, reactiv­
ity with an anti-tubulin antibody was used. Interestingly, the 
Elp3 protein either could not be detected or was present at very 
low levels in cells lacking the ELP1 gene. In cells lacking any of 
the other ELP  genes, the Elp3 levels were also somewhat 
reduced, but the protein was still detectable (Fig. 1A, top panel, 
compare the tubulin/Elp3 ratio in  wild type (WT) cells w ith tha t 
in the mutants). By contrast, Elp4, Elp5, and Elp6 were only 
absent from extracts derived from strains in which their en­
coding gene was deleted (Fig. 1A, middle and bottom panels). 
Importantly, Northern blot analysis of RNA from the same 
cells showed th a t the mRNA level of the ELP3 gene was com­
parable in wild type and all of the e/p A cells (Fig. LB) suggest­
ing tha t reduced protein stability ra the r than  gene expression 
was causing the effect. We conclude th a t deletion of the ELP1 
results in substantial destabilization of the Elp3 protein, sug­
gesting th a t the E lp l protein is required for the integrity of 
Elp3, in all likelihood because of a direct interaction between 
these proteins.
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Fig. 1. Stab ility  and expression  of E longator subunits. A , the
presence of Elp3 (top panels), Elp4 and Elp5 (middle panels), and Elp6 
(bottom panels) in yeast cells lacking the indicated E LP  genes was 
examined by Western blotting using anti-Elp3 antibodies. Detection of 
tubulin was used as a loading control. B, expression of the ELP3  gene 
in the indicated elp mutants was examined by Northern blotting. Note 
that the relevant Elp4 band in different cell types is the lower one. The 
reduced mobility of the Elp4 protein in the control lane with pure 
Elongator is due to Elp4 being tagged (HA-His).
Protein-Protein Interactions among Elongator Subunits—To 
investigate protein-protein interactions in the Elongator com­
plex, we next performed co-immunoprecipitation experiments 
in different elp deletion strains. For these experiments whole 
cell extracts were prepared from cells expressing a tagged 
version of an Elongator subunit while lacking another one, for 
example from elp2 cells expressing Elpl-HA. To enable high 
efficiency immunoprecipitation and to increase specificity, 
whole cell extracts were first subjected to chromatography on 
Bio-Rex before being loaded onto 12CA5-conjugated Sepharose 
A beads. As shown in Fig. 2A, Elongator could, under those 
conditions, be specifically immunoprecipitated from wild type 
cell extracts carrying either Elpl or Elp4 tagged with an HA 
epitope but not from control cells that did not express a tagged 
Elp protein. Remarkably, when the ELP2 gene was deleted, 
Elpl still interacted with the five remaining subunits, although 
the three smaller proteins Elp4, Elp5, and Elp6 appeared to be 
somewhat substoichiometric (Fig. 2B, left panel). This experi­
ment indicates that the Elp2 protein is not required for the 
integrity of the Elongator complex.
When extracts from cells lacking the ELP3 gene were used, 
only the Elpl protein was detected in the precipitates, which 
indicates that none of the remaining four subunits interact 
strongly with Elpl (Fig. 2B, m iddle panel). We conclude that 
the Elp3 protein is not only essential for catalytic function but 
also for the integrity of the Elongator complex.
In the absence of Elp4, the Elpl protein could still interact 
with Elp3 (Fig. 2B, right panel). However, in this case the Elp2, 
Elp5, and Elp6 proteins could not be detected even in the 
inputs. This can be explained in two ways: either those proteins 
no longer co-elute with Elpl and Elp3 from Bio-Rex if Elp4 is 
absent, or deletion of the ELP4 gene results in reduced Elp2, 
Elp5, and Elp6 protein levels. Our previous experiments
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Fig. 2. E longator su b u n it in te ra c tio n s  in v estig a ted  by co-im ­
m u n oprecip itation . Immunoprecipitation of a tagged subunit using 
12CA5 monoclonal antibodies and Western blotting with antibodies 
directed against the six Elongator subunits were used to investigate the 
integrity of the Elongator complex in different mutant strains. A, pre­
cipitations from wild type strains carrying either no tag, Elpl-HA, or 
Elp4-HA as indicated. B, Elp 1-precipitations from the indicated mutant 
strains. C, Elp4 precipitations from the indicated mutant strains.
showed that Elp5 and Elp6 protein levels were not decreased 
significantly in any of the elp  mutants (Fig. 1A), pointing to a 
lack of interaction with core Elongator as the likely explana­
tion. Unfortunately, the Elp2 protein could not be detected in 
this case in the Bio-Rex-70 eluate (and could generally not be 
detected in crude whole cell extracts with our polyclonal anti- 
Elp2 antibody), precluding any conclusions on the fate of this 
protein in elp4  extracts. We conclude that Elp4 is required for 
the association of Elp2 and the sm all Elp4/5/6 complex with 
Elpl and Elp3.
When extracts from elp5  cells expressing Elp4-HA protein 
were used, Elp4 only co-immunoprecipitated Elp6 and low 
amounts of Elp3 (Fig. 2C, left panel). This suggests that Elp4 
interacts directly with Elp6 and that neither of these two 
proteins interacts strongly with any of the three larger proteins 
Elpl, Elp2, and Elp3, although a weak Elp4/Elp6-Elp3 inter­
action was evident. The absence of a signal for E lpl, even in the 
input, again precluded firm conclusions on the fate of this 
protein in elp5  cells. However, it was obvious from the previous 
experiment with elp3A  cells that E lp l does not interact directly 
with Elp4 or Elp6 (Fig. 2B, m id d le  panel). In elp6  cells express­
ing Elp4-HA protein, Elp4 also only co-precipitated a small 
amount of Elp3 (Fig. 2C, righ t panel), supporting the notion 
that these proteins interact directly, albeit weakly. Elp4 did not 
interact with Elp5 in the absence of Elp6. As Elp5 is stable in 
elp6  cells (Fig. LA, m id d le  pan els), this indicates that it is 
incorporated into the small subcomplex in an Elp6-dependent 
manner.
We conclude from- the above experiments that there is a 
direct interaction between E lp l and Elp3, as well as between 
Elp4 and Elp6. Because a core-Elongator complex consisting of
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Fig. 3. B inary E longator subunit interaction s revealed  by two- 
hybrid interaction  or direct protein-protein  in teraction  m ap­
ping in  v itro . A , Elp4 and Elp6 interaction shown by two-hybrid 
interaction. Positive and negative controls were from the Clontech 
matchmaker kit. Please note that for the large number of negative 
interaction results we obtained, it was ensured that the relevant Elp- 
Gal fusion protein rescued the mutant phenotype of the corresponding 
elp strain, showing that the Elp protein in question was correctly folded 
and functional even in the presence of the Gal moiety. B, protein- 
protein interactions investigated with recombinant Elongator subunits. 
Upper left panel, Elpl does not directly interact with Elp4 and Elp6. 
Upper right panel, Elp2 does not directly interact with Elp4 and Elp6. 
Lower panels, Elp5 interacts directly with Elp6.
Elpl, Elp2, and Elp3 has previously been isolated (1), the 
absence Elp2 in Elp 1-precipitates from elp3 cells also indicate 
that interactions with Elp3 are required for the incorporation 
of Elp2 into core-Elongator. Surprisingly, the co-immunopre- 
cipitation experiments do not indicate any strong direct binary 
interactions between any individual protein in the Elp4/5/6 
module and any one of the proteins in core Elongator. This 
suggests that it is primarily novel interaction surfaces created 
by the association of Elpl, Elp2, and Elp3 in core-Elongator, 
and Elp4, Elp5, and Elp6 in the small subcomplex, respectively, 
that are important for the later association of these subassem­
blies into holo-Elongator.
Pairwise Elongator Protein Interactions—To compliment the 
co-immunoprecipitation studies, pairwise interactions between 
individual Elongator proteins were examined by use of the 
yeast two-hybrid system. The genes encoding all the Elongator 
subunits were cloned in-frame with the activation domain and 
the DNA-binding domains of the GAL4 activator, respectively, 
and tester yeast strains were transformed with combinations of 
these 12 plasmids. All possible combinations of pairwise Elon­
gator proteins interactions were tested in both directions, but, 
surprisingly, the only interaction detected was between Elp4 
and Elp6 (Fig. 3A, negative results not shown).
Finally, we sought to investigate the in vitro pairwise inter­
actions of several Elongator components (Fig. 3B). Purified 
recombinant His-tagged Elpl and His-tagged Elp2 proteins 
were obtained via expression in insect cells and recombinant 
GST-Elp5 via expression in bacteria, and Elp4 and Elp6 were
Fig. 4. M odel for th e  a rch itec tu re  o f  th e  y ea st holo-E longator  
com plex. Spheres delineate the two three-subunit subcomplexes. The 
thickness of lines between proteins, between protein subcomplexes, and 
between subcomplexes represents the strength of a particular interac­
tion based on the available evidence. See text for details.
transcribed/translated in vitro . Unfortunately, despite at­
tempts in several expression system s, we were unable to obtain 
soluble recombinant or in vitro  transcribed/translated Elp3 
protein. Examples of the results obtained are shown in Fig. 3B. 
Of all of the many combinations that were tested, only a direct 
interaction between Elp5 and Elp6 was detected.
Taken together, these results make it possible to propose a 
model to describe the molecular architecture of the Elongator 
complex (Fig. 4). In the large core-Elongator subcomplex, Elpl 
protein interacts with Elp3 but does not interact strongly with 
Elp2 in the absence of Elp3. This suggests a direct Elp2-Elp3 
interaction. On the other hand, the small subcomplex is formed 
based on direct interactions between Elp4 and Elp6 and be­
tween Elp6 and Elp5. Although not absolutely required, the 
Elp2 protein serves to somewhat stabilize the core Elongator- 
Elp4/5/6 interaction, whereas Elp3 is essential for the integrity 
of the complex. Furthermore, a weak interaction between Elp3 
and Elp4 was detected. Based on these results we suggest that, 
rather than relying solely on strong binary interactions be­
tween individual subunits of the respective subcomplexes, the 
formation of the small subcomplex creates new interaction 
surfaces to enable contacts with Elp3 and Elp2, as well as with 
novel interaction surfaces created by the association of Elpl, 
Elp2, and Elp3 into core-Elongator (Fig. 4).
The WD40 R epeat Protein, E lp2, Is D ispensable for the in 
Vitro H A T A ctiv ity  o f  E longator—The data presented above 
revealed that although an elp2  strain displayed the typical 
Elongator phenotypes (5), the remaining five subunits still 
exist as a complex in these cells. To investigate whether the 
five-subunit e/p2A complex also retained Elongator activity, we 
purified the “mutant” complex and tested its in vitro  HAT 
activity. This was particularly relevant, because several HAT 
and histone deacetylase complexes harbor subunits, which, like 
Elp2, contain WD40 repeats. It has thus been suggested that 
WD40 repeats might be involved in contacting histones to 
facilitate the acetyltransferase and deacetylation reactions, re­
spectively (18, 19). The purification scheme employed was iden­
tical to that used previously for the purification of a six-subunit 
Elongator complex from cells carrying a double affinity-tagged 
Elpl protein (13). As indicated by Fig. 5A, a purified elp2A  
Elongator complex from two independent purifications re­
tained the five other subunits, although the three smaller 
subunits as well as the Elp3 protein appeared to be somewhat 
substoichiometric compared with the wild type complex. To be 
able to compare the HAT activity of the elp2A  complex with 
that purified from wild type cells, we therefore used similar 
amounts of the catalytic Elp3 subunit in the HAT reactions, 
with the consequence that other subunits, particularly Elpl, 
were present in larger amounts in the reactions containing the 
mutant five-subunit complex. Fig. 5B shows the result of HAT 
assays comparing wild type and the two independently purified 
mutant complexes. Surprisingly, Elongator retained in vitro  
HAT activity directed against H3 even in the absence of Elp2. 
Adding recombinant, His-tagged Elp2 to the reactions did not
Core-Elongator
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Fig. 5. F ive-subunit e lp 2  E longator com plex reta ins HAT ac­
tiv ity  in  v itro . A, two independently purified elp2 Elongator complexes 
and their subunit stoichiometry compared with wild type (WT). The 
Elp2 subunit is present only in wild type, but this Western blot is not 
shown. B, HAT activity of wild type and mutant Elongator complex with 
or without the addition of Elp2 as indicated. Please note that the 
activity of Elongator in HAT assays differs significantly from prepara­
tion to preparation and with freeze-thawing. It is therefore not possible 
to make a definitive judgment on the possible minor quantitative dif­
ferences in activity, if any, between wild type and mutant Elongator.
dramatically affect the activity (the apparent stimulation of 
wild type complex (Fig. 5B, lanes 1 and 2) was because of 
loading differences). These data demonstrate that the WD40 
repeat protein Elp2 is not required for Elongator HAT activity 
in vitro.
Elp3, but N ot Elp2 or Elp4, Is Required for RNA B inding in 
Vivo—We have recently shown that the Elongator complex 
binds to RNA in vitro  and that it is in close vicinity of nascent 
pre-mRNA in vivo (12). These results indicate that Elongator is 
associated with active genes in living cells. To investigate the 
subunit requirements for RNA association in vivo, we com­
pared Elongator RNA-immunoprecipitation in wild type, elp2, 
and elp4 cells expressing myc-tagged Elp3 (Fig. 6A). As shown 
previously (12), efficient cross-linking of Elp3 protein to GAL1 
mRNA was observed in wild type cells (Fig. 6A, compare Elp3- 
myc with no tag). Interestingly, although the levels were some­
what reduced, RNA interaction was also observed in cells lack­
ing Elp2 (a component of core Elongator) and Elp4 (a core 
component of the small Elongator subcomplex). This indicates 
that neither the small subcomplex, nor Elp2 play crucial roles 
in the association of Elongator (Elp3) with transcripts in vivo. 
Because Elp3 levels are dramatically reduced in cells lacking 
Elpl, we could not investigate whether Elpl is required for 
Elongator-RNA interaction. However, by tagging Elpl rather 
than Elp3, the importance of the Elp3 protein for Elongator- 
RNA interaction could be investigated (Fig. 6B). Remarkably, 
Elongator-RNA interaction was ~5-fold reduced in the absence 
of Elp3, and this dramatic decrease was not because of changes 
in the expression level of the Elpl protein (Fig. 6B, bottom  
panel). Taken together, these data indicate that the Elp3 pro­
tein plays a crucial role for the association of Elongator with 
active genes.
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Fig. 6. Elp3, bu t n ot E lp2 and  Elp4, is  req u ired  for E longator- 
RNA a sso cia tio n  in  v iv o . RNA-immunoprecipitation experiments in 
strains expressing myc-tagged Elongator subunits. GAL1 mRNA was 
quantitated using reverse transcriptase real time PCR. Bars represent 
the average of two independent experiments. E rro r bars indicate vari­
ance. A, RNA-immunoprecipitation experiments with the indicated 
strains expressing Elp3-myc or the untagged control. B, RNA-immuno­
precipitation experiments with the indicated strains expressing Elpl- 
myc or the untagged control. Bottom panel shows the result of an 
Elpl-myc Western blot with loading control (Ponceau S-stained mem­
brane section) to demonstrate that E lp l is stable in elp3 cells. The 
resolution of Elpl into two distinct bands has previously been 
described (22).
DISCUSSION
The results presented here represent the first comprehensive 
investigation of the structure-function relationship of Elonga­
tor, a histone acetyltransferase complex with a role in RNAPII 
transcription. Our results reveal the detailed molecular archi­
tecture of the complex and suggest roles, or unexpected lack of 
roles, for individual subunits.
Previous work (13—15) showed that holo-Elongator is com­
posed of two weakly associated subcomplexes. Subsequent
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work by Schaffrath and co-workers (20, 21) using immunopre­
cipitation of tagged Elongator subunits and detection of a co­
precipitated differently tagged subunit gave some information 
about subunit requirements for Elongator stability. Although 
the present work confirms and significantly extends the con­
clusions derived from these studies, there are also surprising 
contradictions. For example, Frohloff et al. (21) detected the 
Elp3 protein in cells lacking ELP1, whereas our results indi­
cate that normal Elp3 stability in vivo requires ELP1 (Fig. 1). 
Likewise, these authors concluded that the structural integrity 
of the small Elp4/5/6 subcomplex requires the ELP4, ELP5, and 
ELP6 genes, whereas our work shows that Elp4 can interact 
with Elp6 in the absence of ELPS (Fig. 2C). The reasons for 
these differences are presently unclear.
One of the theses for the architecture of the Elongator com­
plex before starting our studies was that the WD40 repeat- 
containing Elp2 protein would turn out to either be essential 
for the integrity of the Elongator complex, or be required for its 
HAT activity. WD40 repeats are protein-protein interaction 
domains, and WD40-repeat proteins have been identified in 
other histone modifying/interacting proteins (18, 19). Surpris­
ingly, Elp2 turned out to be dispensable for both; a five-subunit 
e/p2A Elongator complex can be isolated, and this complex 
retains the ability to acetylate histones (Fig. 5). Elongator 
complex is also capable of binding RNA in the absence of ELP2 
(Fig. 6). Data from Schaffrath and co-workers (20) suggests 
that the role of Elp2 might be to allow interactions with other 
proteins, such as Ktil2/Tot4. The Elongator-interacting pro­
tein, Ktil2/Tot4 has been proposed to bridge interactions be­
tween RNAPII and Elongator. For example, the protein was 
shown to co-immunoprecipitate promoter DNA (chromatin im­
munoprecipitation) from the ADH1 gene and to also be able to 
co-immunoprecipitate hyperphosphorylated RNAPII (20, 21). 
These authors also reported co-immunoprecipitation of hyper­
phosphorylated RNAPII with Elongator from the DNA-free 
soluble fraction of a yeast whole cell extract (21). For unknown 
reasons, we have so far not been able to reproduce these co- 
immunoprecipitation results, although we can detect Elonga- 
tor-Ktil2 interaction.3 We therefore presently favor the idea 
that besides the hyperphosphorylated C-terminal domain, 
RNA in the ternary complex might play an important stabiliz­
ing role for the Elongator-RNAPII interaction (12).
In contrast to the Elp2 protein, the Elp3 subunit appears to
* T. G. Petrakis and J. Q. Svejstrup, unpublished data.
play a crucial role for all Elongator functions. I t is the catalytic 
subunit (2), it is crucial for the integrity of the holo-Elongator 
complex (Fig. 2), and it is essential for RNA binding (Fig. 6). In 
light of the fact th a t Elp3, but not the other subunits, is con­
served from Archaea to m an (2), this is perhaps not surprising. 
It thus seems reasonable to expect th a t the fundamental func­
tions of the Elongator complex be supplied by the abilities 
intrinsic to Elp3 with the other subunits playing primarily 
function/augmentative or regulatory roles.
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